FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Sedda, L
   Taylor, BM
   Eiras, AE
   Marques, JT
   Dillon, R
AF Sedda, Luigi
   Taylor, Benjamin M.
   Eiras, Alvaro E.
   Marques, Joao Trindade
   Dillon, Rod J.
TI Using the intrinsic growth rate of the mosquito population improves
   spatiotemporal dengue risk estimation
SO ACTA TROPICA
LA English
DT Article
DE Moran curve; Ricker model; Density dependent and independent
   mortalities; Log-Gaussian cox process; Dengue; Aedes aegypti
ID ALBOPICTUS DIPTERA-CULICIDAE; AEDES-AEGYPTI; MATHEMATICAL-MODELS;
   DENSITY-DEPENDENCE; TIME-SERIES; DYNAMICS; DISEASE; SURVEILLANCE;
   TEMPERATURE; ABUNDANCE
AB Understanding geographic population dynamics of mosquitoes is an essential requirement for estimating the risk of mosquito-borne disease transmission and geographically targeted interventions. However, the use of population dynamics measures, such as the intrinsic growth rate, as predictors in spatio-temporal point processes has not been investigated before. In this work we compared the predictive accuracy of four spatio-temporal log-Gaussian Cox models: (i) With no predictors; (ii) mosquito abundance as predictor; (iii) intrinsic growth rate as predictor; (iv) intrinsic growth rate and mosquito abundance as predictors. This analysis is based on Aedes aegypti mosquito surveillance and human dengue data obtained from the urban area of Caratinga, Brazil. We used a statistical Moran Curve approach to estimate the intrinsic growth rate and a zero inflated Poisson kriging model for estimating mosquito abundance at locations of dengue cases. The incidence of dengue cases was positively associated with mosquito intrinsic growth rate and this model outperformed, in terms of predictive accuracy, the abundance and the null models. The latter includes only the spatio-temporal random effect but no predictors. In the light of these results we suggest that the intrinsic growth rate should be investigated further as a potential tool for predicting the risk of dengue transmission and targeting health interventions for vector-borne diseases.
C1 [Sedda, Luigi] Univ Lancaster, Lancaster Med Sch, Furness Bldg, Lancaster LA1 4YG, England.
   [Taylor, Benjamin M.] Univ Lancaster, Ctr Hlth Informat Comp & Stat CHICAS, Lancaster Med Sch, Furness Bldg, Lancaster LA1 4YG, England.
   [Eiras, Alvaro E.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Marques, Joao Trindade] Univ Strasbourg, Inst Biol Mol & Cellulaire, Inserm U1257, CNRS,UPR9022, F-67084 Strasbourg, France.
   [Dillon, Rod J.] Univ Lancaster, Biomed & Life Sci, Furness Bldg, Lancaster LA1 4YG, England.
RP Sedda, L (corresponding author), Univ Lancaster, Lancaster Med Sch, Furness Bldg, Lancaster LA1 4YG, England.
EM l.sedda@lancaster.ac.uk
RI Sedda, Luigi/ABD-8784-2020; Trindade Marques, Joao/F-7683-2012
OI Dillon, Rod/0000-0002-3551-0030; Trindade Marques,
   Joao/0000-0002-3457-3320; Sedda, Luigi/0000-0002-9271-6596
FU Wellcome TrustWellcome Trust [212501/Z/18/Z]; Biotechnology and
   Biological Sciences Research CouncilBiotechnology and Biological
   Sciences Research Council (BBSRC) [BB/R005362/1]; National Council for
   Scientific and Technological DevelopmentNational Council for Scientific
   and Technological Development (CNPq) [312335/2018-0];
   CAPES/MEC-CNPq/MCTI-Decit/SCTIE/MS [440358/2016-7]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas Gerais State Research
   Foundation (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior, Brasil (CAPES) [001]
FX LS thank Prof David Rogers at University of Oxford for his inspirational
   guidance. This work was supported by the Wellcome Trust Seed
   Award(212501/Z/18/Z). LS and RD are also supported by the Biotechnology
   and Biological Sciences Research Council (BB/R005362/1), AEE by the
   National Council for Scientific and Technological Development
   (312335/2018-0) and CAPES/MEC-CNPq/MCTI-Decit/SCTIE/MS (440358/2016-7);
   and JM by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG) and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior, Brasil (CAPES), Finance Code 001.
CR Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822
   Allen JC, 2001, CHAOS SOLITON FRACT, V12, P333, DOI 10.1016/S0960-0779(00)00092-8
   Alto BW, 2012, MED VET ENTOMOL, V26, P396, DOI 10.1111/j.1365-2915.2012.01010.x
   Armbruster P.A., 2016, PHOTOPERIODIC DIAPAU, V53
   Attaway DF, 2017, J INFECT PUBLIC HEAL, V10, P120, DOI 10.1016/j.jiph.2016.09.008
   Berryman AA, 1999, PRINCIPLES POPULATIO
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Chambers JM, 2008, STAT COMPUT SER, P1
   Chaves LF, 2015, B ENTOMOL RES, V105, P589, DOI 10.1017/S0007485315000474
   Chaves LF, 2018, J MED ENTOMOL, V55, P329, DOI 10.1093/jme/tjx200
   Chen YR, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1108-5
   Chuang TW, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030396
   Cianci D, 2015, J MED ENTOMOL, V52, P329, DOI 10.1093/jme/tjv026
   Cortes F, 2018, ACTA TROP, V182, P190, DOI 10.1016/j.actatropica.2018.03.006
   Cromwell EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005429
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   Reyes-Solis GD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003177
   DERRICK E. H., 1958, AUSTRALASIAN ANN MED, V7, P102
   Desenclos JC, 2011, MED MALADIES INFECT, V41, P588, DOI 10.1016/j.medmal.2011.07.016
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a
   Ehrlen J, 2015, ECOL LETT, V18, P303, DOI 10.1111/ele.12410
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   Elderd B., 2017, ECOL INVERTEBRATE DI, P441
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Farinelli EC, 2018, ACTA TROP, V180, P47, DOI 10.1016/j.actatropica.2018.01.005
   Favaro EA, 2006, J VECTOR ECOL, V31, P285, DOI 10.3376/1081-1710(2006)31[285:PSOASA]2.0.CO;2
   Ferreira G, 2017, PROC IEEE ACM INT C, P100, DOI 10.1109/ICSE-C.2017.156
   GALUN R, 1961, J INSECT PHYSIOL, V7, P161, DOI 10.1016/0022-1910(61)90069-5
   Gelman A, 2014, STAT COMPUT, V24, P997, DOI 10.1007/s11222-013-9416-2
   Gerber LR, 2005, ECOL APPL, V15, P1402, DOI 10.1890/04-0880
   Hancock PA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0319-5
   HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0
   Hastie T.J., 2017, STAT MODELS S
   Herrando-Perez S, 2012, OECOLOGIA, V170, P585, DOI 10.1007/s00442-012-2347-3
   Hoshi T, 2017, CAN ENTOMOL, V149, P338, DOI 10.4039/tce.2016.64
   Hoshi T, 2014, ANN ENTOMOL SOC AM, V107, P136, DOI 10.1603/AN13071
   Jian Y., 2014, PLOS ONE, V9
   Jian Y, 2014, ECOL MODEL, V272, P301, DOI 10.1016/j.ecolmodel.2013.10.019
   Kraemer MUG, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-018-0144-x
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547
   Lana RM, 2014, ACTA TROP, V129, P25, DOI 10.1016/j.actatropica.2013.07.025
   Lega J, 2017, J MED ENTOMOL, V54, P1375, DOI 10.1093/jme/tjx077
   Legros M, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1515
   Li QX, 2018, ACTA TROP, V183, P8, DOI 10.1016/j.actatropica.2018.03.026
   Li RY, 2019, P NATL ACAD SCI USA, V116, P3624, DOI 10.1073/pnas.1806094116
   Lippi CA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040827
   Padmanabha H, 2012, J INSECT PHYSIOL, V58, P1597, DOI 10.1016/j.jinsphys.2012.09.015
   Parham PE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-271
   Pepin KM, 2013, EMERG INFECT DIS, V19, P542, DOI 10.3201/eid1904.120117
   Parra MCP, 2018, ACTA TROP, V182, P43, DOI 10.1016/j.actatropica.2018.02.018
   Perkins TA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P99, DOI 10.1079/9781845939649.0099
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Riley S, 2015, EPIDEMICS-NETH, V10, P68, DOI 10.1016/j.epidem.2014.07.001
   Robert MA, 2014, EVOL APPL, V7, P1238, DOI 10.1111/eva.12219
   Robert MA, 2012, J MED ENTOMOL, V49, P1177, DOI 10.1603/ME11205
   ROBERTS MW, 2010, COLD SPRING HARB PRO, V2010, DOI DOI 10.1155/2010/868492
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   ROGERS D, 1979, J ANIM ECOL, V48, P825, DOI 10.2307/4197
   Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x
   Ruiz-Moreno D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1348-y
   Sanna M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19168-6
   SARFRAZ MS, 2014, GEOSPAT HLTH, V8, pS68
   Sarfraz MS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-853
   Schwab SR, 2018, EPIDEMICS-NETH, V23, P55, DOI 10.1016/j.epidem.2017.12.004
   Sedda L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2662-6
   Sedda L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096002
   Slavov SN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213793
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Tatem A.J., 2017, SCI DATA, V4
   Taylor B.M., 2019, LGCPGPU INFERENCE AG
   Taylor BM, 2018, J R STAT SOC A STAT, V181, P1125, DOI 10.1111/rssa.12347
   Tonnang HEZ, 2017, ECOL MODEL, V354, P88, DOI 10.1016/j.ecolmodel.2017.03.015
   Trajer A, 2017, APPL ECOL ENV RES, V15, P275, DOI 10.15666/aeer/1501_275298
   Turchin P, 2003, COMPLEX POPULATION D
   Vargas WP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2097-3
   Varley G.C., 1973, INSECT POPULATION EC
   VARLEY GC, 1960, J ANIM ECOL, V29, P399, DOI 10.2307/2213
   Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4
   Vincenti-Gonzalez MF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24003-z
   Walker DD, 1997, MATH GEOL, V29, P1011, DOI 10.1023/A:1022309619605
   Wang X, 2016, J THEOR BIOL, V411, P27, DOI 10.1016/j.jtbi.2016.09.015
   Weetman D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020220
   Wen TH, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0131-2
   Wen TH, 2015, APPL GEOGR, V62, P256, DOI 10.1016/j.apgeog.2015.05.003
   Whiten SR, 2016, J MED ENTOMOL, V53, P139, DOI 10.1093/jme/tjv159
   WHO, 2012, GLOB STRAT DENG PREV
   WHO, 2014, GLOB BRIEF VECT BORN
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08
NR 95
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD AUG
PY 2020
VL 208
AR 105519
DI 10.1016/j.actatropica.2020.105519
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LY8XY
UT WOS:000540814000010
PM 32389450
OA Green Published, Other Gold
DA 2020-12-16
ER

PT J
AU Aguiar, ERGR
   de Almeida, JPP
   Queiroz, LR
   Oliveira, LS
   Olmo, RP
   de Faria, IJD
   Imler, JL
   Gruber, A
   Matthews, BJ
   Marques, JT
AF Guimaraes Rocha Aguiar, Eric Roberto
   Pereira de Almeida, Joao Paulo
   Queiroz, Lucio Rezende
   Oliveira, Liliane Santana
   Olmo, Roenick Proveti
   da Silva de Faria, Isaque Joao
   Imler, Jean-Luc
   Gruber, Arthur
   Matthews, Benjamin J.
   Marques, Joao Trindade
TI A single unidirectional piRNA cluster similar to the flamenco locus is
   the major source of EVE-derived transcription and small RNAs in Aedes
   aegypti mosquitoes
SO RNA
LA English
DT Article
DE endogenous viral elements; EVE; A. aegypti; flamenco locus; RNA
   interference; piRNAs
ID TRANSPOSABLE ELEMENTS; SEQUENCE; VIRUSES; EVOLUTION; RETROTRANSPOSITION;
   BIOGENESIS; DIVERSITY; ALIGNMENT; GENOME
AB Endogenous viral elements (EVEs) are found in many eukaryotic genomes. Despite considerable knowledge about genomic elements such as transposons (TEs) and retroviruses, we still lack information about nonretroviral EVEs. Aedes aegypti mosquitoes have a highly repetitive genome that is covered with EVEs. Here, we identified 129 nonretroviral EVEs in the AaegL5 version of the A. aegypti genome. These EVEs were significantly associated with TEs and preferentially located in repeat-rich clusters within intergenic regions. Genome-wide transcriptome analysis showed that most EVEs generated transcripts although only around 1.4% were sense RNAs. The majority of EVE transcription was antisense and correlated with the generation of EVE-derived small RNAs. A single genomic cluster of EVEs located in a 143 kb repetitive region in chromosome 2 contributed with 42% of antisense transcription and 45% of small RNAs derived from viral elements. This region was enriched for TE-EVE hybrids organized in the same coding strand. These generated a single long antisense transcript that correlated with the generation of phased primary PIWI-interacting RNAs (piRNAs). The putative promoter of this region had a conserved binding site for the transcription factor Cubitus interruptus, a key regulator of the flamenco locus in Drosophila melanogaster. Here, we have identified a single unidirectional piRNA cluster in the A. aegypti genome that is the major source of EVE transcription fueling the generation of antisense small RNAs in mosquitoes. We propose that this region is a flamenco-like locus in A. aegypti due to its relatedness to the major unidirectional piRNA cluster in Drosophila melanogaster.
C1 [Guimaraes Rocha Aguiar, Eric Roberto; Pereira de Almeida, Joao Paulo; Queiroz, Lucio Rezende; Olmo, Roenick Proveti; da Silva de Faria, Isaque Joao; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Guimaraes Rocha Aguiar, Eric Roberto] Univ Fed Bahia, Inst Ciencias Saude, BR-40101909 Salvador, BA, Brazil.
   [Oliveira, Liliane Santana; Gruber, Arthur] Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, BR-05508000 Sao Paulo, SP, Brazil.
   [Olmo, Roenick Proveti; Imler, Jean-Luc; Marques, Joao Trindade] Univ Strasbourg, INSERM, CNRS, UPR9022,U1257, F-67084 Strasbourg, France.
   [Matthews, Benjamin J.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.; Marques, JT (corresponding author), Univ Strasbourg, INSERM, CNRS, UPR9022,U1257, F-67084 Strasbourg, France.
EM jtm@ufmg.br
RI Kashiwabara, Liliane/AAS-3433-2020; Aguiar, Eric/T-5076-2019; Trindade
   Marques, Joao/F-7683-2012
OI Kashiwabara, Liliane/0000-0002-1538-8541; Aguiar,
   Eric/0000-0002-8143-5756; Almeida, Joao Paulo Pereira
   de/0000-0001-7532-8420; Queiroz, Lucio/0000-0002-6090-1834; Trindade
   Marques, Joao/0000-0002-3457-3320; Faria, Isaque/0000-0002-8810-8133
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Instituto
   Nacional de Ciencia e Tecnologia de Vacinas (INCTV); Investissement
   d'Avenir ProgramsFrench National Research Agency (ANR)
   [ANR-10-LABX-0036, ANR-11-EQPX-0022]; Google Latin American Research
   Award; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior,
   Brasil (CAPES) [001]; CAPESCAPES
FX We thank members of the Marques and Imler laboratories for discussion
   and the IGBMC core facility in Strasbourg for sequencing services. We
   also thank anonymous reviewers whose criticisms have contributed to this
   manuscript. This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) to E.R.G.R.A. and
   J.T.M.; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG) and Instituto Nacional de Ciencia e Tecnologia de Vacinas
   (INCTV) to J.T.M.; the Investissement d'Avenir Programs
   (ANR-10-LABX-0036 and ANR-11-EQPX-0022) to J.T.M. and J.L.I.; and Google
   Latin American Research Award (LARA 2019) to J.T.M. and J.P.P.A. This
   study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior, Brasil (CAPES), Finance Code 001. E.R.G.R.A.,
   L.S.O., R.P.O., I.J.S.F., L.R.Q., and J.P.P.A. were supported with
   fellowships from CAPES.
CR Aiewsakun P, 2015, VIROLOGY, V479, P26, DOI 10.1016/j.virol.2015.02.011
   Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238
   Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109
   Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223
   Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199
   Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226
   Fujino K, 2014, P NATL ACAD SCI USA, V111, P13175, DOI 10.1073/pnas.1407046111
   Gainetdinov I, 2018, MOL CELL, V71, P775, DOI 10.1016/j.molcel.2018.08.007
   Geuking MB, 2009, SCIENCE, V323, P393, DOI 10.1126/science.1167375
   Girardi E, 2017, NUCLEIC ACIDS RES, V45, P4881, DOI 10.1093/nar/gkw1368
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goriaux C, 2014, EMBO REP, V15, P411, DOI 10.1002/embr.201337898
   Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064
   Grob S, 2014, MOL CELL, V55, P678, DOI 10.1016/j.molcel.2014.07.009
   Grybchuk D, 2018, P NATL ACAD SCI USA, V115, pE506, DOI 10.1073/pnas.1717806115
   Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264
   Honda Tomoyuki, 2016, Mob Genet Elements, V6, pe1165785, DOI 10.1080/2159256X.2016.1165785
   Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695
   Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030
   Juneja P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002652
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704
   Kryukov K, 2019, VIRUS RES, V262, P30, DOI 10.1016/j.virusres.2018.02.002
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32
   Lara Pinto AZd, 2017, PLOS ONE, V12, DOI 10 .1371/journal.pone.0187429
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040
   Maori E, 2007, VIROLOGY, V362, P342, DOI 10.1016/j.virol.2006.11.038
   Marques JT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003579
   Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z
   Mette MF, 2002, EMBO J, V21, P461, DOI 10.1093/emboj/21.3.461
   Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Ou JH, 2018, NAT METHODS, V15, P8, DOI 10.1038/nmeth.4555
   Ozata DM, 2019, NAT REV GENET, V20, P89, DOI 10.1038/s41576-018-0073-3
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Parrish NF, 2015, RNA, V21, P1691, DOI 10.1261/rna.052092.115
   Preston BD, 1996, P NATL ACAD SCI USA, V93, P7427, DOI 10.1073/pnas.93.15.7427
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Sayers E, 2009, ENTREZ PROGRAMMING U
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Tassetto M, 2019, ELIFE, V8, DOI 10.7554/eLife.41244
   Taylor DJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-88
   ter Horst AM, 2019, J VIROL, V93, DOI 10.1128/JVI.02124-18
   Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017
   Timoshevskiy VA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-27
   TOWER J, 1993, GENETICS, V133, P347
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Whitfield ZJ, 2017, CURR BIOL, V27, P3511, DOI 10.1016/j.cub.2017.09.067
   Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165
   Zanni V, 2013, P NATL ACAD SCI USA, V110, P19842, DOI 10.1073/pnas.1313677110
   ZHDANOV VM, 1975, NATURE, V256, P471, DOI 10.1038/256471a0
NR 61
TC 1
Z9 1
U1 2
U2 3
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD MAY
PY 2020
VL 26
IS 5
BP 581
EP 594
DI 10.1261/rna.073965.119
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA LF3IJ
UT WOS:000527314200005
PM 31996404
OA Bronze
DA 2020-12-16
ER

PT J
AU Pereira, LM
   de Castro, CM
   Guerra, LTL
   Queiroz, TM
   Marques, JT
   Pereira, GS
AF Pereira, Luciana M.
   de Castro, Caio M.
   Guerra, Lorena T. L.
   Queiroz, Thais M.
   Marques, Joao T.
   Pereira, Grace Schenatto
TI Hippocampus and Prefrontal Cortex Modulation of Contextual Fear Memory
   Is Dissociated by Inhibiting De Novo Transcription During Late
   Consolidation
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Contextual fear memory; Late consolidation; Dorsal hippocampus;
   Dorsomedial prefrontal cortex; De novo transcription
ID ANTERIOR CINGULATE CORTEX; RECEPTOR ANTAGONIST; DORSAL HIPPOCAMPUS;
   PROTEIN-SYNTHESIS; BASOLATERAL AMYGDALA; DOPAMINE CONTROLS;
   GENE-EXPRESSION; LEARNED FEAR; PERSISTENCE; MICE
AB To uncover the factors that dictate the persistence of a memory, it is critical to determine the molecular basis of consolidation. Here, we submitted male adult C57/BL6 mice to contextual fear conditioning using 1US (US: foot-shock, 0.7mA, 2s) or 5US, to generate recent (24 to 48h) and remote (30days) memories, respectively. To access the functional role of de novo transcription, we injected actinomycin D (ActD: 2.5ng/side) directly into the dorsal hippocampus (HIP) or dorsomedial prefrontal cortex (dmPFC), 0 (early consolidation) or 12h (late consolidation) after training. Our results showed that de novo transcription at 0h was required for recent and remote memories. However, 12h was a critical time point to memory persistence. In the dHIP, de novo transcription at 12h post-training differentiated the recent memory from the remote. In the dmPFC, ActD affected memory formation depending on the training intensity (1 or 5US). Specifically, freezing was amplified after 5US conditioning. Furthermore, inhibiting de novo transcription at 12h post-training in the dmPFC rapidly increased c-Fos expression in the amygdala. Altogether, our results indicate that contextual fear memory duration is particularly sensitive to de novo transcription in the dHIP and dmPFC, at a specific time point of late consolidation.
C1 [Pereira, Luciana M.; de Castro, Caio M.; Guerra, Lorena T. L.; Queiroz, Thais M.; Pereira, Grace Schenatto] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Nucleo Neurociencias, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Marques, Joao T.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
RP Pereira, GS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Nucleo Neurociencias, Av Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM grace@icb.ufmg.br
RI Marques, Joao T/F-7683-2012; Pereira, Grace S/B-9698-2013; Pereira,
   Grace Schenatto/O-6860-2019
OI Marques, Joao T/0000-0002-3457-3320; Pereira, Grace
   S/0000-0003-4371-7020; Pereira, Grace Schenatto/0000-0003-4371-7020
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq) [PVE
   401273/2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES [88881.068460/2014-01]; Fundacao de Amparo a Pesquisa do
   Estado de Minas GeraisMinas Gerais State Research Foundation (FAPEMIG)
   [APQ01396-15]
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (PVE 401273/2014), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Procad
   88881.068460/2014-01), and Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (APQ01396-15).
CR Abate G, 2018, BEHAV BRAIN RES, V344, P120, DOI 10.1016/j.bbr.2018.02.011
   Alvares LD, 2012, HIPPOCAMPUS, V22, P1092, DOI 10.1002/hipo.20983
   Alvarez RP, 2008, J NEUROSCI, V28, P6211, DOI 10.1523/JNEUROSCI.1246-08.2008
   Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445
   Bailey CH, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021758
   Baldi E, 2004, NEUROBIOL LEARN MEM, V81, P162, DOI 10.1016/j.nlm.2004.02.004
   Balogh SA, 2002, BEHAV NEUROSCI, V116, P947, DOI 10.1037//0735-7044.116.6.947
   Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1
   Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105
   Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025
   Bekinschtein P, 2010, NEUROTOX RES, V18, P377, DOI 10.1007/s12640-010-9155-5
   Bourtchouladze R, 1998, LEARN MEMORY, V5, P365
   Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732
   Casagrande MA, 2018, NEUROBIOL LEARN MEM, V150, P42, DOI 10.1016/j.nlm.2018.03.002
   Cheriyan J, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0002-16.2016
   Choi DC, 2010, P NATL ACAD SCI USA, V107, P2675, DOI 10.1073/pnas.0909359107
   Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007
   Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755
   Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027
   Dejean C, 2016, NATURE, V535, P420, DOI 10.1038/nature18630
   Diehl MM, 2018, ELIFE, V7, DOI 10.7554/eLife.34657
   Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023
   Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3
   Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050
   Einarsson EO, 2012, LEARN MEMORY, V19, P449, DOI 10.1101/lm.027227.112
   FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177
   Frankland PW, 2006, LEARN MEMORY, V13, P451, DOI 10.1101/lm.183406
   Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607
   Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804
   Frohardt RJ, 1999, BEHAV NEUROSCI, V113, P222, DOI 10.1037/0735-7044.113.1.222
   Gilmartin MR, 2010, LEARN MEMORY, V17, P289, DOI 10.1101/lm.1597410
   Gonzalez MC, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00408
   Guarraci FA, 2000, BEHAV NEUROSCI, V114, P647, DOI 10.1037/0735-7044.114.3.647
   Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553
   HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037/0735-7044.108.5.1005
   Huff NC, 2006, J NEUROSCI, V26, P1616, DOI 10.1523/JNEUROSCI.4964-05.2006
   Karalis N, 2016, NAT NEUROSCI, V19, P605, DOI 10.1038/nn.4251
   Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344
   Karunakaran S, 2016, NAT NEUROSCI, V19, P454, DOI 10.1038/nn.4231
   Katche C, 2010, P NATL ACAD SCI USA, V107, P349, DOI 10.1073/pnas.0912931107
   Kim EJ, 2013, P NATL ACAD SCI USA, V110, P14795, DOI 10.1073/pnas.1310845110
   Kitamura T, 2017, SCIENCE, V356, P73, DOI 10.1126/science.aam6808
   Koba Marcin, 2005, Postepy Hig Med Dosw (Online), V59, P290
   Korte M, 2016, PHYSIOL REV, V96, P647, DOI 10.1152/physrev.00010.2015
   Lechner HA, 1999, LEARN MEMORY, V6, P77
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marek R, 2013, J PHYSIOL-LONDON, V591, P2381, DOI 10.1113/jphysiol.2012.248575
   McGaugh JL, 1999, BRAIN RES BULL, V50, P445, DOI 10.1016/S0361-9230(99)00126-4
   MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681
   Muller G, 2000, RRD ENDOCRINOL, V1, P1
   Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013
   Nakayama D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21007
   Nakayama D, 2015, J NEUROSCI, V35, P819, DOI 10.1523/JNEUROSCI.2525-14.2015
   Parsons RG, 2006, EUR J NEUROSCI, V23, P1853, DOI 10.1111/j.1460-9568.2006.04723.x
   Pereira LM, 2014, NEUROBIOL LEARN MEM, V114, P1, DOI 10.1016/j.nlm.2014.04.001
   Poulos AM, 2016, LEARN MEMORY, V23, P379, DOI 10.1101/lm.041400.115
   Quinn JJ, 2008, LEARN MEMORY, V15, P368, DOI 10.1101/lm.813608
   Radulovic J, 1998, BEHAV BRAIN RES, V95, P179, DOI 10.1016/S0166-4328(98)00039-4
   Ressler RL, 2019, CURR OPIN NEUROBIOL, V54, P54, DOI 10.1016/j.conb.2018.08.012
   Rizzo V, 2017, BIOL PSYCHIAT-COGN N, V2, P158, DOI 10.1016/j.bpsc.2016.10.002
   Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545
   Schafe GE, 1999, LEARN MEMORY, V6, P97
   Schulz B, 2001, NEUROPHARMACOLOGY, V41, P1, DOI 10.1016/S0028-3908(01)00036-3
   Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519
   Stiedl O, 2000, BEHAV BRAIN RES, V116, P157, DOI 10.1016/S0166-4328(00)00269-2
   Tonegawa S, 2018, NAT REV NEUROSCI, V19, P485, DOI 10.1038/s41583-018-0031-2
   Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106
   Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907
   Zelikowsky M, 2014, J NEUROSCI, V34, P8462, DOI 10.1523/JNEUROSCI.3624-13.2014
NR 69
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD AUG
PY 2019
VL 56
IS 8
BP 5507
EP 5519
DI 10.1007/s12035-018-1463-4
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA IJ1QK
UT WOS:000475673100018
PM 30623374
DA 2020-12-16
ER

PT J
AU Olmo, RP
   Martins, NE
   Aguiar, ERGR
   Marques, JT
   Imler, JL
AF Olmo, Roenick P.
   Martins, Nelson Eduardo
   Aguiar, Eric Roberto G. R.
   Marques, Joao T.
   Imler, Jean-Luc
TI The insect reservoir of biodiversity for viruses and for antiviral
   mechanisms
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Article
DE antiviral immunity; insects; metagenomics; restriction factors; RNA
   interference; virome
ID SMALL RNAS; DISCOVERY; IMMUNITY; DROSOPHILA; SEQUENCE; PATHWAY; PATTERN
AB Insects are the most diverse group of animals. They can be infected by an extraordinary diversity of viruses. Among them, arthropod-borne viruses (arboviruses) can be transmitted to humans. High-throughput sequencing of small RNAs from insects provides insight into their virome, which may help understand the dynamics of vector borne infectious diseases. Furthermore, investigating the mechanisms that restrict viral infections in insects points to genetic innovations that may inspire novel antiviral strategies.
C1 [Olmo, Roenick P.; Martins, Nelson Eduardo; Imler, Jean-Luc] Univ Strasbourg, CNRS UPR9022, INSERM U1257, Inst Biol Mol & Cellulaire, 15 Rue Rene Descartes, F-67084 Strasbourg, France.
   [Olmo, Roenick P.; Aguiar, Eric Roberto G. R.; Marques, Joao T.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Aguiar, Eric Roberto G. R.] Univ Fed Bahia, Inst Ciencias Saude, Av Reitor Miguel Calmon, BR-40110902 Salvador, BA, Brazil.
RP Olmo, RP; Imler, JL (corresponding author), Univ Strasbourg, CNRS UPR9022, INSERM U1257, Inst Biol Mol & Cellulaire, 15 Rue Rene Descartes, F-67084 Strasbourg, France.; Olmo, RP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM rprovetiolmo@unistra.fr; jl.imler@unistra.fr
RI Marques, Joao T/F-7683-2012; Aguiar, Eric/T-5076-2019; Olmo,
   Roenick/AAF-6412-2020; Martins, Nelson/L-7143-2013
OI Marques, Joao T/0000-0002-3457-3320; Aguiar, Eric/0000-0002-8143-5756;
   Martins, Nelson/0000-0002-3923-2998
FU University of Strasbourg Institute for Advanced Studies, CNRS; Institut
   Universitaire de France; Agence Nationale de la RechercheFrench National
   Research Agency (ANR) [ANR-17-CE15-0014-01]; Programme Investissements
   d'AvenirFrench National Research Agency (ANR) [ANR-10-LABX-0036,
   ANR-11-EQPX-0022]
FX This work was funded by the University of Strasbourg Institute for
   Advanced Studies, CNRS, the Institut Universitaire de France, the
   Programme Investissements d'Avenir (ANR-10-LABX-0036 and
   ANR-11-EQPX-0022), the Agence Nationale de la Recherche
   (ANR-17-CE15-0014-01).
CR Cao C, 2017, GENETICS, V206, P2159, DOI 10.1534/genetics.117.201970
   Carre-Mouka A, 2007, GENETICS, V176, P409, DOI 10.1534/genetics.106.063826
   Dietrich I, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00090-17
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Dudas G, 2015, ELIFE, V4, DOI 10.7554/eLife.06837
   Ferreira FV, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006569
   Goto A, 2018, IMMUNITY, V49, P225, DOI 10.1016/j.immuni.2018.07.013
   Aguiar ERGR, 2016, WIRES RNA, V7, P824, DOI 10.1002/wrna.1361
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Marques JT, 2016, CURR OPIN MICROBIOL, V32, P71, DOI 10.1016/j.mib.2016.05.002
   Marques JT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003579
   Martins N, 2016, CURR OPIN VIROL, V20, P64, DOI 10.1016/j.coviro.2016.09.005
   Merkling SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12758
   Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570
   Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Mussabekova A, 2017, CELL MOL LIFE SCI, V74, P2039, DOI 10.1007/s00018-017-2453-9
   Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Paro S, 2015, CURR OPIN IMMUNOL, V32, P106, DOI 10.1016/j.coi.2015.01.009
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Stork NE, 2018, ANNU REV ENTOMOL, V63, P31, DOI 10.1146/annurev-ento-020117-043348
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
NR 27
TC 1
Z9 1
U1 0
U2 4
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PY 2019
VL 91
SU 3
AR e20190122
DI 10.1590/0001-3765201920190122
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IC2DQ
UT WOS:000470770400003
PM 31166476
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Cataneo, AHD
   Kuczera, D
   Mosimann, ALP
   Silva, EG
   Ferreira, AGA
   Marques, JT
   Wowk, PF
   dos Santos, CND
   Bordignon, J
AF Depieri Cataneo, Allan Henrique
   Kuczera, Diogo
   Pamplona Mosimann, Ana Luiza
   Silva, Emanuele Guimaraes
   Araujo Ferreira, Alvaro Gil
   Marques, Joao Trindade
   Wowk, Pryscilla Fanini
   Duarte dos Santos, Claudia Nunes
   Bordignon, Juliano
TI Detection and clearance of a mosquito densovirus contaminant from
   laboratory stocks of Zika virus
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE arixwirus isolation; contamination; C6/36 cultures; densovirus;
   vertebrate cells; Zika virus
ID AEDES-ALBOPICTUS; A549 CELLS; INFECTION; IDENTIFICATION; PATHOGENICITY;
   SEQUENCE; LINE
AB BACKGROUND The Zika virus (ZIKV) epidemics that affected South America in 2016 raised several research questions and prompted an increase in studies in the field. The transient and low viraemia observed in the course of ZIKV infection is a challenge for viral isolation from patient serum, which leads to many laboratories around the world sharing viral strains for their studies. C6/36 cells derived from Aedes albopictus larvae are commonly used for arbovirus isolation from clinical samples and for the preparation of viral stocks.
   OBJECTIVES Here, we report the contamination of two widely used ZIKV strains by Brevidensovirus, here designated as mosquito densovirus (MDV).
   METHODS Molecular and immunological techniques were used to analyse the MDV contamination of ZIKV stocks. Also, virus passages in mammalian cell line and infecting susceptible mice were used to MDV clearance from ZIKV stocks.
   FINDINGS MDV contamination was confirmed by molecular and immunological techniques and likely originated from C6/36 cultures commonly used to grow viral stocks. We applied two protocols that successfully eliminated MDV contamination from ZIKV stocks, and these protocols can be widely applied in the field. As MDV does not infect vertebrate cells, we performed serial passages of contaminated stocks using a mammalian cell line and infecting susceptible mice prior to re-isolating ZIKV from the animals' blood scrum. MDV elimination was confirmed with immunostaining, polymerase chain reaction (PCR), and analysis of the mosquitoes that were allowed to feed on the infected mice.
   MAIN CONCLUSIONS Since the putative impact of viral contaminants in ZIKV strains generally used for research purposes is unknown, researchers working in the field must be aware of potential contaminants and test viral stocks to certify sample purity.
C1 [Depieri Cataneo, Allan Henrique; Kuczera, Diogo; Pamplona Mosimann, Ana Luiza; Wowk, Pryscilla Fanini; Duarte dos Santos, Claudia Nunes; Bordignon, Juliano] Fundacao Oswaldo Cruz Fiocruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
   [Silva, Emanuele Guimaraes; Araujo Ferreira, Alvaro Gil; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
RP Bordignon, J (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
EM juliano.bordignon@fiocruz.br
RI Wowk, Pryscilla/AAA-3281-2019; Wowk, Pryscilla Fanini/AAR-7230-2020;
   Bordignon, Juliano/Z-6268-2019; Cataneo, Allan/AAB-7997-2020; Ferreira,
   Alvaro G A/O-3649-2015; Marques, Joao T/F-7683-2012; Mosimann, Ana Luiza
   Pamplona/AAB-4714-2019; Santos, Claudia Duarte dos/P-4868-2019
OI Bordignon, Juliano/0000-0002-1965-6152; Marques, Joao
   T/0000-0002-3457-3320; Mosimann, Ana Luiza Pamplona/0000-0002-3504-5562;
   Santos, Claudia Duarte dos/0000-0001-8707-6638; Wowk,
   Pryscilla/0000-0002-8976-2647
FU Ministerio da Saude e Fundacao Araucaria (PPSUS/2013); Fundacao
   Araucaria/SESA-PR/CNPq/MS-Decit PPSUS/2015 [019/2017]
FX Ministerio da Saude e Fundacao Araucaria (PPSUS/2013), Fundacao
   Araucaria/SESA-PR/CNPq/MS-Decit PPSUS/2015 - (019/2017). JTM
   (305357/2014-0), CNDS (309432/2015-4) and JB (303306/2017-3) are CNPq
   fellows.
CR AFANASIEV BN, 1991, VIROLOGY, V185, P323, DOI 10.1016/0042-6822(91)90780-F
   Barreau C, 1996, J INVERTEBR PATHOL, V68, P299, DOI 10.1006/jipa.1996.0100
   Bergoin M, 2000, CONTRIB MICROBIOL, V4, P12
   Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X
   Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1
   DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   FONG CKY, 1975, J CLIN MICROBIOL, V1, P219, DOI 10.1128/JCM.1.2.219-224.1975
   FONG CKY, 1992, J CLIN MICROBIOL, V30, P1611, DOI 10.1128/JCM.30.6.1611-1613.1992
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   HIRUMI H, 1976, IN VITRO CELL DEV B, V12, P83
   Horbach SPJM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186281
   JOUSSET FX, 1993, VIRUS RES, V29, P99, DOI 10.1016/0168-1702(93)90052-O
   LEBEDEVA OP, 1973, ACTA VIROL, V17, P253
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moser LA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006880
   Olmo RP, 2018, NAT MICROBIOL, V3, P1385, DOI 10.1038/s41564-018-0268-6
   ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067
   Mosimann ALP, 2011, MEM I OSWALDO CRUZ, V106, P285, DOI 10.1590/S0074-02762011000300006
   Paterson A, 2005, VIROLOGY, V337, P253, DOI 10.1016/j.virol.2005.04.037
   Sivaram A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-95
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Suchman EL, 2006, BIOL CONTROL, V39, P465, DOI 10.1016/j.biocontrol.2006.05.001
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wei W, 2006, AM J TROP MED HYG, V75, P1118, DOI 10.4269/ajtmh.2006.75.1118
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 2
Z9 2
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR e180432
DI 10.1590/0074-02760180432
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HL3KY
UT WOS:000458615100001
PM 30758394
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Donald, CL
   Varjak, M
   Aguiar, ERGR
   Marques, JT
   Sreenu, VB
   Schnettler, E
   Kohl, A
AF Donald, Claire L.
   Varjak, Margus
   Guimaraes Rocha Aguiar, Eric Roberto
   Marques, Joao T.
   Sreenu, Vattipally B.
   Schnettler, Esther
   Kohl, Alain
TI Antiviral RNA Interference Activity in Cells of the Predatory Mosquito,
   Toxorhynchites amboinensis
SO VIRUSES-BASEL
LA English
DT Article
DE RNA interference (RNAi); antiviral responses; Toxorhynchites
   amboinensis; alphavirus; virus discovery
ID INSECT-SPECIFIC VIRUSES; LINE TRA-171; HOST-DEFENSE; INFECTION;
   DROSOPHILA; ARBOVIRUS; DENGUE; IMMUNITY; ALPHAVIRUS; REPLICATION
AB Arthropod vectors control the replication of arboviruses through their innate antiviral immune responses. In particular, the RNA interference (RNAi) pathways are of notable significance for the control of viral infections. Although much has been done to understand the role of RNAi in vector populations, little is known about its importance in non-vector mosquito species. In this study, we investigated the presence of an RNAi response in Toxorhynchites amboinensis, which is a non-blood feeding species proposed as a biological control agent against pest mosquitoes. Using a derived cell line (TRA-171), we demonstrate that these mosquitoes possess a functional RNAi response that is active against a mosquito-borne alphavirus, Semliki Forest virus. As observed in vector mosquito species, small RNAs are produced that target viral sequences. The size and characteristics of these small RNAs indicate that both the siRNA and piRNA pathways are induced in response to infection. Taken together, this data suggests that Tx. amboinensis are able to control viral infections in a similar way to natural arbovirus vector mosquito species. Understanding their ability to manage arboviral infections will be advantageous when assessing these and similar species as biological control agents.
C1 [Donald, Claire L.; Varjak, Margus; Sreenu, Vattipally B.; Schnettler, Esther; Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
   [Guimaraes Rocha Aguiar, Eric Roberto; Marques, Joao T.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, 6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Guimaraes Rocha Aguiar, Eric Roberto] Univ Fed Bahia, Inst Ciencias Saude, BR-40110100 Salvador, BA, Brazil.
   [Schnettler, Esther] Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Schnettler, Esther] Partner Site Hamburg Lubeck Borstel Riems, German Ctr Infect Res DZIF, D-20359 Hamburg, Germany.
RP Donald, CL; Kohl, A (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
EM Claire.Donald@glasgow.ac.uk; Margus.Varjak@glasgow.ac.uk;
   ericgdp@gmail.com; jtm@ufmg.br; Sreenu.Vattipally@glasgow.ac.uk;
   schnettler@bnitm.de; Alain.Kohl@glasgow.ac.uk
RI Marques, Joao T/F-7683-2012; Schnettler, Esther/AAV-8774-2020; Aguiar,
   Eric RGR/L-7989-2018; Aguiar, Eric/T-5076-2019; Donald,
   Claire/AAC-7556-2019
OI Marques, Joao T/0000-0002-3457-3320; Aguiar, Eric
   RGR/0000-0002-8143-5756; Aguiar, Eric/0000-0002-8143-5756; Donald,
   Claire/0000-0002-4370-0707; Vattipally, Bala Sreenu/0000-0001-6673-4697
FU UK Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014/8]
FX This study was supported by the UK Medical Research Council
   (MC_UU_12014/8).
CR Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001
   Antoniewski C, 2014, METHODS MOL BIOL, V1173, P135, DOI 10.1007/978-1-4939-0931-5_12
   Arensburger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-606
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47
   Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021
   Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7
   DAVEY MW, 1974, J GEN VIROL, V24, P453, DOI 10.1099/0022-1317-24-3-453
   Dietrich I, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00090-17
   Dietrich I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005272
   Donald Claire L, 2012, Insects, V3, P511, DOI 10.3390/insects3020511
   Focks DA, 2007, J AM MOSQUITO CONTR, V23, P118, DOI 10.2987/8756-971X(2007)23[118:TABA]2.0.CO;2
   Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Halbach R, 2017, CURR OPIN INSECT SCI, V22, P16, DOI 10.1016/j.cois.2017.05.004
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   KUNO G, 1982, INTERVIROLOGY, V18, P45, DOI 10.1159/000149303
   KUNO G, 1985, B WORLD HEALTH ORGAN, V63, P279
   KUNO G, 1981, IN VITRO CELL DEV B, V17, P1011, DOI 10.1007/BF02618427
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   LEGRAND FS, 1983, MICROBIOL IMMUNOL, V27, P101, DOI 10.1111/j.1348-0421.1983.tb03561.x
   Lequime S, 2014, INFECT GENET EVOL, V28, P681, DOI 10.1016/j.meegid.2014.07.025
   Lewis SH, 2016, GENOME BIOL EVOL, V8, P507, DOI 10.1093/gbe/evw018
   Marques JT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003579
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Merkling SH, 2013, J INSECT PHYSIOL, V59, P159, DOI 10.1016/j.jinsphys.2012.07.004
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Myles KM, 2009, RNA BIOL, V6, P387, DOI 10.4161/rna.6.4.8946
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nouri S, 2018, CURR OPIN VIROL, V33, P33, DOI 10.1016/j.coviro.2018.07.006
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Ongus JR, 2006, J GEN VIROL, V87, P3397, DOI 10.1099/vir.0.82122-0
   Ou JH, 2018, NAT METHODS, V15, P8, DOI 10.1038/nmeth.4555
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   ROSEN L, 1985, AM J TROP MED HYG, V34, P805, DOI 10.4269/ajtmh.1985.34.805
   ROSEN L, 1981, AM J TROP MED HYG, V30, P177, DOI 10.4269/ajtmh.1981.30.177
   ROSEN L, 1978, SCIENCE, V199, P909, DOI 10.1126/science.203035
   Roundy CM, 2017, ADV VIRUS RES, V98, P119, DOI 10.1016/bs.aivir.2016.10.001
   Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712
   Samuel GH, 2018, TRENDS MICROBIOL, V26, P447, DOI 10.1016/j.tim.2017.12.005
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   SCHERER WF, 1981, J CLIN MICROBIOL, V13, P947, DOI 10.1128/JCM.13.5.947-950.1981
   SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353
   Schnettler E, 2008, J GEN VIROL, V89, P336, DOI 10.1099/vir.0.83293-0
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schnettler E, 2013, J VIROL, V87, P2441, DOI 10.1128/JVI.02848-12
   Schreiber ET, 2007, J AM MOSQUITO CONTR, V23, P129, DOI 10.2987/8756-971X(2007)23[129:T]2.0.CO;2
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10
   STEFFAN WA, 1981, ANNU REV ENTOMOL, V26, P159, DOI 10.1146/annurev.en.26.010181.001111
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   TESH RB, 1981, T ROY SOC TROP MED H, V75, P426, DOI 10.1016/0035-9203(81)90112-7
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Varjak M, 2018, J GEN VIROL, V99, P1551, DOI 10.1099/jgv.0.001157
   Varjak M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020088
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Varjak M, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00144-17, 10.1128/msphere.00144-17]
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x
   Zhou XF, 2014, GENOME BIOL EVOL, V6, P2883, DOI 10.1093/gbe/evu231
   Zuharah WF, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev115
NR 74
TC 5
Z9 5
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2018
VL 10
IS 12
AR 694
DI 10.3390/v10120694
PG 15
WC Virology
SC Virology
GA HG9FQ
UT WOS:000455313100033
PM 30563205
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Olmo, RP
   Ferreira, AGA
   Izidoro-Toledo, TC
   Aguiar, ERGR
   de Faria, IS
   de Souza, KPR
   Osorio, KP
   Kuhn, L
   Hammann, P
   de Amadou, EG
   Todjro, YM
   Rocha, MN
   Leite, THJF
   Amadou, SCG
   Armache, JN
   Paro, S
   de Oliveira, CD
   Carvalho, FD
   Moreire, LA
   Marois, E
   Imler, JL
   Marques, JT
AF Olmo, Roenick P.
   Ferreira, Alvaro G. A.
   Izidoro-Toledo, Tatiane C.
   Aguiar, Eric R. G. R.
   de Faria, Isaquel S.
   de Souza, Katia P. R.
   Osorio, Katia P.
   Kuhn, Lauriane
   Hammann, Philippe
   de Amadou, Elisa G.
   Todjro, Yaovi Mathias
   Rocha, Marcele N.
   Leite, Thiago H. J. F.
   Amadou, Siad C. G.
   Armache, Juliana N.
   Paro, Simona
   de Oliveira, Caroline D.
   Carvalho, Fabiano D.
   Moreire, Luciano A.
   Marois, Eric
   Imler, Jean-Luc
   Marques, Joao T.
TI Control of dengue virus in the midgut of Aedes aegypti by ectopic
   expression of the dsRNA-binding protein Loqs2
SO NATURE MICROBIOLOGY
LA English
DT Article
ID RNA INTERFERENCE; ANTIVIRAL IMMUNITY; ANOPHELES-GAMBIAE; DISTINCT ROLES;
   IDENTIFICATION; PATHWAYS; MOSQUITO; RDE-1; GENE
AB Dengue virus (DENV) is an arbovirus transmitted to humans by Aedes mosquitoes'. In the insect vector, the small interfering RNA (siRNA) pathway is an important antiviral mechanism against DENV2-5. However, it remains unclear when and where the siRNA pathway acts during the virus cycle. Here, we show that the siRNA pathway fails to efficiently silence DENV in the midgut of Aedes aegypti although it is essential to restrict systemic replication. Accumulation of DENV-derived siRNAs in the midgut reveals that impaired silencing results from a defect downstream of small RNA biogenesis. Notably, silencing triggered by endogenous and exogenous dsRNAs remained effective in the midgut where known components of the siRNA pathway, including the double-stranded RNA (dsRNA)-binding proteins Loquacious and r2d2, had normal expression levels. We identified an Aedes-specific paralogue of loquacious and r2d2, hereafter named loqs2, which is not expressed in the midgut. Loqs2 interacts with Loquacious and r2d2 and is required to control systemic replication of DENV and also Zika virus. Furthermore, ectopic expression of Loqs2 in the midgut of transgenic mosquitoes is sufficient to restrict DENV replication and dissemination. Together, our data reveal a mechanism of tissue-specific regulation of the mosquito siRNA pathway controlled by Loqs2.
C1 [Olmo, Roenick P.; Ferreira, Alvaro G. A.; Izidoro-Toledo, Tatiane C.; Aguiar, Eric R. G. R.; de Faria, Isaquel S.; de Souza, Katia P. R.; Osorio, Katia P.; de Amadou, Elisa G.; Todjro, Yaovi Mathias; Leite, Thiago H. J. F.; Amadou, Siad C. G.; Armache, Juliana N.; Marques, Joao T.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Olmo, Roenick P.; de Faria, Isaquel S.; de Amadou, Elisa G.; Paro, Simona; Marois, Eric; Imler, Jean-Luc; Marques, Joao T.] Univ Strasbourg, CNRS, UPR9022, INSERM U1257, Strasbourg, France.
   [Kuhn, Lauriane; Hammann, Philippe] Inst Biol Mol & Cellulaire, Plateforme Prote Strasbourg Esplanade FRC 1589, Strasbourg, France.
   [Rocha, Marcele N.; de Oliveira, Caroline D.; Carvalho, Fabiano D.; Moreire, Luciano A.] Inst Pesquisas Rene Rachou Fiocruz, Mosquitos Vetores Endossimbiontes & Interacao Pat, Belo Horizonte, MG, Brazil.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.; Marques, JT (corresponding author), Univ Strasbourg, CNRS, UPR9022, INSERM U1257, Strasbourg, France.
EM jtm@ufmg.br
RI Ferreira, Alvaro G A/O-3649-2015; Oliveira, Caroline/D-8667-2014;
   Aguiar, Eric/T-5076-2019; Aguiar, Eric RGR/L-7989-2018; Olmo,
   Roenick/AAF-6412-2020; Marques, Joao T/F-7683-2012
OI Aguiar, Eric/0000-0002-8143-5756; Aguiar, Eric RGR/0000-0002-8143-5756;
   Marques, Joao T/0000-0002-3457-3320; Dantas de Oliveira,
   Caroline/0000-0001-5849-6457; Proveti Olmo, Roenick/0000-0002-3849-8591
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Agence
   Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-11-ASV3-002]; Investissement d'Avenir ProgramsFrench National
   Research Agency (ANR) [ANR-10-LABX-36, ANR-11-EQPX-0022]; Inserm, CNRS;
   University of Strasbourg, IdEx Equipement mi-lourd 2015; CAPESCAPES;
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX The authors thank C.N.D. dos Santos for providing 4G2 monoclonal
   antibodies. This work was supported with funding from Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) to J.T.M., Agence
   Nationale de la Recherche (ANR-11-ASV3-002) and Investissement d'Avenir
   Programs (ANR-10-LABX-36; ANR-11-EQPX-0022) to J.T.M and J.-L.I., and
   Inserm, CNRS and the University of Strasbourg to E.M. and J.-L.I. Mass
   spectrometry instrumentation was funded by the University of Strasbourg,
   IdEx Equipement mi-lourd 2015 to L.K. and P.H. National and/or
   international fellowships from CAPES were granted to R.P.O., T.C.I.-T.,
   A.G.A.F., E.R.G.R.A., K.P.R.S., K.P.O. and C.D.O., and national and/or
   international fellowships from CNPq were granted to I.J.S.F., L.A.M. and
   J.T.M.
CR Ashe A, 2013, ELIFE, V2, DOI 10.7554/eLife.00994
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Chicher J, 2015, PROTEOMICS, V15, P2417, DOI 10.1002/pmic.201400628
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Edwards MJ, 2000, INSECT MOL BIOL, V9, P33, DOI 10.1046/j.1365-2583.2000.00159.x
   Engler C, 2013, METHODS MOL BIOL, V1073, P141, DOI 10.1007/978-1-62703-625-2_12
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509
   Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396
   Aguiar ERGR, 2016, WIRES RNA, V7, P824, DOI 10.1002/wrna.1361
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Haac ME, 2015, NUCLEIC ACIDS RES, V43, P3688, DOI 10.1093/nar/gkv152
   Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324
   Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Jasinskiene Nijole, 2007, J Vis Exp, P219, DOI 10.3791/219
   Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693
   Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130
   LANFORD RE, 1994, VIROLOGY, V202, P606, DOI 10.1006/viro.1994.1381
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911
   Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930
   Marques JT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003579
   Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   MORRIS AC, 1989, MED VET ENTOMOL, V3, P1, DOI 10.1111/j.1365-2915.1989.tb00467.x
   Parrish S, 2001, RNA, V7, P1397
   Pereira TN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25236-8
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Sarkies P, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002061
   Sedda L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2662-6
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Stoetzel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13586
   Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6
   Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672
   Villalon JM, 2003, J INSECT PHYSIOL, V49, P891, DOI 10.1016/S0022-1910(03)00135-5
   Volohonsky G, 2015, G3-GENES GENOM GENET, V5, P1151, DOI 10.1534/g3.115.016808
NR 48
TC 11
Z9 11
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD DEC
PY 2018
VL 3
IS 12
BP 1385
EP 1393
DI 10.1038/s41564-018-0268-6
PG 9
WC Microbiology
SC Microbiology
GA HB7LP
UT WOS:000451259600012
PM 30374169
DA 2020-12-16
ER

PT J
AU Fonseca, PLC
   Badotti, F
   de Oliveira, TFP
   Fonseca, A
   Vaz, ABM
   Tome, LMR
   Abrahao, JS
   Marques, JT
   Trindade, GS
   Chaverri, P
   Aguiar, ERGR
   Goes-Neto, A
AF Fonseca, Paula L. C.
   Badotti, Fernanda
   de Oliveira, Tatiana F. P.
   Fonseca, Antonio
   Vaz, Aline B. M.
   Tome, Luiz M. R.
   Abrahao, Jonatas S.
   Marques, Joao T.
   Trindade, Giliane S.
   Chaverri, Priscila
   Aguiar, Eric R. G. R.
   Goes-Neto, Aristoteles
TI Virome analyses of Hevea brasiliensis using small RNA deep sequencing
   and PCR techniques reveal the presence of a potential new virus
SO VIROLOGY JOURNAL
LA English
DT Article
DE Hevea brasiliensis; Virome; RNA deep sequencing; ddPCR; HBrV
ID DIGITAL PCR; IDENTIFICATION; DISCOVERY; DIAGNOSIS
AB Background: Hevea brasiliensis is an important commercial crop due to the high quality of the latex it produces; however, little is known about viral infections in this plant. The only virus described to infect H. brasiliensis until now is a Carlavirus, which was described more than 30years ago. Virus-derived small interfering RNA (vsiRNAs) are the product of the plant's antiviral defense triggered by dsRNA viral intermediates generated, during the replication cycle. These vsiRNAs are complementar to viral genomes and have been widely used to identify and characterize viruses in plants.
   Methods: In the present study, we investigated the virome of leaf and sapwood samples from native H. brasiliensis trees collected in two geographic areas in the Brazilian Amazon. Small RNA (sRNA) deep sequencing and bioinformatic tools were used to assembly, identify and characterize viral contigs. Subsequently, PCR amplification techniques were performed to experimentally verify the presence of the viral sequences. Finally, the phylogenetic relationship of the putative new virus with related viral genomes was analyzed.ResultsOur strategy allowed the identification of 32 contigs with high similarity to viral reference genomes, from which 23exhibited homology to viruses of the Tymoviridae family. The reads showed a predominant size distribution at 21nt derived from both strands, which was consistent with the vsiRNAs profile. The presence and genome position of the viral contigs were experimentally confirmed using droplet digital PCR amplifications. A 1913aa long fragment was obtained and used to infer the phylogenetic relationship of the putative new virus, which indicated that it is taxonomically related to the Grapevine fleck virus, genus Maculavirus. The putative new virus was named Hevea brasiliensis virus (HBrV) in reference to its host.
   Conclusion: The methodological strategy applied here proved to be efficient in detecting and confirming the presence of new viral sequences on a very difficult to manage' sample. This is the second time that viral sequences, that could be ascribed as a putative novel virus, associated to the rubber tree has been identified.
C1 [Fonseca, Paula L. C.; de Oliveira, Tatiana F. P.; Vaz, Aline B. M.; Tome, Luiz M. R.; Abrahao, Jonatas S.; Trindade, Giliane S.; Goes-Neto, Aristoteles] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Badotti, Fernanda] Ctr Fed Educ Tecnol Minas Gerais CEFET MG, Dept Chem, BR-30421169 Belo Horizonte, MG, Brazil.
   [de Oliveira, Tatiana F. P.; Fonseca, Antonio] Minist Agr MAPA, LANAGRO MG Lab Nacl Agr, BR-33600000 Pedro Leopoldo, MG, Brazil.
   [Vaz, Aline B. M.] Fac Minas FAMINAS, BR-31744007 Belo Horizonte, MG, Brazil.
   [Marques, Joao T.; Aguiar, Eric R. G. R.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Chaverri, Priscila] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.
   [Chaverri, Priscila] Univ Costa Rica, Escuela Biol, San Jose 115012060, Costa Rica.
   [Aguiar, Eric R. G. R.] Univ Fed Bahia, Inst Ciencias Saude, BR-40110100 Salvador, BA, Brazil.
RP Goes-Neto, A (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.; Aguiar, ERGR (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.; Aguiar, ERGR (corresponding author), Univ Fed Bahia, Inst Ciencias Saude, BR-40110100 Salvador, BA, Brazil.
EM ericgdp@gmail.com; arigoesneto@pq.cnpq.br
RI Aguiar, Eric/T-5076-2019; Vaz, Aline BM/F-7684-2012; Fonseca, Antonio
   Augusto/AAW-4082-2020; Fonseca, Paula/AAL-8690-2020; Aguiar, Eric
   RGR/L-7989-2018; Marques, Joao T/F-7683-2012
OI Aguiar, Eric/0000-0002-8143-5756; Fonseca, Antonio
   Augusto/0000-0002-2962-5616; Fonseca, Paula/0000-0002-8103-9235; Aguiar,
   Eric RGR/0000-0002-8143-5756; Marques, Joao T/0000-0002-3457-3320;
   Oliveira, Tatiana/0000-0001-8805-9039
FU National Academy of Sciences (NAS) [PGA-2000003475]; Fundacao de Amparo
   a Pesquisa do Estado da Bahia Grant [INT008/2014]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq)
FX This work was funded by the National Academy of Sciences (NAS) Sub-Grant
   Number: PGA-2000003475 (2013/2016), Fundacao de Amparo a Pesquisa do
   Estado da Bahia Grant INT008/2014, Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263
   AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Al Rwahnih M, 2011, ARCH VIROL, V156, P397, DOI 10.1007/s00705-010-0869-8
   Aoki Y, 2014, PLANT SCI, V225, P1, DOI 10.1016/j.plantsci.2014.05.003
   Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027
   Cornish K, 2001, PHYTOCHEMISTRY, V57, P1123, DOI 10.1016/S0031-9422(01)00097-8
   da Hora BT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104750
   Duan C, 2010, TREE PHYSIOL, V30, P1349, DOI 10.1093/treephys/tpq066
   Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397
   Gama M., 1983, FITOPATOL BRAS, V8, P621
   Aguiar ERGR, 2016, WIRES RNA, V7, P824, DOI 10.1002/wrna.1361
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Guleria Praveen, 2011, Genomics Proteomics & Bioinformatics, V9, P183, DOI 10.1016/S1672-0229(11)60022-3
   Huggett JF, 2015, CLIN CHEM, V61, P79, DOI 10.1373/clinchem.2014.221366
   Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005
   Kimati H, 1997, DOENCAS PLANTAS CULT
   King AMQ, 2012, VIRUS TAXONOMY
   Kreuze J., 2014, DETECTION DIAGNOSTIC, P21, DOI [10.1007/978-94-017-9020-8_2, 10.1007/978-94-017-9020-8_2.]
   Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lieberei R, 2007, ANN BOT-LONDON, V100, P1125, DOI 10.1093/aob/mcm133
   Limkaisang Saranya, 2005, Mycoscience, V46, P220, DOI 10.1007/s10267-005-0238-8
   Liu X. J, 1987, CHIN J TROP CROPS, V8, P93
   Loconsole G, 2012, VIROLOGY, V432, P162, DOI 10.1016/j.virol.2012.06.005
   Makita Y, 2017, DNA RES, V24, P159, DOI 10.1093/dnares/dsw056
   Romay Gustavo, 2017, Front Microbiol, V8, P47, DOI 10.3389/fmicb.2017.00047
   Rose R, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew022
   Sabanadzovic S, 2001, J GEN VIROL, V82, P2009, DOI 10.1099/0022-1317-82-8-2009
   Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177
   Studholme DJ, 2012, BRIEF FUNCT GENOMICS, V11, P71, DOI 10.1093/bfgp/elr039
   Sunkar R, 2007, J INTEGR PLANT BIOL, V49, P817, DOI 10.1111/j.1744-7909.2007.00499.x
   Vainio EJ, 2015, J GEN VIROL, V96, P714, DOI 10.1099/jgv.0.000003
   van Beilen JB, 2007, TRENDS BIOTECHNOL, V25, P522, DOI 10.1016/j.tibtech.2007.08.009
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Yockteng R, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1300070
   Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457
   Zhang K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00177
   Zhao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159004
NR 38
TC 1
Z9 1
U1 2
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD NOV 26
PY 2018
VL 15
AR 184
DI 10.1186/s12985-018-1095-3
PG 9
WC Virology
SC Virology
GA HB9AX
UT WOS:000451384900003
PM 30477549
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Corsetti, PP
   de Almeida, LA
   Goncalves, ANA
   Gomes, MTR
   Guimaraes, ES
   Marques, JT
   Oliveira, SC
AF Corsetti, Patricia P.
   de Almeida, Leonardo A.
   Aquime Goncalves, Andre Nicolau
   Gomes, Marco Tulio R.
   Guimaraes, Erika S.
   Marques, Joao T.
   Oliveira, Sergio C.
TI miR-181a-5p Regulates TnF-alpha and miRr-21a-5p Influences
   Gualynate-Binding Protein 5 and IL-10 Expression in Macrophages
   Affecting Host Control of Brucella abortus Infection
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE microRNA; epigenetics; Brucella abortus; guanylate-binding protein 5;
   inflammation; miR-21a-5p
ID MICRORNA RESPONSE; INTRACELLULAR REPLICATION; MELITENSIS INFECTION;
   DOWN-REGULATION; ACTIVATION; CELLS; TUBERCULOSIS; PATHOGEN;
   IDENTIFICATION; INFLAMMATION
AB Brucella abortus is a Gram-negative intracellular bacterium that causes a worldwide zoonosis termed brucellosis, which is characterized as a debilitating infection with serious clinical manifestations leading to severe complications. In spite of great advances in studies involving host-B. abortus interactions, there are many gaps related to B. abortus modulation of the host immune response through regulatory mechanisms. Here, we deep sequenced small RNAs from bone marrow-derived macrophages infected with B. abortus, identifying 69 microRNAs (miRNAs) that were differentially expressed during infection. We further validated the expression of four upregulated and five downregulated miRNAs during infection in vitro that displayed the same profile in spleens from infected mice at 1, 3, or 6 days post-infection. Among these miRNAs, mmu-miR-181a-5p (upregulated) or mmu-miR-21a-5p (downregulated) were selected for further analysis. First, we determined that changes in the expression of both miRNAs induced by infection were dependent on the adaptor molecule MyD88. Furthermore, evaluating putative targets of mmu-miR-181a-5p, we demonstrated this miRNA negatively regulates TNF-alpha expression following Brucella infection. By contrast, miR-21a-5p targets included a negative regulator of IL-10, programmed cell death protein 4, and several guanylate-binding proteins (GBPs). As a result, during infection, miR-21a-5p led to upregulation of IL-10 expression and downregulation of GBP5 in macrophages infected with Brucella. Since GBP5 and IL-10 are important molecules involved in host control of Brucella infection, we decided to investigate the role of mmu-miR-21a-5p in bacterial replication in macrophages. We observed that treating macrophages with a mmu-miR-21a-5p mimic enhanced bacterial growth, whereas transfection of its inhibitor reduced Brucella load in macrophages. Taken together, the results indicate that downregulation of mmu-miR-21a-5p induced by infection increases GBP5 levels and decreases IL-10 expression thus contributing to bacterial control in host cells.
C1 [Corsetti, Patricia P.; de Almeida, Leonardo A.; Gomes, Marco Tulio R.; Guimaraes, Erika S.; Marques, Joao T.; Oliveira, Sergio C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   [Corsetti, Patricia P.; de Almeida, Leonardo A.] Univ Fed Alfenas, Dept Microbiol & Imunol, Alfenas, Brazil.
   [Aquime Goncalves, Andre Nicolau] Univ Fed Santa Catarina, Lab Sorol Microbiol & Biol Mol, Florianopolis, SC, Brazil.
   [Oliveira, Sergio C.] Minist Ciencia Tecnol & Inovacao Salvador, INCT DT, Conselho Nacl Desenvolvimento Cient & Tecnol, Salvador, BA, Brazil.
   [Corsetti, Patricia P.] Univ Jose do Rosario Vellano UNIFENAS, Alfenas, MG, Brazil.
RP Oliveira, SC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.; Oliveira, SC (corresponding author), Minist Ciencia Tecnol & Inovacao Salvador, INCT DT, Conselho Nacl Desenvolvimento Cient & Tecnol, Salvador, BA, Brazil.
EM scozeus1@gmail.com
RI de Almeida, Leonardo A/G-2482-2012; Marques, Joao T/F-7683-2012
OI de Almeida, Leonardo A/0000-0003-1886-5080; Marques, Joao
   T/0000-0002-3457-3320
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [464711/2014-2, 402527/2013-5, 443662/2014-2, 302660/2015-1]; Fundacao
   de Amparo a Pesquisa do Estado de Minas GeraisMinas Gerais State
   Research Foundation (FAPEMIG) [837/15]; Rede Mineira de Imunobiologicos
   [00140-16]; Pro-Reitoria de Pesquisa, Universidade Federal de Minas
   Gerais; National Institutes of HealthUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI116453]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI116453, R01AI116453, R01AI116453, R01AI116453,
   R01AI116453] Funding Source: NIH RePORTER
FX This study was funded by Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico grants 464711/2014-2, 402527/2013-5, 443662/2014-2, and
   302660/2015-1, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   grant 837/15 and Rede Mineira de Imunobiologicos #00140-16, Pro-Reitoria
   de Pesquisa, Universidade Federal de Minas Gerais, and National
   Institutes of Health grant R01 AI116453.
CR Ahmed W, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00030
   Alam MM, 2011, EUR J IMMUNOL, V41, P2482, DOI 10.1002/eji.201141740
   Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905
   Burriesci MS, 2012, BIOINFORMATICS, V28, P1324, DOI 10.1093/bioinformatics/bts123
   Cohen TS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003682
   Copin R, 2007, J IMMUNOL, V178, P5182, DOI 10.4049/jimmunol.178.8.5182
   Corsetti PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074729
   Franco MMC, 2018, J IMMUNOL, V200, P607, DOI 10.4049/jimmunol.1700725
   Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508
   Dan Cao, 2015, EMBO Mol Med, V7, P140, DOI 10.15252/emmm.201404797
   de Figueiredo P, 2015, AM J PATHOL, V185, P1505, DOI 10.1016/j.ajpath.2015.03.003
   Duval M, 2017, SEMIN CELL DEV BIOL, V65, P11, DOI 10.1016/j.semcdb.2016.06.016
   Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018
   FERNANDES DM, 1995, INFECT IMMUN, V63, P1130, DOI 10.1128/IAI.63.3.1130-1133.1995
   Gomes MT, 2016, J LEUKOCYTE BIOL, V99, P771, DOI 10.1189/jlb.4A0815-346R
   Gomes MTR, 2013, J IMMUNOL, V190, P3629, DOI 10.4049/jimmunol.1202817
   Gomes MTR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00130
   Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6
   Izar B, 2012, INT J MOL SCI, V13, P1173, DOI 10.3390/ijms13011173
   Jentho E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176204
   Jiang KF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00142
   Keck J, 2017, INT REV IMMUNOL, V36, P287, DOI 10.1080/08830185.2017.1347649
   Kumar R, 2012, CELL MICROBIOL, V14, P1620, DOI 10.1111/j.1462-5822.2012.01827.x
   Lario S, 2012, CLIN MICROBIOL INFEC, V18, pE273, DOI 10.1111/j.1469-0691.2012.03849.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Luo XM, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.02013
   Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080
   Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x
   Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157
   Quinn SR, 2014, CURR TOP MICROBIOL, V380, P145, DOI 10.1007/978-3-662-43492-5_7
   Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108
   Schnitger AKD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027435
   Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94
   Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258
   Sharbati S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-23
   Spinelli SV, 2013, MOL IMMUNOL, V53, P265, DOI 10.1016/j.molimm.2012.08.008
   Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x
   Wu ZW, 2012, FEBS LETT, V586, P2459, DOI 10.1016/j.febslet.2012.06.004
   Xavier MN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003454
   Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009
   Zheng K, 2012, INT J BIOL SCI, V8, P1013, DOI 10.7150/ijbs.3836
   Zhong ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25123
NR 42
TC 9
Z9 9
U1 0
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUN 11
PY 2018
VL 9
AR 1331
DI 10.3389/fimmu.2018.01331
PG 14
WC Immunology
SC Immunology
GA GI8TV
UT WOS:000434799400001
PM 29942317
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Ferreira, FV
   Aguiar, ERGR
   Olmo, RP
   de Oliveira, KPV
   Silva, EG
   Sant'Anna, MRV
   Gontijo, ND
   Kroon, EG
   Imler, JL
   Marques, JT
AF Ferreira, Flavia Viana
   Guimaraes Rocha Aguiar, Eric Roberto
   Olmo, Roenick Proveti
   Vieira de Oliveira, Karla Pollyanna
   Silva, Emanuele Guimaraes
   Viana Sant'Anna, Mauricio Roberto
   Gontijo, Nelder de Figueiredo
   Kroon, Erna Geessien
   Imler, Jean Luc
   Marques, Joao Trindade
TI The small non-coding RNA response to virus infection in the Leishmania
   vector Lutzomyia longipalpis
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VESICULAR STOMATITIS-VIRUS; PHLEBOTOMINE SAND FLIES; CONTINUOUS
   CELL-LINE; NEW-JERSEY SEROTYPE; ANTIVIRAL IMMUNITY; SHANNONI DIPTERA;
   SINDBIS VIRUS; TOSCANA-VIRUS; AEDES-AEGYPTI; PIRNA PATHWAY
AB Sandflies are well known vectors for Leishmania but also transmit a number of arthropodborne viruses (arboviruses). Few studies have addressed the interaction between sandflies and arboviruses. RNA interference (RNAi) mechanisms utilize small non-coding RNAs to regulate different aspects of host-pathogen interactions. The small interfering RNA (siRNA) pathway is a broad antiviral mechanism in insects. In addition, at least in mosquitoes, another RNAi mechanism mediated by PIWI interacting RNAs (piRNAs) is activated by viral infection. Finally, endogenous microRNAs (miRNA) may also regulate host immune responses. Here, we analyzed the small non-coding RNA response to Vesicular stomatitis virus (VSV) infection in the sandfly Lutzoymia longipalpis. We detected abundant production of virus-derived si-RNAs after VSV infection in adult sandflies. However, there was no production of virus-derived piRNAs and only mild changes in the expression of vector miRNAs in response to infection. We also observed abundant production of virus-derived siRNAs against two other viruses in Lutzomyia Lulo cells. Together, our results suggest that the siRNA but not the piRNA pathway mediates an antiviral response in sandflies. In agreement with this hypothesis, pre-treatment of cells with dsRNA against VSV was able to inhibit viral replication while knock-down of the central siRNA component, Argonaute-2, led to increased virus levels. Our work begins to elucidate the role of RNAi mechanisms in the interaction between L. longipalpis and viruses and should also open the way for studies with other sandfly-borne pathogens.
C1 [Ferreira, Flavia Viana; Guimaraes Rocha Aguiar, Eric Roberto; Olmo, Roenick Proveti; Vieira de Oliveira, Karla Pollyanna; Silva, Emanuele Guimaraes; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Ferreira, Flavia Viana; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Viana Sant'Anna, Mauricio Roberto; Gontijo, Nelder de Figueiredo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Imler, Jean Luc] Univ Strasbourg, CNRS M3I UPR9022, Inserm MIR U1257, Strasbourg, France.
   [Guimaraes Rocha Aguiar, Eric Roberto] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Kroon, Erna/V-5444-2019; Aguiar, Eric/T-5076-2019; Aguiar, Eric
   RGR/L-7989-2018; Marques, Joao T/F-7683-2012; Olmo,
   Roenick/AAF-6412-2020; Gontijo, Nelder/D-2539-2013
OI Aguiar, Eric/0000-0002-8143-5756; Aguiar, Eric RGR/0000-0002-8143-5756;
   Marques, Joao T/0000-0002-3457-3320; Gontijo, Nelder/0000-0003-3357-2497
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenancao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG); Agence
   Nationale de la Recherche, Investissement d'AvenirProgramsFrench
   National Research Agency (ANR) [ANR-11-ASV3-002, ANR-10-LABX-36,
   ANR-11-EQPX-0022]
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (http://www.cnpq.br),
   Coordenancao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   (http://www.capes.gov.br/) and Fundacao de Amparo a Pesquisa do Estado
   de Minas Gerais (FAPEMIG) (http://www.fapemig.br) to JTM and EGK; and
   Agence Nationale de la Recherche
   (http://www.agence-nationale-recherche.fr/)(ANR-11-ASV3-002),
   Investissement d'AvenirPrograms (ANR-10-LABX-36; ANR-11-EQPX-0022) to
   JLI. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Adelman ZN, 2001, INSECT MOL BIOL, V10, P265, DOI 10.1046/j.1365-2583.2001.00267.x
   Alkan C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004519
   Bichaud L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001328
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Campbell CL, 2014, INSECT MOL BIOL, V23, P132, DOI 10.1111/imb.12070
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Chang YJE, 2000, J VIROL, V74, P4174, DOI 10.1128/JVI.74.9.4174-4182.2000
   Charrel RN, 2007, EMERG INFECT DIS, V13, P465, DOI 10.3201/eid1303.061086
   Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07
   Clarke GR, 1996, J VET DIAGN INVEST, V8, P105, DOI 10.1177/104063879600800117
   COMER JA, 1990, AM J TROP MED HYG, V42, P483, DOI 10.4269/ajtmh.1990.42.483
   COMER JA, 1992, J MED ENTOMOL, V29, P368, DOI 10.1093/jmedent/29.2.368
   Corbeil A, 2001, GENOME RES, V11, P1198, DOI 10.1101/gr.GR-1802R
   DAROSA APAT, 1984, AM J TROP MED HYG, V33, P999, DOI 10.4269/ajtmh.1984.33.999
   Depaquit J, 2010, EUROSURVEILLANCE, V15, P40
   DHANDA V, 1970, INDIAN J MED RES, V58, P179
   Dietrich I, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00090-17
   Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688
   Galbraith DA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004713
   Gammon DB, 2015, CURR OPIN INSECT SCI, V8, P111, DOI 10.1016/j.cois.2015.01.006
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313
   Aguiar ERGR, 2016, WIRES RNA, V7, P824, DOI 10.1002/wrna.1361
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Khoo CCH, 2013, INSECT MOL BIOL, V22, P104, DOI 10.1111/imb.12008
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Liu JS, 2013, J INSECT PHYSIOL, V59, P646, DOI 10.1016/j.jinsphys.2013.03.013
   Llewellyn ZN, 2002, VIRUS RES, V89, P65, DOI 10.1016/S0168-1702(02)00113-2
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Marques J, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/712603
   Mbow ML, 1998, J IMMUNOL, V161, P5571
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Moriconi M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005660
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nayak A, 2013, CURR TOP MICROBIOL, V371, P183, DOI 10.1007/978-3-642-37765-5_7
   Petit M, 2016, P NATL ACAD SCI USA, V113, pE4218, DOI 10.1073/pnas.1607952113
   Remoli ME, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1488-3
   Rey GJ, 2000, MEM I OSWALDO CRUZ, V95, P103, DOI 10.1590/S0074-02762000000100017
   Rossi E, 2008, ACTA TROP, V105, P158, DOI 10.1016/j.actatropica.2007.10.005
   Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schnettler E, 2013, J VIROL, V87, P2441, DOI 10.1128/JVI.02848-12
   Shrinet J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002616
   Sidwell RW, 2003, ANTIVIR RES, V57, P101, DOI 10.1016/S0166-3542(02)00203-6
   Slonchak A, 2014, J VIROL, V88, P8457, DOI 10.1128/JVI.00317-14
   Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525
   Spellberg MJ, 2015, P NATL ACAD SCI USA, V112, P14587, DOI 10.1073/pnas.1517124112
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Telleria EL, 2012, J BIOL CHEM, V287, P12985, DOI 10.1074/jbc.M111.331561
   TESH RB, 1988, ANNU REV ENTOMOL, V33, P169, DOI 10.1146/annurev.en.33.010188.001125
   TESH RB, 1987, AM J TROP MED HYG, V36, P653, DOI 10.4269/ajtmh.1987.36.653
   TESH RB, 1971, AM J EPIDEMIOL, V93, P491
   TESH RB, 1983, J MED ENTOMOL, V20, P199, DOI 10.1093/jmedent/20.2.199
   TESH RB, 1969, AM J EPIDEMIOL, V90, P255, DOI 10.1093/oxfordjournals.aje.a121068
   TESH RB, 1974, AM J TROP MED HYG, V23, P258, DOI 10.4269/ajtmh.1974.23.258
   TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436
   Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
NR 65
TC 4
Z9 7
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2018
VL 12
IS 6
AR e0006569
DI 10.1371/journal.pntd.0006569
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GL8CX
UT WOS:000437442000044
PM 29864168
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Garcia, CC
   Tavares, LP
   Dias, ACF
   Kehdy, F
   Alvarado-Arnez, LE
   Queiroz, CM
   Galvao, I
   Lima, BH
   Matos, AR
   Goncalves, APF
   Soriani, FM
   Moraes, MO
   Marques, JT
   Siqueira, MM
   Machado, AMV
   Sousa, LP
   Russo, RC
   Teixeira, MM
AF Garcia, Cristiana C.
   Tavares, Luciana P.
   Dias, Ana Carolina F.
   Kehdy, Fernanda
   Alvarado-Arnez, Lucia Elena
   Queiroz-Junior, Celso M.
   Galvao, Izabela
   Lima, Braulio H.
   Matos, Aline R.
   Goncalves, Ana Paula F.
   Soriani, Frederico M.
   Moraes, Milton O.
   Marques, Joao T.
   Siqueira, Marilda M.
   Machado, Alexandre M. V.
   Sousa, Lirlandia P.
   Russo, Remo C.
   Teixeira, Mauro M.
TI Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory
   Responses During Influenza A H1N1 Infection: From Murine Model to
   Genetic Association in Patients
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE neutrophils; CD8(+) T cells; natural killer cells; type-I IFN; p38;
   disease severity; single-nucleotide polymorphism
ID ACUTE LUNG INJURY; PHOSPHOINOSITIDE 3-KINASE GAMMA; VIRUS-INFECTION;
   REACTIVE OXYGEN; PHOSPHATIDYLINOSITOL-3-KINASE PI3K; IMMUNE-RESPONSE;
   CUTTING EDGE; NEUTROPHILS; ACTIVATION; PI3K-GAMMA
AB Influenza A virus (IAV) infection causes severe pulmonary disease characterized by intense leukocyte infiltration. Phosphoinositide-3 kinases (PI3Ks) are central signaling enzymes, involved in cell growth, survival, and migration. Class IB PI3K or phosphatidyl inositol 3 kinase-gamma (PI3K gamma), mainly expressed by leukocytes, is involved in cell migration during inflammation. Here, we investigated the contribution of PI3K gamma for the inflammatory and antiviral responses to IAV. PI3K gamma knockout (KO) mice were highly susceptible to lethality following infection with influenza A/WSN/33 H1N1. In the early time points of infection, infiltration of neutrophils was higher than WT mice whereas type-I and type-III IFN expression and p38 activation were reduced in PI3K gamma KO mice resulting in higher viral loads when compared with WT mice. Blockade of p38 in WT macrophages infected with IAV reduced levels of interferon-stimulated gene 15 protein to those induced in PI3K gamma KO macrophages, suggesting that p38 is downstream of antiviral responses mediated by PI3K gamma. PI3K gamma KO-derived fibroblasts or macrophages showed reduced type-I IFN transcription and altered pro-inflammatory cytokines suggesting a cell autonomous imbalance between inflammatory and antiviral responses. Seven days after IAV infection, there were reduced infiltration of natural killer cells and CD8(+) T lymphocytes, increased concentration of inflammatory cytokines in bronchoalveolar fluid, reduced numbers of resolving macrophages, and IL-10 levels in PI3K gamma KO. This imbalanced environment in PI3K gamma KO-infected mice culminated in enhanced lung neutrophil infiltration, reactive oxygen species release, and lung damage that together with the increased viral loads, contributed to higher mortality in PI3K gamma KO mice compared with WT mice. In humans, we tested the genetic association of disease severity in influenza A/H1N1pdm09-infected patients with three potentially functional PIK3CG single-nucleotide polymorphisms (SNPs), rs1129293, rs17847825, and rs2230460. We observed that SNPs rs17847825 and rs2230460 (A and T alleles, respectively) were significantly associated with protection from severe disease using the recessive model in patients infected with influenza A(H1N1) pdm09. Altogether, our results suggest that PI3K gamma is crucial in balancing antiviral and inflammatory responses to IAV infection.
C1 [Garcia, Cristiana C.; Matos, Aline R.; Siqueira, Marilda M.] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, Rio De Janeiro, Brazil.
   [Garcia, Cristiana C.; Tavares, Luciana P.; Dias, Ana Carolina F.; Galvao, Izabela; Lima, Braulio H.; Goncalves, Ana Paula F.; Soriani, Frederico M.; Sousa, Lirlandia P.; Russo, Remo C.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab Imunofarmacol, Belo Horizonte, MG, Brazil.
   [Tavares, Luciana P.; Russo, Remo C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Lab Imunol & Mecan Pulmonar, Belo Horizonte, MG, Brazil.
   [Kehdy, Fernanda; Alvarado-Arnez, Lucia Elena; Moraes, Milton O.] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, Brazil.
   [Alvarado-Arnez, Lucia Elena] UNIFRANZ, Coordinac Nacl Invest, La Paz, Bolivia.
   [Queiroz-Junior, Celso M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil.
   [Lima, Braulio H.] Univ Sao Paulo, Dept Farmacol Predio Cent, Lab Inflamacao & Dor, Ribeirao Preto, Brazil.
   [Goncalves, Ana Paula F.; Machado, Alexandre M. V.] Fundacao Oswaldo Cruz Fiocruz, Ctr Pesquisas Rene Rachou, Lab Imunol Doencas Virais, Belo Horizonte, MG, Brazil.
   [Soriani, Frederico M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.
   [Marques, Joao T.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab RNA Interferencia, Belo Horizonte, MG, Brazil.
   [Sousa, Lirlandia P.] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil.
RP Garcia, CC (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, Rio De Janeiro, Brazil.; Garcia, CC; Teixeira, MM (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab Imunofarmacol, Belo Horizonte, MG, Brazil.
EM cristiana.garcia@ioc.fiocruz.br; mmtex@icb.ufmg.br
RI Moraes, Milton Ozorio/G-9753-2011; Marques, Joao T/F-7683-2012; Russo,
   Remo Castro/O-8980-2019; Garcia, Cristiana C/G-9509-2013; Machado,
   Alexandre M Vieira/G-2468-2012; Queiroz-Junior, Celso/L-5438-2013; da
   Rocha Matos, Aline/AAG-9577-2020; Arnez, Lucia Elena
   Alvarado/D-4690-2016; Teixeira, Mauro M/A-4587-2008
OI Moraes, Milton Ozorio/0000-0003-2653-0037; Marques, Joao
   T/0000-0002-3457-3320; Russo, Remo Castro/0000-0002-1715-3834; Garcia,
   Cristiana C/0000-0002-4400-9141; Machado, Alexandre M
   Vieira/0000-0003-1506-4093; Queiroz-Junior, Celso/0000-0002-7884-7709;
   Arnez, Lucia Elena Alvarado/0000-0002-3537-6361; Teixeira, Mauro
   M/0000-0002-6944-3008; Kehdy, Fernanda/0000-0001-8964-9049; Padua
   Tavares, Luciana/0000-0002-5319-0210; Matos, Aline da
   Rocha/0000-0001-7763-2127
FU National Institute of Science and Technology in Dengue from CNPq/Fapemig
   [INCTD 573876/2008]; National Institute of Science and Technology in
   Vaccines (INCTV) from CNPq/Fapemig [015/2008]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [474887/2011-1,
   478413/2012-2, 459527/2014-2]; JCNE from FAPERJ [26/203.156/2017];
   European Community's Seventh Framework Programme [FP7]European Union
   (EU) [HEALTH-F4-2011-281608]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior/CAPESCAPES
FX We were funded by the National Institute of Science and Technology in
   Dengue (INCTD 573876/2008 to MT), the National Institute of Science and
   Technology in Vaccines (INCTV, 015/2008 to AMVM) from CNPq/Fapemig,
   Universal Program from CNPq (474887/2011-1 to RR, 478413/2012-2 to AMVM,
   and 459527/2014-2 to CG), JCNE from FAPERJ (E-26/203.156/2017 to CG),
   and the European Community's Seventh Framework Programme [FP7-2007-2013]
   (HEALTH-F4-2011-281608 to MT). LA-A was supported as a postdoctoral
   fellow by the funding agency Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior/CAPES. The funders had no role in study design, data
   collection and interpretation, or the decision to submit the work for
   publication.
CR Adams JN, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-77
   Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448
   Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393
   Barbosa RPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098685
   Antonopoulou A, 2012, INT J INFECT DIS, V16, pE204, DOI 10.1016/j.ijid.2011.11.012
   Aranda-Romo S, 2012, IMMUNOGENETICS, V64, P653, DOI 10.1007/s00251-012-0623-3
   Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004
   Borgeling Y, 2014, J BIOL CHEM, V289, P13, DOI 10.1074/jbc.M113.469239
   Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039
   Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013
   Castor MGM, 2011, J LEUKOCYTE BIOL, V89, P955, DOI 10.1189/jlb.0810464
   Ciancanelli MJ, 2016, CURR OPIN IMMUNOL, V38, P109, DOI 10.1016/j.coi.2015.12.002
   Condliffe A M, 2000, Respir Res, V1, P24, DOI 10.1186/rr8
   Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944
   Conte E, 2013, LAB INVEST, V93, P566, DOI 10.1038/labinvest.2013.6
   Dalli J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01400
   Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392
   Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770
   Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395
   Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06
   Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x
   Esposito S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-270
   Fumagalli L, 2013, J IMMUNOL, V190, P3648, DOI 10.4049/jimmunol.1201951
   Garcia CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064443
   Garcia CC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001171
   Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017
   Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105
   Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200
   Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049
   Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x
   Hsu ACY, 2015, AM J RESP CRIT CARE, V191, P1012, DOI 10.1164/rccm.201501-0188OC
   Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2
   Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604
   Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5
   Kachele M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144494
   Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316
   Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112
   Keynan Y, 2013, PUBLIC HEALTH GENOM, V16, P9, DOI 10.1159/000345937
   Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495
   Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625
   Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209
   Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590
   Lehmann K, 2009, BIOCHEM J, V419, P603, DOI 10.1042/BJ20081268
   Li WZ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-36
   Lim K, 2015, SCIENCE, V349, DOI 10.1126/science.aaa4352
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110
   Martin D, 2011, CANCER CELL, V19, P805, DOI 10.1016/j.ccr.2011.05.005
   Maus UA, 2007, AM J RESP CRIT CARE, V175, P958, DOI 10.1164/rccm.200610-1533OC
   Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013
   Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841
   Nigorikawa K, 2012, J PHARMACOL SCI, V120, P270, DOI 10.1254/jphs.12134FP
   Nobs SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005508
   Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589
   Pinho V, 2007, J IMMUNOL, V179, P7891, DOI 10.4049/jimmunol.179.11.7891
   Reif K, 2004, J IMMUNOL, V173, P2236, DOI 10.4049/jimmunol.173.4.2236
   Rodriguez-Borlado L, 2003, J IMMUNOL, V170, P4475, DOI 10.4049/jimmunol.170.9.4475
   Ruckle T, 2006, NAT REV DRUG DISCOV, V5, P903, DOI 10.1038/nrd2145
   Russo RC, 2011, J LEUKOCYTE BIOL, V89, P269, DOI 10.1189/jlb.0610346
   Russo RC, 2009, AM J RESP CELL MOL, V40, P410, DOI 10.1165/rcmb.2007-0364OC
   Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040
   Sawczuk M, 2014, POL ARCH MED WEWN, V124, P210, DOI 10.20452/pamw.2198
   Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801
   Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181
   Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304
   Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0
   Sugimoto MA, 2017, BLOOD, V129, P2896, DOI 10.1182/blood-2016-09-742825
   To KKW, 2015, CURR OPIN VIROL, V14, P7, DOI 10.1016/j.coviro.2015.04.010
   Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005
   Vago JP, 2015, J IMMUNOL, V194, P4940, DOI 10.4049/jimmunol.1401722
   Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271
   Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922
   Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319
   Wareing MD, 2004, J LEUKOCYTE BIOL, V76, P886, DOI 10.1189/jlb.1203644
   Wong SS, 2018, J INFECT DIS, V217, P245, DOI 10.1093/infdis/jix571
   Yang KY, 2003, CELL SIGNAL, V15, P225, DOI 10.1016/S0898-6568(02)00063-3
   Yum HK, 2001, J IMMUNOL, V167, P6601, DOI 10.4049/jimmunol.167.11.6601
   Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433
NR 80
TC 7
Z9 7
U1 0
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAY 15
PY 2018
VL 9
AR 975
DI 10.3389/fimmu.2018.00975
PG 18
WC Immunology
SC Immunology
GA GF9QL
UT WOS:000432313100001
PM 29867955
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Sedda, L
   Vilela, APP
   Aguiar, ERGR
   Gaspar, CHP
   Goncalves, ANA
   Olmo, RP
   Silva, ATS
   da Silveira, LD
   Eiras, AE
   Drumond, BP
   Kroon, EG
   Marques, JT
AF Sedda, Luigi
   Pessoa Vilela, Ana Paula
   Guimaraes Rocha Aguiar, Eric Roberto
   Pessoa Gaspar, Caio Henrique
   Aquime Goncalves, Andre Nicolau
   Olmo, Roenick Proveti
   Saraiva Silva, Ana Teresa
   da Silveira, Lizia de Cassia
   Eiras, Alvaro Eduardo
   Drumond, Betania Paiva
   Kroon, Erna Geessien
   Marques, Joao Trindade
TI The spatial and temporal scales of local dengue virus transmission in
   natural settings: a retrospective analysis
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Dengue virus serotypes 1 and 3;
   Bivariate point-process; Kriging; Geostatistical additive models; Urban
   dengue
ID AEDES-ALBOPICTUS DIPTERA; RIO-DE-JANEIRO; POLYMERASE-CHAIN-REACTION;
   AEGYPTI MOSQUITOS; LARVAL INDEXES; SEROTYPES 1; SAO-PAULO; CULICIDAE;
   VECTOR; SURVEILLANCE
AB Background: Dengue is a vector-borne disease caused by the dengue virus (DENV). Despite the crucial role of Aedes mosquitoes in DENV transmission, pure vector indices poorly correlate with human infections. Therefore there is great need for a better understanding of the spatial and temporal scales of DENV transmission between mosquitoes and humans. Here, we have systematically monitored the circulation of DENV in individual Aedes spp. mosquitoes and human patients from Caratinga, a dengue endemic city in the state of Minas Gerais, in Southeast Brazil. From these data, we have developed a novel stochastic point process pattern algorithm to identify the spatial and temporal association between DENV infected mosquitoes and human patients.
   Methods: The algorithm comprises of: (i) parameterization of the variogram for the incidence of each DENV serotype in mosquitoes; (ii) identification of the spatial and temporal ranges and variances of DENV incidence in mosquitoes in the proximity of humans infected with dengue; and (iii) analysis of the association between a set of environmental variables and DENV incidence in mosquitoes in the proximity of humans infected with dengue using a spatio-temporal additive, geostatistical linear model.
   Results: DENV serotypes 1 and 3 were the most common virus serotypes detected in both mosquitoes and humans. Using the data on each virus serotype separately, our spatio-temporal analyses indicated that infected humans were located in areas with the highest DENV incidence in mosquitoes, when incidence is calculated within 2.5-3 km and 50 days (credible interval 30-70 days) before onset of symptoms in humans. These measurements are in agreement with expected distances covered by mosquitoes and humans and the time for virus incubation. Finally, DENV incidence in mosquitoes found in the vicinity of infected humans correlated well with the low wind speed, higher air temperature and northerly winds that were more likely to favor vector survival and dispersal in Caratinga.
   Conclusions: We have proposed a new way of modeling bivariate point pattern on the transmission of arthropodborne pathogens between vector and host when the location of infection in the latter is known. This strategy avoids some of the strong and unrealistic assumptions made by other point-process models. Regarding virus transmission in Caratinga, our model showed a strong and significant association between high DENV incidence in mosquitoes and the onset of symptoms in humans at specific spatial and temporal windows. Together, our results indicate that vector surveillance must be a priority for dengue control. Nevertheless, localized vector control at distances lower than 2.5 km around premises with infected vectors in densely populated areas are not likely to be effective.
C1 [Sedda, Luigi] Univ Lancaster, CHICAS, Furness Bldg, Lancaster LA1 4YG, England.
   [Pessoa Vilela, Ana Paula; Guimaraes Rocha Aguiar, Eric Roberto; Aquime Goncalves, Andre Nicolau; Olmo, Roenick Proveti; Saraiva Silva, Ana Teresa; da Silveira, Lizia de Cassia; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Pessoa Vilela, Ana Paula; Pessoa Gaspar, Caio Henrique; Drumond, Betania Paiva; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Guimaraes Rocha Aguiar, Eric Roberto] Univ Fed Bahia, Inst Ciencias Saude, BR-40110100 Salvador, BA, Brazil.
   [Eiras, Alvaro Eduardo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, BR-30270901 Belo Horizonte, MG, Brazil.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Aguiar, Eric/T-5076-2019; Marques, Joao T/F-7683-2012; Aguiar, Eric
   RGR/L-7989-2018; Vilela, Ana Paula Pessoa/Q-7538-2018; Kroon,
   Erna/V-5444-2019; Sedda, Luigi/ABD-8784-2020; Eiras, Alvaro/Z-6023-2019;
   Olmo, Roenick/AAF-6412-2020
OI Aguiar, Eric/0000-0002-8143-5756; Marques, Joao T/0000-0002-3457-3320;
   Aguiar, Eric RGR/0000-0002-8143-5756; Vilela, Ana Paula
   Pessoa/0000-0001-9030-0688; Eiras, Alvaro/0000-0002-3045-0673; Sedda,
   Luigi/0000-0002-9271-6596
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX This work was supported with grants from CAPES, CNPq and FAPEMIG to EGK
   and JTM. EGK and JTM are researchers from CNPq.
CR Azil AH, 2014, J VECTOR ECOL, V39, P153, DOI 10.1111/j.1948-7134.2014.12082.x
   Barmak DH, 2016, PHYSICA A, V447, P129, DOI 10.1016/j.physa.2015.12.015
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Cecilio SG, 2015, J VECTOR ECOL, V40, P71, DOI 10.1111/jvec.12134
   Chadee DD, 2009, ACTA TROP, V112, P174, DOI 10.1016/j.actatropica.2009.07.017
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen CF, 2010, VECTOR-BORNE ZOONOT, V10, P1017, DOI 10.1089/vbz.2008.0069
   Cheong YL, 2013, INT J ENV RES PUB HE, V10, P6319, DOI 10.3390/ijerph10126319
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   Costa ACC, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0219-6
   Cressie N, 2015, STAT SPATIAL DATA
   Cummins B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002500
   Taranto MFD, 2015, TROP MED INT HEALTH, V20, P77, DOI 10.1111/tmi.12402
   de Bronzoni RV Morais, 2005, J CLIN MICROBIOL, V43, P7
   de Castro MG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-3
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   Degener CM, 2015, MEM I OSWALDO CRUZ, V110, P517, DOI 10.1590/0074-02760140374
   Depradine CA, 2004, INT J ENVIRON HEAL R, V14, P429, DOI 10.1080/09603120400012868
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   Diggle P J, 2013, STAT ANAL SPATIAL SP
   Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Favaro EA, 2006, J VECTOR ECOL, V31, P285, DOI 10.3376/1081-1710(2006)31[285:PSOASA]2.0.CO;2
   de Figueiredo MLG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-60
   Gaye A, 2014, TROP MED INT HEALTH, V19, P1355, DOI 10.1111/tmi.12373
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Heringer M, 2015, T ROY SOC TROP MED H, V109, P268, DOI 10.1093/trstmh/trv006
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Kan CC, 2008, AM J TROP MED HYG, V79, P344, DOI 10.4269/ajtmh.2008.79.344
   Karl S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-447
   Khalid B, 2015, INT J BIOMETEOROL, V59, P267, DOI 10.1007/s00484-014-0840-6
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277
   Maciel-de-Freitas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065252
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Mendez-Galvan J, 2014, SOUTHWEST ENTOMOL, V39, P307, DOI 10.3958/059.039.0208
   Mercado-Hernandez R, 2003, J AM MOSQUITO CONTR, V19, P15
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Mwangangi JM, 2012, PARASITOL RES, V110, P61, DOI 10.1007/s00436-011-2449-6
   Naish S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092524
   Nino L, 2008, BIOMEDICA, V28, P578, DOI 10.7705/biomedica.v28i4.64
   de Melo DPO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042125
   Pepin KM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0659-y
   Pepin KM, 2013, EMERG INFECT DIS, V19, P542, DOI 10.3201/eid1904.120117
   Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28
   Pinheiro J. C, 2012, NLME PACKAGE LINEAR, V6
   Piovezan R, 2013, J VECTOR ECOL, V38, P317, DOI 10.1111/j.1948-7134.2013.12046.x
   Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648
   Richards SL, 2012, J MED ENTOMOL, V49, P942, DOI 10.1603/ME11293
   Rosa-Freitas Maria Goreti, 2006, Rev Panam Salud Publica, V20, P256, DOI 10.1590/S1020-49892006000900006
   Sanchez L, 2006, EMERG INFECT DIS, V12, P800
   Schlather M., 2012, ADV CHALLENGES SPACE, P25, DOI DOI 10.1007/978-3-642-17086-7_2
   Sedda L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1024-5
   Simoes TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064773
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Sun CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088025
   Taber ED, 2017, J VECTOR ECOL, V42, P3, DOI 10.1111/jvec.12234
   Talagala T, 2015, EPIDEMIOL BIOSTAT PU, V12, DOI 10.2427/11522
   Telle O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146539
   Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004
   Vargas WP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2097-3
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Vikram K, 2015, J VECTOR DIS, V52, P129
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649
   Wang CG, 2014, ASIA-PAC J PUBLIC HE, V26, P48, DOI 10.1177/1010539513490195
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Wen TH, 2015, APPL GEOGR, V62, P256, DOI 10.1016/j.apgeog.2015.05.003
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
   Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004964
   Wong GKL, 2017, BUILD ENVIRON, V112, P63, DOI 10.1016/j.buildenv.2016.11.028
   Wong GKL, 2016, SCI TOTAL ENVIRON, V573, P222, DOI 10.1016/j.scitotenv.2016.08.102
   World Health Organization, 2009, DENG GUID DIAGN TREA
   ZIMMERMAN DL, 1993, MATH GEOL, V25, P453, DOI 10.1007/BF00894779
NR 88
TC 5
Z9 5
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 2
PY 2018
VL 11
AR 79
DI 10.1186/s13071-018-2662-6
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FU9CY
UT WOS:000424154800001
PM 29394906
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-16
ER

PT J
AU Lourenco-de-Oliveira, R
   Marques, JT
   Sreenu, VB
   Nten, CA
   Aguiar, ERGR
   Varjak, M
   Kohl, A
   Failloux, AB
AF Lourenco-de-Oliveira, Ricardo
   Marques, Joao T.
   Sreenu, Vattipally B.
   Nten, Celestine Atyame
   Guimaraes Rocha Aguiar, Eric Roberto
   Varjak, Margus
   Kohl, Alain
   Failloux, Anna-Bella
TI Culex quinquefasciatus mosquitoes do not support replication of Zika
   virus
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE mosquito; Culex spp; mosquitoes; Zika virus; transmission; replication
ID AEDES-AEGYPTI; PIPIENS COMPLEX; WOLBACHIA; COMPETENCE; BRAZIL;
   TRANSMISSION; INHIBITION; VECTORS; DISEASE; STRAIN
AB The rapid spread of Zika virus (ZIKV) in the Americas raised many questions about the role of Culex quinquefasciatus mosquitoes in transmission, in addition to the key role played by the vector Aedes aegypti. Here we analysed the competence of Cx. quinquefasciatus (with or without Wolbachia endosymbionts) for a ZIKV isolate. We also examined the induction of RNA interference pathways after viral challenge and the production of small virus-derived RNAs. We did not observe any infection nor such small virus-derived RNAs, regardless of the presence or absence of Wolbachia. Thus, Cx. quinquefasciatus does not support ZIKV replication and Wolbachia is not involved in producing this phenotype. In short, these mosquitoes are very unlikely to play a role in transmission of ZIKV.
C1 [Lourenco-de-Oliveira, Ricardo; Nten, Celestine Atyame; Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.
   [Lourenco-de-Oliveira, Ricardo] Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Marques, Joao T.; Guimaraes Rocha Aguiar, Eric Roberto] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, 6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
   [Sreenu, Vattipally B.; Varjak, Margus; Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
   [Nten, Celestine Atyame] Univ Reunion Isl, CNRS 9192, UMR PIMIT Proc Infect Milieu Insulaire Trop, INSERM,U1187,IRD 249, St Clotilde, Reunion, France.
RP Failloux, AB (corresponding author), Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.; Kohl, A (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
EM alain.Kohl@glasgow.ac.uk; anna-bella.failloux@pasteur.fr
RI Aguiar, Eric RGR/L-7989-2018; Aguiar, Eric/T-5076-2019; Marques, Joao
   T/F-7683-2012
OI Aguiar, Eric RGR/0000-0002-8143-5756; Aguiar, Eric/0000-0002-8143-5756;
   Marques, Joao T/0000-0002-3457-3320; Vattipally, Bala
   Sreenu/0000-0001-6673-4697; Varjak, Margus/0000-0003-2608-5148
FU European Union's Horizon research and innovation programme under
   ZIKAlliance grant [734548]; European Union's Horizon research and
   innovation programme under Marie Sklodowska-Curie grant [661232];
   CAPES-COFECUB programme grantCAPES [799-14]; Fundacao Carlos Chagas
   Filho de Amparoa Pesquisa do Estado do Rio de Janeiro grant
   [E-26/201.335/2016]; UK Medical Research CouncilMedical Research Council
   UK (MRC) [MC_UU_12014]; Medical Research CouncilMedical Research Council
   UK (MRC) [MC_UU_12014/12, G0801822, MC_UU_12014/8] Funding Source:
   researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01AI115595, U01AI115595, U01AI115595,
   U01AI115595, U01AI115595, U01AI115595] Funding Source: NIH RePORTER
FX This study was partially supported by the European Union's Horizon 2020
   research and innovation programme under ZIKAlliance grant agreement no.
   734548 (A.K., A.B.F., J.M., R.L.O.) and under Marie Sklodowska-Curie
   grant agreement no. 661232 (M.V.). Moreover, the project received
   support under the CAPES-COFECUB programme grant agreement no, 799-14
   (A.B.F., R.L.O.), and the Fundacao Carlos Chagas Filho de Amparoa
   Pesquisa do Estado do Rio de Janeiro grant agreement no.
   E-26/201.335/2016 (R.L.O.). This work was also funded by the UK Medical
   Research Council (MC_UU_12014) (A.K.).
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Atyame CM, 2011, MOL BIOL EVOL, V28, P2761, DOI 10.1093/molbev/msr083
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Caragata EP, 2016, FUTURE MICROBIOL, V11, P1499, DOI 10.2217/fmb-2016-0177
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Demir T, 2016, FOLIA MICROBIOL, V61, P523, DOI 10.1007/s12223-016-0467-6
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Donald Claire L, 2012, Insects, V3, P511, DOI 10.3390/insects3020511
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GEORGHIOU GP, 1966, B WORLD HEALTH ORGAN, V35, P691
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Aguiar ERGR, 2016, NUCLEIC ACIDS RES, V44, P3477, DOI 10.1093/nar/gkw044
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hang J, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01644-15
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew035
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li CX, 2015, ELIFE, V4, DOI 10.7554/eLife.05378
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005511
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Parrish NF, 2015, RNA, V21, P1691, DOI 10.1261/rna.052092.115
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.00305, 10.3389/fmicb.2017.00581]
   Richard V, 2017, ACTA TROP, V173, P200, DOI 10.1016/j.actatropica.2017.04.036
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354
   Sinkins SP, 2013, FUTURE MICROBIOL, V8, P1249, DOI 10.2217/fmb.13.95
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   YEN JH, 1973, J INVERTEBR PATHOL, V22, P242, DOI 10.1016/0022-2011(73)90141-9
NR 63
TC 17
Z9 17
U1 0
U2 5
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD FEB
PY 2018
VL 99
IS 2
BP 258
EP 264
DI 10.1099/jgv.0.000949
PG 7
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GE2AU
UT WOS:000431018700012
PM 29076805
OA Green Accepted, Green Published
DA 2020-12-16
ER

PT J
AU Marinho, FV
   Benmerzoug, S
   Rose, S
   Campos, PC
   Marques, JT
   Bafica, A
   Barber, G
   Ryffel, B
   Oliveira, SC
   Quesniaux, VFJ
AF Marinho, Fabio, V
   Benmerzoug, Sulayman
   Rose, Stephanie
   Campos, Priscila C.
   Marques, Joao T.
   Bafica, Andre
   Barber, Glen
   Ryffel, Bernhard
   Oliveira, Sergio C.
   Quesniaux, Valerie F. J.
TI The cGAS/STING Pathway Is Important for Dendritic Cell Activation but Is
   Not Essential to Induce Protective Immunity against Mycobacterium
   tuberculosis Infection
SO JOURNAL OF INNATE IMMUNITY
LA English
DT Article
DE STING; cGAS; Mycobacterium tuberculosis; Dendritic cells
ID CYTOSOLIC SURVEILLANCE PATHWAY; GMP-AMP SYNTHASE; CYCLIC DI-GMP; INNATE
   IMMUNITY; ANTIVIRAL DEFENSE; INTRACELLULAR DNA; DEFICIENT MICE; SENSOR;
   CGAS; ROLES
AB Mycobacterium tuberculosis (Mtb) infection remains a major public health concern. The STING (stimulator of interferon genes) pathway contributes to the cytosolic surveillance of host cells. Most studies on the role of STING activation in Mtb infection have focused on macrophages. Moreover, a detailed investigation of the role of STING during Mtb infection in vivo is required. Here, we deciphered the involvement of STING in the activation of dendritic cells (DCs) and the host response to Mtb infection in vivo. In DCs, this adaptor molecule was important for Ifn-beta expression and IL-12 production as well as for the surface expression of the activation markers CD40 and CD86. We also documented that Mtb DNA induces STING activation in murine fibroblasts. In vivo Mtb aerogenic infection induced the upregulation of the STING and cGAS (cyclic GMP-AMP synthase) genes, and Ifn-beta pulmonary expression was dependent on both sensors. However, mice deficient for STING or cGAS presented a similar outcome to wild-type controls, with no major alterations in body weight gain, bacterial burden, or survival. Lung inflammation, proinflammatory cytokine production, and inflammatory cell recruitment were similar in STING- and cGAS-deficient mice compared to wild-type controls. In summary, although the STING pathway seems to be crucial for DC activation during Mtb infection, it is dispensable for host protection in vivo. (C) 2018 S. Karger AG, Basel
C1 [Marinho, Fabio, V; Benmerzoug, Sulayman; Rose, Stephanie; Ryffel, Bernhard; Quesniaux, Valerie F. J.] CNRS, UMR7355, FR-45071 Orleans, France.
   [Marinho, Fabio, V; Benmerzoug, Sulayman; Rose, Stephanie; Ryffel, Bernhard; Quesniaux, Valerie F. J.] Univ Orleans, Expt & Mol Immunol & Neurogenet, Orleans, France.
   [Marinho, Fabio, V; Campos, Priscila C.; Marques, Joao T.; Oliveira, Sergio C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Marinho, Fabio, V; Oliveira, Sergio C.] Minist Ciencia Tecnol & Inovacao Salvador, INCT DT, Conselho Nacl Desenvolvimento Cient & Tecnol, Salvador, BA, Brazil.
   [Bafica, Andre] Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil.
   [Barber, Glen] Univ Miami, Dept Cell Biol, Miami, FL USA.
RP Quesniaux, VFJ (corresponding author), CNRS, UMR7355, FR-45071 Orleans, France.; Oliveira, SC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil.
EM scozeus@icb.ufmg.br; quesniaux@cnrs-orleans.fr
RI Benmerzoug, Sulayman/T-6721-2019; Bafica, Andre/ABF-5986-2020; Marques,
   Joao T/F-7683-2012
OI Bafica, Andre/0000-0002-5148-600X; Marques, Joao T/0000-0002-3457-3320;
   Marinho, Fabio/0000-0001-6885-3438
FU Brazilian CNPq/PDE [201452/2015-4]; Brazilian CNPq/PDJ [150044/2017-8];
   Brazilian CAPES/PVE [030448/2013-01, 030490/2013-01]; Brazilian
   CNPq/INCT-DT [465229/2014-0]; Brazilian CNPqNational Council for
   Scientific and Technological Development (CNPq) [443662/2014-2];
   Brazilian CAPES/COFECUB [868/2015]; Brazilian French Region Centre-Val
   de Loire [2015-00099232]; European funding in Region Centre-Val de Loire
   (FEDER) [2016-00110366]; CNRS LIACentre National de la Recherche
   Scientifique (CNRS) [1047]
FX This study was supported by grants from Brazilian CNPq/PDE
   (201452/2015-4), CNPq/PDJ (150044/2017-8), CAPES/PVE (030448/2013-01 and
   030490/2013-01), CNPq/INCT-DT (465229/2014-0), CNPq (443662/2014-2),
   CAPES/COFECUB (868/2015), French Region Centre-Val de Loire (No.
   2015-00099232), and European funding in Region Centre-Val de Loire
   (FEDER No. 2016-00110366) and CNRS LIA (No. 1047).
CR Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14
   Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109
   Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782
   Bean AGD, 1999, J IMMUNOL, V162, P3504
   Bourigault ML, 2013, IMMUN INFLAMM DIS, V1, P47, DOI 10.1002/iid3.9
   Brown N, 2005, INFECT IMMUN, V73, P666, DOI 10.1128/IAI.73.1.666-670.2005
   Chandra D, 2014, CANCER IMMUNOL RES, V2, P901, DOI 10.1158/2326-6066.CIR-13-0123
   Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022
   Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005
   Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019
   Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813
   Domingo-Gonzalez R, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0018-2016
   DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995
   Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027
   HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476
   Khan M, 2016, INFECT IMMUN, V84, P3458, DOI 10.1128/IAI.00531-16
   Konig N, 2017, ANN RHEUM DIS, V76, P468, DOI 10.1136/annrheumdis-2016-209841
   Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039
   Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040
   Lio CWJ, 2016, J VIROL, V90, P7789, DOI 10.1128/JVI.01040-16
   Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007
   Marinho FV, 2017, TRENDS MICROBIOL, V25, P906, DOI 10.1016/j.tim.2017.05.008
   Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093
   Moliva Juan I, 2017, Front Immunol, V8, P407, DOI 10.3389/fimmu.2017.00407
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460
   Spaulding E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005975
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426
   Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200
   Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932
   Wassermann R, 2015, CELL HOST MICROBE, V17, P799, DOI 10.1016/j.chom.2015.05.003
   Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004
   Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040
   Wiens KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005809
   Xu MM, 2017, IMMUNITY, V47, P363, DOI 10.1016/j.immuni.2017.07.016
   Yao XY, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005930
   Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051
   Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4
NR 41
TC 8
Z9 8
U1 1
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1662-811X
EI 1662-8128
J9 J INNATE IMMUN
JI J. Innate Immun.
PY 2018
VL 10
IS 3
BP 239
EP 252
DI 10.1159/000488952
PG 14
WC Immunology
SC Immunology
GA GK2KR
UT WOS:000435959200009
PM 29791904
OA Green Published, Bronze
DA 2020-12-16
ER

PT J
AU Alves-Silva, J
   Tavares, IP
   Guimaraes, ES
   Franco, MMC
   Figueiredo, BC
   Marques, JT
   Splitter, G
   Oliveira, SC
AF Alves-Silva, Juliana
   Tavares, Isabela P.
   Guimaraes, Erika S.
   Costa Franco, Miriam M.
   Figueiredo, Barbara C.
   Marques, Joao T.
   Splitter, Gary
   Oliveira, Sergio C.
TI Modulation of Microtubule Dynamics Affects Brucella abortus
   Intracellular Survival, Pathogen-Containing Vacuole Maturation, and
   Pro-inflammatory Cytokine Production in Infected Macrophages
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Brucella abortus; microtubules; TcpB; innate immunity; bacterial
   pathogenesis
ID ENDOPLASMIC-RETICULUM; INNATE IMMUNITY; PROTEIN; REPLICATION;
   TRAFFICKING; INVASION; CELLS; TLR4; MICE
AB The microtubule (MT) cytoskeleton regulates several cellular processes related to the immune system. For instance, an intricate intracellular transport mediated by MTs is responsible for the proper localization of vesicular receptors of innate immunity and its adaptor proteins. In the present study, we used nocodazole to induce MTs depolymerization and paclitaxel or recombinant (r) TIR (Toll/interleukin-1 receptor) domain containing protein (TcpB) to induce MT stabilization in bone marrow-derived macrophages infected with Brucella abortus. Following treatment of the cells, we evaluated their effects on pathogen intracellular replication and survival, and in pro-inflammatory cytokine production. First, we observed that intracellular trafficking and maturation of Brucella-containing vesicles (BCVs) is affected by partial destabilization or stabilization of the MTs network. A typical marker of early BCVs, LAMP-1, is retained in late BCVs even 24 h after infection in the presence of low doses of nocodazole or paclitaxel and in the presence of different amounts of rTcpB. Second, microscopy and colony forming unit analysis revealed that bacterial load was increased in infected macrophages treated with lower doses of nocodazole or paclitaxel and with rTcpB compared to untreated cells. Third, innate immune responses were also affected by disturbing MT dynamics. MT depolymerization by nocodazole reduced IL-12 production in infected macrophages. Conversely, rTcpB-treated cells augmented IL-12 and IL-1 beta secretion in infected cells. In summary, these findings demonstrate that modulation of MTs affects several crucial steps of B. abortus pathogenesis, including BCV maturation, intracellular survival and IL-12 secretion in infected macrophages.
C1 [Alves-Silva, Juliana; Tavares, Isabela P.; Guimaraes, Erika S.; Costa Franco, Miriam M.; Figueiredo, Barbara C.; Marques, Joao T.; Oliveira, Sergio C.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   [Splitter, Gary] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
RP Oliveira, SC (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
EM scozeus1@gmail.com
RI Silva, Juliana A/C-4299-2019; Marques, Joao T/F-7683-2012
OI Marques, Joao T/0000-0002-3457-3320
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPQ)National Council for Scientific and Technological Development
   (CNPq) [402527/2013-5, 443662/2014-2, 302660/2015-1]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [030448/2013-01]; Fundacao de Amparo a Pesquisa do estado de Minas
   Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
   [APQ-00837-15, APQ-00704-14]; Fundacao de Amparo a Pesquisa do estado de
   Minas Gerais (Rede Mineira de Imunobiologicos) [00140-16];
   CAPES/PVECAPES; CAPES/PNPDCAPES; CNPq/CT-Biotec; CNPq/CBAB; National
   Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI116453];
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI116453, R01AI116453, R01AI116453, R01AI116453, R01AI116453]
   Funding Source: NIH RePORTER
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPQ, Nos: 402527/2013-5, 443662/2014-2, and
   302660/2015-1), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES, No: 030448/2013-01), Fundacao de Amparo a Pesquisa do
   estado de Minas Gerais (FAPEMIG, Nos: APQ-00837-15, APQ-00704-14 and
   Rede Mineira de Imunobiologicos No: 00140-16), CAPES/PVE, CAPES/PNPD,
   CNPq/CT-Biotec, CNPq/CBAB and National Institute of Health R01 AI116453.
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Alaidarous M, 2014, J BIOL CHEM, V289, P654, DOI 10.1074/jbc.M113.523274
   Milillo MA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006527
   Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631
   Bellaire BH, 2005, INFECT IMMUN, V73, P3702, DOI 10.1128/IAI.73.6.3702-3713.2005
   Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X
   Campos PC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00028
   Celli J, 2005, P NATL ACAD SCI USA, V102, P1673, DOI 10.1073/pnas.0406873102
   Colonne PM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00107
   Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x
   de Souza JA, 2015, INFECT IMMUN, V83, P1458, DOI 10.1128/IAI.02790-14
   Delrue RM, 2001, CELL MICROBIOL, V3, P487, DOI 10.1046/j.1462-5822.2001.00131.x
   Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635
   Gomes MT, 2016, J LEUKOCYTE BIOL, V99, P771, DOI 10.1189/jlb.4A0815-346R
   de Assis NRG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125075
   Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6
   Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080
   Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506
   Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6
   Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711
   Radhakrishnan Girish K, 2012, Biomol Concepts, V3, P571
   Radhakrishnan GK, 2011, BIOCHEM J, V439, P79, DOI 10.1042/BJ20110577
   Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200
   Reyes AWB, 2017, MICROB PATHOGENESIS, V103, P87, DOI 10.1016/j.micpath.2016.11.028
   Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021
   Salcedo SP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00028
   Smith JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003785
   Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x
   Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002
   Uronen-Hansson H, 2004, IMMUNOLOGY, V111, P173, DOI 10.1111/j.0019-2805.2003.01803.x
   von Bargen K, 2012, FEMS MICROBIOL REV, V36, P533, DOI 10.1111/j.1574-6976.2012.00334.x
   Yang Xinghong, 2013, Front Biol (Beijing), V8, P60
   Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4
NR 33
TC 4
Z9 4
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD NOV 14
PY 2017
VL 8
AR 2217
DI 10.3389/fmicb.2017.02217
PG 10
WC Microbiology
SC Microbiology
GA FM4XU
UT WOS:000415033800001
PM 29184543
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Olmo, IG
   Carvalho, TG
   Costa, VV
   Alves-Silva, J
   Ferrari, CZ
   Izidoro-Toledo, TC
   da Silva, JF
   Teixeira, AL
   Souza, DG
   Marques, JT
   Teixeira, MM
   Vieira, LB
   Ribeiro, FM
AF Olmo, Isabella G.
   Carvalho, Toniana G.
   Costa, Vivian V.
   Alves-Silva, Juliana
   Ferrari, Carolina Z.
   Izidoro-Toledo, Tatiane C.
   da Silva, Juliana F.
   Teixeira, Antonio L.
   Souza, Danielle G.
   Marques, Joao T.
   Teixeira, Mauro M.
   Vieira, Luciene B.
   Ribeiro, Fabiola M.
TI Zika Virus Promotes neuronal cell Death in a non-cell autonomous Manner
   by Triggering the release of neurotoxic Factors
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika virus; N-methyl-D-aspartate receptors; GluN2B; tumor necrosis
   factor-alpha; interleukin-1 beta
ID NECROSIS-FACTOR-ALPHA; EXTRASYNAPTIC NMDA RECEPTORS;
   ENDOPLASMIC-RETICULUM STRESS; RAT HIPPOCAMPAL-NEURONS;
   ENCEPHALITIS-VIRUS; TNF-ALPHA; SYNAPTIC PLASTICITY; DIFFERENTIAL ROLES;
   HUMAN NEUROSPHERES; GLUTAMATE RELEASE
AB Zika virus (ZIKV) has recently caused a worldwide outbreak of infections associated with severe neurological complications, including microcephaly in infants born from infected mothers. ZIKV exhibits high neurotropism and promotes neuroinflammation and neuronal cell death. We have recently demonstrated that N-methyl-d-aspartate receptor (NMDAR) blockade by memantine prevents ZIKV-induced neuronal cell death. Here, we show that ZIKV induces apoptosis in a non-cell autonomous manner, triggering cell death of uninfected neurons by releasing cytotoxic factors. Neuronal cultures infected with ZIKV exhibit increased levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-1 eta (IL-1 beta), and glutamate. Moreover, infected neurons exhibit increased expression of GluN2B and augmented intracellular Ca2+ concentration. Blockade of GluN2B-containing NMDAR by ifenprodil normalizes Ca2+ levels and rescues neuronal cell death. Notably, TNF-alpha and IL-1 beta blockade decreases ZIKV-induced Ca2+ flux through GluN2B-containing NMDARs and reduces neuronal cell death, indicating that these cytokines might contribute to NMDAR sensitization and neurotoxicity. In addition, ZIKV-infected cultures treated with ifenprodil exhibits increased activation of the neuroprotective pathway including extracellular signal-regulated kinase and cAMP response element-binding protein, which may underlie ifenprodil-mediated neuroprotection. Together, our data shed some light on the neurotoxic mechanisms triggered by ZIKV and begin to elucidate how GluN2Bcontaining NMDAR blockade can prevent neurotoxicity.
C1 [Olmo, Isabella G.; Carvalho, Toniana G.; Costa, Vivian V.; Alves-Silva, Juliana; Izidoro-Toledo, Tatiane C.; Marques, Joao T.; Teixeira, Mauro M.; Ribeiro, Fabiola M.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci ICB, Belo Horizonte, MG, Brazil.
   [Ferrari, Carolina Z.; Vieira, Luciene B.] Univ Fed Minas Gerais, Dept Pharmacol, ICB, Belo Horizonte, MG, Brazil.
   [da Silva, Juliana F.] Inst Educ & Res Santa Casa, Belo Horizonte, MG, Brazil.
   [Teixeira, Antonio L.] UT Hlth, Neuropsychiat Program, Dept Psychiat & Behav Sci, Houston, TX USA.
   [Souza, Danielle G.] Univ Fed Minas Gerais, Dept Microbiol, ICB, Belo Horizonte, MG, Brazil.
RP Ribeiro, FM (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci ICB, Belo Horizonte, MG, Brazil.
EM fmribeiro@icb.ufmg.br
RI Marques, Joao T/F-7683-2012; Silva, Juliana A/C-4299-2019; Teixeira,
   Antonio L/N-3315-2014; Vieira, Luciene B/F-1655-2013; Costa, Vivian
   VVC/I-2499-2018; Ribeiro, Fabiola/E-8831-2013; Olmo, Isabella
   Guimaraes/W-5050-2019
OI Marques, Joao T/0000-0002-3457-3320; Teixeira, Antonio
   L/0000-0002-9621-5422; Vieira, Luciene B/0000-0002-3496-6749; Costa,
   Vivian VVC/0000-0002-0175-642X; Ribeiro, Fabiola/0000-0001-7042-9433;
   Olmo, Isabella Guimaraes/0000-0002-0007-3280; Zaniboni Ferrari,
   Carolina/0000-0001-8817-4774; DE CARVALHO, TONIANA/0000-0002-6475-9222
FU FINEPCiencia Tecnologia e Inovacao (FINEP); FAPEMIGMinas Gerais State
   Research Foundation (FAPEMIG)
FX This work was supported by FINEP and FAPEMIG grants to FR.
CR BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen CJ, 2012, GLIA, V60, P487, DOI 10.1002/glia.22282
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Costa VV, 2014, MED MICROBIOL IMMUN, V203, P231, DOI 10.1007/s00430-014-0334-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong YL, 2017, J NEUROIMMUNOL, V307, P7, DOI 10.1016/j.jneuroim.2017.03.005
   Doria JG, 2013, BRIT J PHARMACOL, V169, P909, DOI 10.1111/bph.12164
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835
   Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911
   Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Ignatowski TA, 1997, J NEUROIMMUNOL, V79, P84, DOI 10.1016/S0165-5728(97)00107-0
   Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510
   Jara JH, 2007, J NEUROCHEM, V100, P1407, DOI 10.1111/j.1471-4159.2006.04330.x
   Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73
   Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009
   Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268
   Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liao CL, 1997, J VIROL, V71, P5963, DOI 10.1128/JVI.71.8.5963-5971.1997
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481
   Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7
   MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0
   NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x
   Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231
   Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504
   Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005
   Parquet MC, 2002, ARCH VIROL, V147, P1105, DOI 10.1007/s00705-002-0806-6
   Parquet MD, 2001, FEBS LETT, V500, P17
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petralia RS, 2012, SCI WORLD J, DOI 10.1100/2012/267120
   Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734
   Prow NA, 2008, J NEUROCHEM, V105, P1276, DOI 10.1111/j.1471-4159.2008.05230.x
   RANDALL RD, 1992, J NEUROSCI, V12, P1882
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003
   Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Szymocha R, 2000, J VIROL, V74, P6433, DOI 10.1128/JVI.74.14.6433-6441.2000
   Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005
   Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346
   Tovar KR, 1999, J NEUROSCI, V19, P4180
   Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306
   Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Viviani B, 2003, J NEUROSCI, V23, P8692
   Weaver-Mikaere L, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-153
   Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025
   Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604
NR 76
TC 28
Z9 29
U1 0
U2 28
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD AUG 23
PY 2017
VL 8
AR 1016
DI 10.3389/fimmu.2017.01016
PG 14
WC Immunology
SC Immunology
GA FE5AZ
UT WOS:000408225700002
PM 28878777
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Pacidonio, EC
   Caragata, EP
   Alves, DM
   Marques, JT
   Moreira, LA
AF Pacidonio, Etiene Casagrande
   Caragata, Eric Pearce
   Alves, Debora Magalhaes
   Marques, Joao Trindade
   Moreira, Luciano Andrade
TI The impact of Wolbachia infection on the rate of vertical transmission
   of dengue virus in Brazilian Aedes aegypti
SO PARASITES & VECTORS
LA English
DT Article
DE Wolbachia; Dengue virus; Aedes aegypti; Vertical transmission; Arbovirus
ID ZIKA VIRUS; DIPTERA-CULICIDAE; MOSQUITOS; POPULATIONS; CHIKUNGUNYA;
   STRAIN
AB Background: Wolbachia pipientis is a common endosymbiotic bacterium of arthropods that strongly inhibits dengue virus (DENV) infection and transmission in the primary vector, the mosquito Aedes aegypti. For that reason, Wolbachiainfected Ae. aegypti are currently being released into the field as part of a novel strategy to reduce DENV transmission. However, there is evidence that DENV can be transmitted vertically from mother to progeny, and this may help the virus persist in nature in the absence of regular human transmission. The effect of Wolbachia infection on this process had not previously been examined.
   Results: We challenged Ae. aegypti with different Brazilian DENV isolates either by oral feeding or intrathoracic injection to ensure disseminated infection. We examined the effect of Wolbachia infection on the prevalence of DENV infection, and viral load in the ovaries. For orally infected mosquitoes, Wolbachia decreased the prevalence of infection by 71.29%, but there was no such effect when the virus was injected. Interestingly, regardless of the method of infection, Wolbachia infection strongly reduced DENV load in the ovaries. We then looked at the effect of Wolbachia on vertical transmission, where we observed only very low rates of vertical transmission. There was a trend towards lower rates in the presence of Wolbachia, with overall maximum likelihood estimate of infection rates of 5.04 per 1000 larvae for mosquitoes without Wolbachia, and 1.93 per 1000 larvae for Wolbachia-infected mosquitoes, after DENV injection. However, this effect was not statistically significant.
   Conclusions: Our data support the idea that vertical transmission of DENV is rare in nature, even in the absence of Wolbachia. Indeed, we observed that vertical transmission rates were low even when the midgut barrier was bypassed, which might help to explain why we only observed a trend towards lower vertical transmission rates in the presence of Wolbachia. Nevertheless, the low prevalence of disseminated DENV infection and lower DENV load in the ovaries supports the hypothesis that the presence of Wolbachia in Ae. aegypti would have an effect on the vertical transmission of DENV in the field.
C1 [Pacidonio, Etiene Casagrande; Caragata, Eric Pearce; Alves, Debora Magalhaes; Moreira, Luciano Andrade] Ctr Pesquisas Rene Rachou Fiocruz, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.
   [Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Pacidonio, Etiene Casagrande] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.
RP Moreira, LA (corresponding author), Ctr Pesquisas Rene Rachou Fiocruz, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.
EM luciano@cpqrr.fiocruz.br
RI Marques, Joao T/F-7683-2012
OI Marques, Joao T/0000-0002-3457-3320
FU Brazilian Ministery of Health (Secretaria de Vigilancia em Saude/ SVS e
   Departamento de Ciencia e Tecnologia da Secretaria de Ciencia,
   Tecnologia e Insumos Estrategicos/DECIT/SCTIE); CAPESCAPES; CNPqNational
   Council for Scientific and Technological Development (CNPq); Bill and
   Melinda Gates FoundationBill & Melinda Gates Foundation
FX This project was funded by the Brazilian Ministery of Health (Secretaria
   de Vigilancia em Saude/SVS e Departamento de Ciencia e Tecnologia da
   Secretaria de Ciencia, Tecnologia e Insumos Estrategicos/DECIT/SCTIE),
   CAPES, CNPq, and a grant to Monash University through the Bill and
   Melinda Gates Foundation.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Amuzu HE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005145
   Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619
   Buckner EA, 2013, J MED ENTOMOL, V50, P1291, DOI 10.1603/ME13047
   Caragata EP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005158
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   dos Santos CND, 2002, VIRUS RES, V90, P197, DOI 10.1016/S0168-1702(02)00180-6
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   Gu WD, 2003, J MED ENTOMOL, V40, P595, DOI 10.1603/0022-2585-40.5.595
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 24
TC 4
Z9 4
U1 0
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 17
PY 2017
VL 10
AR 296
DI 10.1186/s13071-017-2236-z
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EX8JR
UT WOS:000403496100003
PM 28623959
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Aguiar, ERGR
   Olmo, RP
   Marques, JT
AF Guimaraes Rocha Aguiar, Eric Roberto
   Olmo, Roenick Proveti
   Marques, Joao Trindade
TI Virus-derived small RNAs: molecular footprints of host-pathogen
   interactions
SO WILEY INTERDISCIPLINARY REVIEWS-RNA
LA English
DT Review
ID DOUBLE-STRANDED-RNA; 2-5A-DEPENDENT RNASE; ANTIVIRAL IMMUNITY;
   AEDES-AEGYPTI; PIWI PROTEINS; INTERFERENCE; MICRORNAS; ARBOVIRUS;
   PIRNAS; DECAY
AB Viruses are obligatory intracellular parasites that require the host machinery to replicate. During their replication cycle, viral RNA intermediates can be recognized and degraded by different antiviral mechanisms that include RNA decay, RNA interference, and RNase L pathways. As a consequence of viral RNA degradation, infected cells can accumulate virus-derived small RNAs at high levels compared to cellular molecules. These small RNAs are imprinted with molecular characteristics that reflect their origin. First, small RNAs can be used to reconstruct viral sequences and identify the virus from which they originated. Second, other molecular features of small RNAs such as size, polarity, and base preferences depend on the type of viral substrate and host mechanism of degradation. Thus, the pattern of small RNAs generated in infected cells can be used as a molecular footprint to identify and characterize viruses independent on sequence homology searches against known references. Hence, sequencing of small RNAs obtained from infected cells enables virus discovery and characterization using both sequence-dependent strategies and novel pattern-based approaches. Recent studies are helping unlock the full application of small RNA sequencing for virus discovery and characterization.
C1 [Guimaraes Rocha Aguiar, Eric Roberto; Olmo, Roenick Proveti; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Marques, Joao T/F-7683-2012; Aguiar, Eric RGR/L-7989-2018; Olmo,
   Roenick/AAF-6412-2020; Aguiar, Eric/T-5076-2019
OI Marques, Joao T/0000-0002-3457-3320; Aguiar, Eric
   RGR/0000-0002-8143-5756; Aguiar, Eric/0000-0002-8143-5756
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPEMIGMinas Gerais State Research Foundation
   (FAPEMIG)
FX We would like to thank Alvaro Gil Araujo Ferreira, Isaque Joao da Silva
   de Faria, and other members of our laboratory for invaluable suggestions
   and criticism. This work was supported by CAPES, CNPq, and FAPEMIG.
CR Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007
   Batista TM, 2011, J PROTEOMICS, V74, P1504, DOI 10.1016/j.jprot.2011.02.032
   Berry B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005866
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Castellano L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1257-2
   Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002
   Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chen CYA, 2011, WIRES RNA, V2, P167, DOI 10.1002/wrna.40
   Chen LX, 2015, ISME J, V9, P1579, DOI 10.1038/ismej.2014.245
   Coffey LL, 2014, VIROLOGY, V448, P146, DOI 10.1016/j.virol.2013.09.026
   Cook S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080720
   Cooper DA, 2015, J VIROL, V89, P2764, DOI 10.1128/JVI.02953-14
   Cooper DA, 2014, NUCLEIC ACIDS RES, V42, P5202, DOI 10.1093/nar/gku118
   Czech B, 2016, TRENDS BIOCHEM SCI, V41, P324, DOI 10.1016/j.tibs.2015.12.008
   den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010
   Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824
   DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133
   Endres MW, 2011, METHODS MOL BIOL, V732, P209, DOI 10.1007/978-1-61779-083-6_15
   FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080
   Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056
   Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226
   Gaglia MM, 2010, WIRES RNA, V1, P47, DOI 10.1002/wrna.3
   GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108
   Garcia D, 2014, CELL HOST MICROBE, V16, P391, DOI 10.1016/j.chom.2014.08.001
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Girardi E, 2013, MBIO, V4, DOI 10.1128/mBio.00698-13
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494
   Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009
   Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Harris CJ, 2015, NUCLEIC ACIDS RES, V43, P7590, DOI 10.1093/nar/gkv604
   Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7
   Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026
   Huang LL, 2012, WIRES RNA, V3, P807, DOI 10.1002/wrna.1137
   Ipsaro JJ, 2015, NAT STRUCT MOL BIOL, V22, P20, DOI 10.1038/nsmb.2931
   Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004
   Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644
   Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018
   Kolliopoulou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121447
   Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024
   LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029
   Le Thomas A, 2014, GENOME BIOL, V15, DOI 10.1186/gb4154
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Li XL, 1998, J VIROL, V72, P2752, DOI 10.1128/JVI.72.4.2752-2759.1998
   Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911
   Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037
   Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930
   Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042
   Malathi K, 2010, RNA, V16, P2108, DOI 10.1261/rna.2244210
   Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040
   Manoharan M, 2004, CURR OPIN CHEM BIOL, V8, P570, DOI 10.1016/j.cbpa.2004.10.007
   Marques J, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/712603
   Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004
   Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8
   Moon SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003762
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89
   Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058
   Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505
   Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764
   Peng XX, 2011, MBIO, V2, DOI 10.1128/mBio.00198-11
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021
   Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0
   Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020
   Rigby RE, 2015, TRENDS IMMUNOL, V36, P179, DOI 10.1016/j.it.2015.02.001
   Roovers EF, 2015, CELL REP, V10, P2069, DOI 10.1016/j.celrep.2015.02.062
   Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230
   Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Sawicki DL, 2003, J VIROL, V77, P1801, DOI 10.1128/JVI.77.3.1801-1811.2003
   Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006
   Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schnettler E, 2013, J VIROL, V87, P2441, DOI 10.1128/JVI.02848-12
   Schwentker FF, 1934, J EXP MED, V60, P559, DOI 10.1084/jem.60.5.559
   Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049
   Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309
   Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103
   Vainio EJ, 2015, J GEN VIROL, V96, P714, DOI 10.1099/jgv.0.000003
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
   Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016
   Zhang XM, 2008, J VIROL, V82, P2613, DOI 10.1128/JVI.02324-07
   ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D
NR 96
TC 12
Z9 14
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-7004
EI 1757-7012
J9 WIRES RNA
JI Wiley Interdiscip. Rev.-RNA
PD NOV-DEC
PY 2016
VL 7
IS 6
BP 824
EP 837
DI 10.1002/wrna.1361
PG 14
WC Cell Biology
SC Cell Biology
GA DZ4QH
UT WOS:000385843200007
PM 27170499
OA Green Published
DA 2020-12-16
ER

PT J
AU Marques, JT
   Imler, JL
AF Marques, Joao T.
   Imler, Jean-Luc
TI The diversity of insect antiviral immunity: insights from viruses
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID JAK-STAT PATHWAY; RNA INTERFERENCE; DROSOPHILA-MELANOGASTER; IMD
   PATHWAY; INFECTION; SUPPRESSION; BACULOVIRUS; DEFENSE; PROTEIN;
   ARGONAUTE-2
AB Insects represent over 70% of all animal species. Recent virome analyses reveal unprecedented genetic diversity of insect viruses, which appears to match that of their hosts. Thus, insect-virus interactions may provide information on a vast repertoire of antiviral immune mechanisms. Tapping into this diversity is challenging because of several constraints imposed by the uniqueness of each insect model. Nevertheless, it is clear that many conserved and divergent pathways participate in the control of viral infection in insects. Co-evolution between hosts and viruses favors the development of immune evasion mechanisms by the pathogen. Viral suppressors can offer unique perspective on host pathways and emphasize the importance of RNA interference, apoptosis, but also NF-kappa B pathways and translation control in insect antiviral immunity.
C1 [Marques, Joao T.] Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Marques, Joao T.; Imler, Jean-Luc] IBMC, CNRS, UPR9022, Strasbourg, France.
   [Imler, Jean-Luc] Univ Strasbourg, Fac Sci Vie, Strasbourg, France.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.; Marques, JT; Imler, JL (corresponding author), IBMC, CNRS, UPR9022, Strasbourg, France.; Imler, JL (corresponding author), Univ Strasbourg, Fac Sci Vie, Strasbourg, France.
EM jtm@ufmg.br; jl.imler@unistra.fr
RI Marques, Joao T/F-7683-2012
OI Marques, Joao T/0000-0002-3457-3320
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [PO1 AI070167]; ANRFrench National
   Research Agency (ANR) [ANR-13-BSV3-009]; Infect-ERA [ANR-14-IFEC-0005];
   Investissements d'Avenir ProgramsFrench National Research Agency (ANR)
   [ANR-10-LABX-36 ANR-11-EQPX-0022]; CNPqNational Council for Scientific
   and Technological Development (CNPq); Ciencias sem fronteiras
   [PVE-400648/2013-0]; CAPESCAPES; FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167] Funding Source: NIH
   RePORTER
FX We thank Carine Meignin for discussions and preparation of the figure,
   Stephanie Blandin and Nelson Martins for critical reading of the
   manuscript, and NIH (PO1 AI070167), ANR (ANR-13-BSV3-009), Infect-ERA
   (ANR-14-IFEC-0005), Investissements d'Avenir Programs (ANR-10-LABX-36
   ANR-11-EQPX-0022), CNPq, Ciencias sem fronteiras (PVE-400648/2013-0),
   CAPES and FAPEMIG for funding. We apologize to colleagues whose work
   could not be quoted due to space limitation.
CR Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582
   Bernhardt SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044198
   Bronkhorst AW, 2014, NUCLEIC ACIDS RES, V42, P12237, DOI 10.1093/nar/gku910
   Byers NM, 2016, J VIROL, V90, P533, DOI 10.1128/JVI.02320-15
   Cao C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005387
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Chejanovsky N, 2014, VIROLOGY, V454, P176, DOI 10.1016/j.virol.2014.02.012
   Clem RJ, 2015, SEMIN CELL DEV BIOL, V39, P72, DOI 10.1016/j.semcdb.2015.01.011
   Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436
   Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824
   Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507
   Gammon DB, 2014, ELIFE, V3, DOI 10.7554/eLife.02910
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Aguiar ERGR, 2016, NUCLEIC ACIDS RES, V44, P3477, DOI 10.1093/nar/gkw044
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Ikeda M, 2013, VIROLOGY, V435, P1, DOI 10.1016/j.virol.2012.10.016
   Jayachandran B, 2012, J VIROL, V86, P13729, DOI 10.1128/JVI.02041-12
   Kemp C, 2013, J IMMUNOL BALTIM MD, V1950, P650
   Kolliopoulou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121447
   Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935
   Lamiable O, 2016, J VIROL
   Lamiable O, 2016, P NATL ACAD SCI USA, V113, P698, DOI 10.1073/pnas.1516122113
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948
   Li JJ, 2015, P NATL ACAD SCI USA, V112, pE4364, DOI 10.1073/pnas.1505481112
   Liu B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003137
   Martins NE, 2014, P NATL ACAD SCI USA, V111, P5938, DOI 10.1073/pnas.1400378111
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Merkling SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12758
   Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Nainu F, 2015, J IMMUNOL, V195, P5696, DOI 10.4049/jimmunol.1500613
   Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810
   Obbard DJ, 2011, MOL BIOL EVOL, V28, P1043, DOI 10.1093/molbev/msq280
   Paradkar PN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002823
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657
   Settles EW, 2008, J VIROL, V82, P1378, DOI 10.1128/JVI.01941-07
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   van Cleef KWR, 2014, NUCLEIC ACIDS RES, V42, P8732, DOI 10.1093/nar/gku528
   van Mierlo JT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004256
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Vandergaast R, 2015, J VIROL, V89, P4481, DOI 10.1128/JVI.03659-14
   Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210
   Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Zografidis A, 2015, J VIROL, V89, P11473, DOI 10.1128/JVI.01695-15
NR 50
TC 32
Z9 35
U1 0
U2 52
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
EI 1879-0364
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD AUG
PY 2016
VL 32
BP 71
EP 76
DI 10.1016/j.mib.2016.05.002
PG 6
WC Microbiology
SC Microbiology
GA DU6SK
UT WOS:000382344700015
PM 27232381
OA Green Accepted
DA 2020-12-16
ER

PT J
AU Lamiable, O
   Arnold, J
   de Faria, IJD
   Olmo, RP
   Bergami, F
   Meignin, C
   Hoffmann, JA
   Marques, JT
   Imler, JL
AF Lamiable, Olivier
   Arnold, Johan
   da Silva de Faria, Isaque Joao
   Olmo, Roenick Proveti
   Bergami, Francesco
   Meignin, Carine
   Hoffmann, Jules A.
   Marques, Joao Trindade
   Imler, Jean-Luc
TI Analysis of the Contribution of Hemocytes and Autophagy to Drosophila
   Antiviral Immunity
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID RNA-BASED IMMUNITY; INNATE IMMUNITY; ADULT DROSOPHILA; VIRAL-INFECTION;
   HOST-DEFENSE; VIRUS; INTERFERENCE; PHAGOCYTOSIS; RECEPTORS; RESPONSES
AB Antiviral immunity in the model organism Drosophila melanogaster involves the broadly active intrinsic mechanism of RNA interference (RNAi) and virus-specific inducible responses. Here, using a panel of six viruses, we investigated the role of hemocytes and autophagy in the control of viral infections. Injection of latex beads to saturate phagocytosis, or genetic depletion of hemocytes, resulted in decreased survival and increased viral titers following infection with Cricket paralysis virus (CrPV), Flock House virus (FHV), and vesicular stomatitis virus (VSV) but had no impact on Drosophila C virus (DCV), Sindbis virus (SINV), and Invertebrate iridescent virus 6 (IIV6) infection. In the cases of CrPV and FHV, apoptosis was induced in infected cells, which were phagocytosed by hemocytes. In contrast, VSV did not trigger any significant apoptosis but we confirmed that the autophagy gene Atg7 was required for full virus resistance, suggesting that hemocytes use autophagy to recognize the virus. However, this recognition does not depend on the Toll-7 receptor. Autophagy had no impact on DCV, CrPV, SINV, or IIV6 infection and was required for replication of the sixth virus, FHV. Even in the case of VSV, the increases in titers were modest in Atg7 mutant flies, suggesting that autophagy does not play a major role in antiviral immunity in Drosophila. Altogether, our results indicate that, while autophagy plays a minor role, phagocytosis contributes to virus-specific immune responses in insects.
   IMPORTANCE
   Phagocytosis and autophagy are two cellular processes that involve lysosomal degradation and participate in Drosophila immunity. Using a panel of RNA and DNA viruses, we have addressed the contribution of phagocytosis and autophagy in the control of viral infections in this model organism. We show that, while autophagy plays a minor role, phagocytosis contributes to virus-specific immune responses in Drosophila. This work brings to the front a novel facet of antiviral host defense in insects, which may have relevance in the control of virus transmission by vector insects or in the resistance of beneficial insects to viral pathogens.
C1 [Lamiable, Olivier; Arnold, Johan; da Silva de Faria, Isaque Joao; Bergami, Francesco; Meignin, Carine; Hoffmann, Jules A.; Marques, Joao Trindade; Imler, Jean-Luc] Inst Biol Mol & Cellulaire, CNRS UPR9022, Strasbourg, France.
   [da Silva de Faria, Isaque Joao; Olmo, Roenick Proveti; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Meignin, Carine; Imler, Jean-Luc] Univ Strasbourg, Fac Sci Vie, Strasbourg, France.
   [Hoffmann, Jules A.] Univ Strasbourg, Inst Adv Studies, Strasbourg, France.
RP Imler, JL (corresponding author), Inst Biol Mol & Cellulaire, CNRS UPR9022, Strasbourg, France.; Imler, JL (corresponding author), Univ Strasbourg, Fac Sci Vie, Strasbourg, France.
EM jl.imler@unistra.fr
RI Marques, Joao T/F-7683-2012; Olmo, Roenick/AAF-6412-2020
OI Marques, Joao T/0000-0002-3457-3320; Lamiable,
   Olivier/0000-0001-7571-9253; Meignin, Carine/0000-0002-6588-9045
FU HHS \ NIH \ National Institute of Allergy and Infectious Diseases
   (NIAID) [PO1 AI070167]; MCTI \ Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); Agence Nationale de la Recherche
   (ANR)French National Research Agency (ANR) [ANR-11-ISV3-002
   ANR-13-BSV3-0009]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas
   Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG);
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167] Funding Source: NIH RePORTER
FX This work, including the efforts of Jules A. Hoffmann and Jean-Luc
   Imler, was funded by HHS vertical bar NIH vertical bar National
   Institute of Allergy and Infectious Diseases (NIAID) (PO1 AI070167).
   This work, including the efforts of Joao T. Marques, was funded by MCTI
   vertical bar Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq). This work, including the efforts of Jean-Luc Imler,
   was funded by Agence Nationale de la Recherche (ANR) (ANR-11-ISV3-002
   ANR-13-BSV3-0009). This work, including the efforts of Joao T. Marques,
   was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES). This work, including the efforts of Joao T. Marques,
   was funded by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG).
CR Akhouayri I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002319
   Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001
   Ballard SL, 2014, J CELL BIOL, V204, P1157, DOI 10.1083/jcb.201308115
   Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067
   Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010
   Bronkhorst AW, 2012, P NATL ACAD SCI USA, V109, pE3604, DOI 10.1073/pnas.1207213109
   Clem RJ, 2016, J GEN VIROL
   Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436
   Defaye A, 2009, J INNATE IMMUN, V1, P322, DOI 10.1159/000210264
   Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8
   Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6
   Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Ghosh S, 2015, DEV CELL, V33, P478, DOI 10.1016/j.devcel.2015.03.014
   Gregoire IP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002422
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Imler JL, 2004, J LEUKOCYTE BIOL, V75, P18, DOI 10.1189/jlb.0403160
   Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006
   Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707
   Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006
   Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034
   Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220
   Lamiable O, 2014, CURR OPIN MICROBIOL, V20, P62, DOI 10.1016/j.mib.2014.05.006
   Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123
   Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5
   Ligoxygakis P, 2002, EMBO REP, V3, P666, DOI 10.1093/embo-reports/kvf130
   Liu B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003137
   Marques J., 2013, INT J PHOTOENERGY, V2013, P9, DOI DOI 10.1371/J0URNAL.PPAT.1003579
   McIlroy G, 2013, NAT NEUROSCI, V16, P1248, DOI 10.1038/nn.3474
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nainu F, 2015, J IMMUNOL, V195, P5696, DOI 10.4049/jimmunol.1500613
   Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003
   Narbonne-Reveau K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017470
   Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810
   Pare AC, 2014, NATURE, V515, P523, DOI 10.1038/nature13953
   Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Settles EW, 2008, J VIROL, V82, P1378, DOI 10.1128/JVI.01941-07
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10
   Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797
   van Mierlo JT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004256
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Yagi Y, 2010, DEV GROWTH DIFFER, V52, P771, DOI 10.1111/j.1440-169X.2010.01213.x
   Yang HR, 2015, EMBO REP, V16, P1664, DOI 10.15252/embr.201540277
NR 56
TC 31
Z9 31
U1 1
U2 23
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2016
VL 90
IS 11
BP 5415
EP 5426
DI 10.1128/JVI.00238-16
PG 12
WC Virology
SC Virology
GA DM2ES
UT WOS:000376160200018
PM 27009948
OA Green Published, Bronze
DA 2020-12-16
ER

PT J
AU Aguiar, ERGR
   Olmo, RP
   Paro, S
   Ferreira, FV
   de Faria, IJD
   Todjro, YMH
   Lobo, FP
   Kroon, EG
   Meignin, C
   Gatherer, D
   Imler, JL
   Marques, JT
AF Guimaraes Rocha Aguiar, Eric Roberto
   Olmo, Roenick Proveti
   Paro, Simona
   Ferreira, Flavia Viana
   da Silva de Faria, Isaque Joao
   Honore Todjro, Yaovi Mathias
   Lobo, Francisco Pereira
   Kroon, Erna Geessien
   Meignin, Carine
   Gatherer, Derek
   Imler, Jean-Luc
   Marques, Joao Trindade
TI Sequence-independent characterization of viruses based on the pattern of
   viral small RNAs produced by the host (vol 43, pg 6191, 2015)
SO NUCLEIC ACIDS RESEARCH
LA English
DT Correction
C1 [Guimaraes Rocha Aguiar, Eric Roberto; Olmo, Roenick Proveti; da Silva de Faria, Isaque Joao; Honore Todjro, Yaovi Mathias; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Guimaraes Rocha Aguiar, Eric Roberto; Olmo, Roenick Proveti; Paro, Simona; Meignin, Carine; Imler, Jean-Luc] CNRS, UPR9022, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France.
   [Ferreira, Flavia Viana; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Lobo, Francisco Pereira] Embrapa Informat Agr, Lab Multiusuario Bioinformat, BR-13083886 Sao Paulo, Brazil.
   [Meignin, Carine; Imler, Jean-Luc] Univ Strasbourg, Fac Sci Vie, F-67083 Strasbourg, France.
   [Gatherer, Derek] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England.
   [Imler, Jean-Luc] Univ Strasbourg USIAS, Inst Etud Avancees, F-67084 Strasbourg, France.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Olmo, Roenick/AAF-6412-2020; Kroon, Erna Geessien/B-3631-2015; Aguiar,
   Eric RGR/L-7989-2018
OI Kroon, Erna Geessien/0000-0003-2721-3826; Aguiar, Eric
   RGR/0000-0002-8143-5756; Gatherer, Derek/0000-0002-7385-5734; Pereira
   Lobo, Francisco/0000-0002-9671-9313; Meignin, Carine/0000-0002-6588-9045
CR Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
NR 1
TC 6
Z9 6
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 20
PY 2016
VL 44
IS 7
BP 3477
EP 3478
DI 10.1093/nar/gkw044
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DL7DM
UT WOS:000375800200049
PM 26801643
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-16
ER

PT J
AU Lamiable, O
   Kellenberger, C
   Kemp, C
   Troxler, L
   Pelte, N
   Boutros, M
   Marques, JT
   Daeffler, L
   Hoffmann, JA
   Roussel, A
   Imler, JL
AF Lamiable, Olivier
   Kellenberger, Christine
   Kemp, Cordula
   Troxler, Laurent
   Pelte, Nadege
   Boutros, Michael
   Marques, Joao Trindade
   Daeffler, Laurent
   Hoffmann, Jules A.
   Roussel, Alain
   Imler, Jean-Luc
TI Cytokine Diedel and a viral homologue suppress the IMD pathway in
   Drosophila
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE virokine; cytokine; Sindbis virus; Edin; antiviral immunity
ID NEGATIVE REGULATION; ANTIVIRAL IMMUNITY; BACULOVIRUS GENE; VIRUS;
   RESPONSES; INFECTION; ACTIVATION; EXPRESSION; PROTECTION; INDUCTION
AB Viruses are obligatory intracellular parasites that suffer strong evolutionary pressure from the host immune system. Rapidly evolving viral genomes can adapt to this pressure by acquiring genes that counteract host defense mechanisms. For example, many vertebrate DNA viruses have hijacked cellular genes encoding cytokines or cytokine receptors to disrupt host cell communication. Insect viruses express suppressors of RNA interference or apoptosis, highlighting the importance of these cell intrinsic antiviral mechanisms in invertebrates. Here, we report the identification and characterization of a family of proteins encoded by insect DNA viruses that are homologous to a 12-kDa circulating protein encoded by the virus-induced Drosophila gene diedel (die). We show that die mutant flies have shortened lifespan and succumb more rapidly than controls when infected with Sindbis virus. This reduced viability is associated with deregulated activation of the immune deficiency (IMD) pathway of host defense and can be rescued by mutations in the genes encoding the homolog of IKK. or IMD itself. Our results reveal an endogenous pathway that is exploited by insect viruses to modulate NF-kappa B signaling and promote fly survival during the antiviral response.
C1 [Lamiable, Olivier; Kemp, Cordula; Troxler, Laurent; Daeffler, Laurent; Hoffmann, Jules A.; Imler, Jean-Luc] CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech, F-67084 Strasbourg, France.
   [Kellenberger, Christine; Roussel, Alain] CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille, France.
   [Kellenberger, Christine; Roussel, Alain] Univ Aix Marseille, Unite Mixte Rech 7257, F-13288 Marseille, France.
   [Pelte, Nadege; Boutros, Michael] German Canc Res Ctr, Dept Cell & Mol Biol, Div Signaling & Funct Genom, Med Fac Mannheim, D-69120 Heidelberg, Germany.
   [Pelte, Nadege; Boutros, Michael] Heidelberg Univ, Med Fac Mannheim, German Canc Res Ctr, D-69120 Heidelberg, Germany.
   [Marques, Joao Trindade] Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Ciencias Biol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Hoffmann, Jules A.; Imler, Jean-Luc] Univ Strasbourg, Inst Adv Studies, F-67084 Strasbourg, France.
   [Imler, Jean-Luc] Univ Strasbourg, Fac Sci Vie, F-67083 Strasbourg, France.
RP Imler, JL (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech, F-67084 Strasbourg, France.
EM jl.imler@unistra.fr
RI Daeffler, Laurent/M-8914-2017; Daeffler, Laurent/S-6395-2019; Marques,
   Joao T/F-7683-2012; Boutros, Michael/C-3566-2008; kellenberger,
   christine/AAV-9304-2020
OI Marques, Joao T/0000-0002-3457-3320; Boutros,
   Michael/0000-0002-9458-817X; Lamiable, Olivier/0000-0001-7571-9253;
   Daeffler, laurent/0000-0001-5871-5082
FU CNRSCentre National de la Recherche Scientifique (CNRS); Universite de
   Strasbourg; Universite d'Aix Marseille; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [P01
   AI070167]; Agence Nationale de la Recherche (ANR)French National
   Research Agency (ANR) [ANR-11-ISV3-002, ANR-13-BSV3-0009];
   Investissements d'Avenir ProgramFrench National Research Agency (ANR)
   [NetRNA ANR-10-LABX-36, I2MC ANR-11-EQPX-0022]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167] Funding Source: NIH RePORTER
FX We thank Estelle Santiago for expert technical assistance; Stefanie
   Muller and Safia Deddouche for help in the early stages of the project;
   Yves Bigot and Brian Federici for discussion and providing SfAV-1a DNA;
   and Carine Meignin, Dominique Ferrandon, and David Gubb for discussions,
   help with preparation of the figures, and critical reading of the
   manuscript. The microarray analysis were performed at the Plateforme
   Biopuces et Sequencage, Institut de Genetique et de Biologie Moleculaire
   et Cellulaire, Strasbourg, France. This work was supported by CNRS,
   Universite de Strasbourg, Universite d'Aix Marseille; NIH Grant P01
   AI070167; Agence Nationale de la Recherche (ANR) Grants ANR-11-ISV3-002
   and ANR-13-BSV3-0009; and Investissements d'Avenir Program Grants NetRNA
   ANR-10-LABX-36 and I2MC ANR-11-EQPX-0022.
CR Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980
   Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582
   Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406
   Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004
   Bitra K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002722
   Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8
   Bronkhorst AW, 2014, NUCLEIC ACIDS RES, V42, P12237, DOI 10.1093/nar/gku910
   Bronkhorst AW, 2012, P NATL ACAD SCI USA, V109, pE3604, DOI 10.1073/pnas.1207213109
   Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110
   CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198
   Clem RJ, 2015, SEMIN CELL DEV BIOL, V39, P72, DOI 10.1016/j.semcdb.2015.01.011
   Colinet D, 2013, INSECT BIOCHEM MOLEC, V43, P601, DOI 10.1016/j.ibmb.2013.03.010
   Coste F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033416
   CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993
   Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664
   Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507
   Gammon DB, 2014, ELIFE, V3, DOI 10.7554/eLife.02910
   Goecks J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064125
   Gordon MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000111
   Gueguen G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003580
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021
   Huang ZJ, 2013, J VIROL, V87, P4272, DOI 10.1128/JVI.03360-12
   Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5
   Hussain M, 2010, J VIROL, V84, P3624, DOI 10.1128/JVI.02362-09
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014
   Kroemer JA, 2005, J VIROL, V79, P7617, DOI 10.1128/JVI.79.12.7617-7628.2005
   Lamiable O, 2014, CURR OPIN MICROBIOL, V20, P62, DOI 10.1016/j.mib.2014.05.006
   Lee KZ, 2011, EMBO J, V30, P988, DOI 10.1038/emboj.2011.47
   Lee MJ, 2009, ADV PARASIT, V70, P123, DOI 10.1016/S0065-308X(09)70005-3
   Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004
   Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948
   Liu B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003137
   Magwire MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003057
   Magwire MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002337
   Majzoub K, 2014, CELL, V159, P1086, DOI 10.1016/j.cell.2014.10.041
   Martins NE, 2014, P NATL ACAD SCI USA, V111, P5938, DOI 10.1073/pnas.1400378111
   Merkling SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12758
   Merkling SH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004692
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869
   Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810
   Ouyang P, 2014, J GEN VIROL, V95, P245, DOI 10.1099/vir.0.058966-0
   Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018
   Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801
   Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712
   STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102
   Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302
   van Cleef KWR, 2014, NUCLEIC ACIDS RES, V42, P8732, DOI 10.1093/nar/gku528
   van Mierlo JT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004256
   Vanha-aho LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004895
   Wu XR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004034
   Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5
NR 59
TC 38
Z9 39
U1 0
U2 23
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 19
PY 2016
VL 113
IS 3
BP 698
EP 703
DI 10.1073/pnas.1516122113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DB4BX
UT WOS:000368458800064
PM 26739560
OA Bronze, Green Published
DA 2020-12-16
ER

PT J
AU Aguiar, ERGR
   Olmo, RP
   Paro, S
   Ferreira, FV
   de Faria, IJD
   Todjro, YMH
   Lobo, FP
   Kroon, EG
   Meignin, C
   Gatherer, D
   Imler, JL
   Marques, JT
AF Guimaraes Rocha Aguiar, Eric Roberto
   Olmo, Roenick Proveti
   Paro, Simona
   Ferreira, Flavia Viana
   da Silva de Faria, Isaque Joao
   Honore Todjro, Yaovi Mathias
   Lobo, Francisco Pereira
   Kroon, Erna Geessien
   Meignin, Carine
   Gatherer, Derek
   Imler, Jean-Luc
   Marques, Joao Trindade
TI Sequence-independent characterization of viruses based on the pattern of
   viral small RNAs produced by the host
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID ANTIVIRAL IMMUNITY; GENOME SEQUENCE; AEDES-AEGYPTI; METAGENOMIC
   ANALYSIS; ENDOGENOUS SIRNAS; INTERFERENCE; DROSOPHILA; SUPPRESSION;
   INFECTION; DISCOVERY
AB Virus surveillance in vector insects is potentially of great benefit to public health. Large-scale sequencing of small and long RNAs has previously been used to detect viruses, but without any formal comparison of different strategies. Furthermore, the identification of viral sequences largely depends on similarity searches against reference databases. Here, we developed a sequence-independent strategy based on virus-derived small RNAs produced by the host response, such as the RNA interference pathway. In insects, we compared sequences of small and long RNAs, demonstrating that viral sequences are enriched in the small RNA fraction. We also noted that the small RNA size profile is a unique signature for each virus and can be used to identify novel viral sequences without known relatives in reference databases. Using this strategy, we characterized six novel viruses in the viromes of laboratory fruit flies and wild populations of two insect vectors: mosquitoes and sandflies. We also show that the small RNA profile could be used to infer viral tropism for ovaries among other aspects of virus biology. Additionally, our results suggest that virus detection utilizing small RNAs can also be applied to vertebrates, although not as efficiently as to plants and insects.
C1 [Guimaraes Rocha Aguiar, Eric Roberto; Olmo, Roenick Proveti; da Silva de Faria, Isaque Joao; Honore Todjro, Yaovi Mathias; Marques, Joao Trindade] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Guimaraes Rocha Aguiar, Eric Roberto; Olmo, Roenick Proveti; Paro, Simona; Meignin, Carine; Imler, Jean-Luc] CNRS, Inst Biol Mol & Cellulaire, UPR9022, F-67084 Strasbourg, France.
   [Ferreira, Flavia Viana; Kroon, Erna Geessien] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-30270901 Belo Horizonte, MG, Brazil.
   [Lobo, Francisco Pereira] Embrapa Informat Agr, Lab Multiusuario Bioinformat, BR-13083886 Sao Paulo, Brazil.
   [Meignin, Carine; Imler, Jean-Luc] Univ Strasbourg, Fac Sci, F-67083 Strasbourg, France.
   [Gatherer, Derek] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England.
   [Imler, Jean-Luc] Univ Strasbourg USIAS, Inst Etud Avancees, F-67084 Strasbourg, France.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, BR-30270901 Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Aguiar, Eric/T-5076-2019; Kroon, Erna Geessien/B-3631-2015; Marques,
   Joao T/F-7683-2012; Kroon, Erna/V-5444-2019; Olmo,
   Roenick/AAF-6412-2020; Aguiar, Eric RGR/L-7989-2018
OI Aguiar, Eric/0000-0002-8143-5756; Kroon, Erna
   Geessien/0000-0003-2721-3826; Marques, Joao T/0000-0002-3457-3320;
   Aguiar, Eric RGR/0000-0002-8143-5756; Gatherer,
   Derek/0000-0002-7385-5734
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [478986/2010-6, 590069/2011-0, 400648/2013-0, 473092/2013-1];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG) [CBB -
   APQ-01228-11, CBB-APQ-00239-14]; Agence Nationale de la RechercheFrench
   National Research Agency (ANR) [ANR-11-ASV3-002]; Investissement
   d'Avenir ProgramsFrench National Research Agency (ANR) [ANR-10-LABX-36,
   ANR-11-EQPX-0022]; National Institute of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1
   AI070167]; CAPESCAPES; CNPqNational Council for Scientific and
   Technological Development (CNPq); NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167,
   P01AI070167, P01AI070167, P01AI070167, P01AI070167, P01AI070167] Funding
   Source: NIH RePORTER
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   [478986/2010-6; 590069/2011-0; 400648/2013-0; 473092/2013-1];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [CBB -
   APQ-01228-11; CBB-APQ-00239-14] (to J.T.M. and E.G.K.); Agence Nationale
   de la Recherche [ANR-11-ASV3-002]; Investissement d'Avenir Programs
   [ANR-10-LABX-36; ANR-11-EQPX-0022]; National Institute of Health [PO1
   AI070167] (to J.L.I.). E.R.G.R.A, R.P.O., F.V.F., I.J.S.F. and Y.M.H.T.
   received fellowships from CAPES and CNPq. Funding for open access
   charge: CAPES and CNPq.
CR Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   Adelman ZN, 2012, INSECT MOL BIOL, V21, P357, DOI 10.1111/j.1365-2583.2012.01141.x
   Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Ambrose RL, 2009, J GEN VIROL, V90, P2191, DOI 10.1099/vir.0.012104-0
   Arensburger P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-606
   Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Cao MJ, 2014, P NATL ACAD SCI USA, V111, P14613, DOI 10.1073/pnas.1407131111
   Cook S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080720
   Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264
   Eddy Sean R, 2009, Genome Inform, V23, P205
   Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Girardi E, 2013, MBIO, V4, DOI 10.1128/mBio.00698-13
   Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Josset L, 2014, RNA BIOL, V11, P875, DOI 10.4161/rna.29442
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024
   Ladner J. T., 2014, MBIO, V5
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lepore LS, 1996, J INVERTEBR PATHOL, V68, P131, DOI 10.1006/jipa.1996.0070
   Li CX, 2015, ELIFE, V4, DOI 10.7554/eLife.05378
   Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758
   Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930
   Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040
   Marques J, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/712603
   Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004
   Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI [10.1093/nar/gkt263, 10.1093/nar/gkt1223]
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Mulder Nicola, 2007, V396, P59
   Munnink BBO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078454
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786
   Peng X, 2011, MBIO, V2
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120
   Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14
   Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163
   Vijayakumar K, 2013, SE ASIAN J TROP MED, V44, P54
   Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wang P, 2001, ARCH INSECT BIOCHEM, V47, P110, DOI 10.1002/arch.1041
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370
   Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
   Yamao T, 2009, ARCH VIROL, V154, P153, DOI 10.1007/s00705-008-0285-5
   Yan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019148
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 61
TC 53
Z9 54
U1 0
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL 27
PY 2015
VL 43
IS 13
BP 6191
EP 6206
DI 10.1093/nar/gkv587
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA CP3JZ
UT WOS:000359776500008
PM 26040701
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-12-16
ER

PT J
AU Soares, ZG
   Goncalves, ANA
   de Oliveira, KPV
   Marques, JT
AF Soares, Zamira Guerra
   Aquime Goncalves, Andre Nicolau
   Vieira de Oliveira, Karla Pollyanna
   Marques, Joao Trindade
TI Viral RNA recognition by the Drosophila small interfering RNA pathway
SO MICROBES AND INFECTION
LA English
DT Article
DE RNA interference; Small interfering RNA; dsRNA; Viral infection;
   Drosophila melanogaster
ID DOUBLE-STRANDED-RNA; RIG-I HELICASE; ANTIVIRAL IMMUNITY; MESSENGER-RNA;
   GENETIC INTERFERENCE; INNATE IMMUNITY; DISTINCT ROLES; SIRNA; MICRORNAS;
   MECHANISM
AB Viral RNA is a common activator of antiviral responses. In this review, we dissect the mechanism of viral RNA recognition by the small interfering RNA pathway in Drosophila melanogaster. This antiviral response in fruit flies can help understand general principles of nucleic acid recognition. (C) 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Soares, Zamira Guerra; Aquime Goncalves, Andre Nicolau; Vieira de Oliveira, Karla Pollyanna; Marques, Joao Trindade] Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol ICB, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Marques, Joao T/F-7683-2012
OI Marques, Joao T/0000-0002-3457-3320; Guerra Soares,
   Zamira/0000-0001-9203-4459
FU International Society for Infectious Diseases; CNPqNational Council for
   Scientific and Technological Development (CNPq); CAPESCAPES;
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG)
FX We thank the International Society for Infectious Diseases, CNPq, CAPES
   and FAPEMIG for funding. We apologize for any work that might not have
   been cited in this review due to limitation on the number of references.
CR Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001
   Ashe A, 2013, ELIFE, V2, DOI 10.7554/eLife.00994
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Batista TM, 2011, J PROTEOMICS, V74, P1504, DOI 10.1016/j.jprot.2011.02.032
   Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204
   Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202
   Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002
   Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x
   Chattopadhyay S, 2014, J INTERF CYTOK RES, V34, P427, DOI 10.1089/jir.2014.0034
   Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007
   Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007
   de Faria IJD, 2013, J INTERF CYTOK RES, V33, P239, DOI 10.1089/jir.2013.0026
   Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664
   Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691
   Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103
   Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056
   Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236
   Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494
   Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780
   Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950
   Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Hartig JV, 2011, NUCLEIC ACIDS RES, V39, P3836, DOI 10.1093/nar/gkq1324
   Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220
   Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030
   Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002
   Joshua-Tor L, 2010, COLD SPRING HARB PER, V3
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091
   Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630
   Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531
   Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802
   Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0
   Kim K, 2007, RNA, V13, P22, DOI 10.1261/rna.283207
   Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220
   Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2
   Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948
   Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911
   Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710
   Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870
   Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286
   Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495
   Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930
   Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040
   Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004
   Marques JT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003579
   Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735
   Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205
   Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065
   Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204
   Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015
   Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839
   Parker GS, 2006, RNA, V12, P807, DOI 10.1261/rna.2338706
   Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2
   Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235
   Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712
   Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105
   Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008
   Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002
   Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028
   Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904
   Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755
   Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   White E, 2014, NAT STRUCT MOL BIOL, V21, P552, DOI 10.1038/nsmb.2827
   Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048
   Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156
   Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6
   Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803
   Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033
   Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0
NR 92
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD DEC
PY 2014
VL 16
IS 12
SI SI
BP 1013
EP 1021
DI 10.1016/j.micinf.2014.09.001
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA AZ1RS
UT WOS:000348016200007
PM 25205243
DA 2020-12-16
ER

PT J
AU Campos, RK
   Boratto, PV
   Assis, FL
   Aguiar, ERGR
   Silva, LCF
   Albarnaz, JD
   Dornas, FP
   Trindade, GS
   Ferreira, PP
   Marques, JT
   Robert, C
   Raoult, D
   Kroon, EG
   La Scola, B
   Abrahao, JS
AF Campos, Rafael K.
   Boratto, Paulo V.
   Assis, Felipe L.
   Aguiar, Eric R. G. R.
   Silva, Lorena C. F.
   Albarnaz, Jonas D.
   Dornas, Fabio P.
   Trindade, Giliane S.
   Ferreira, Paulo P.
   Marques, Joao T.
   Robert, Catherine
   Raoult, Didier
   Kroon, Erna G.
   La Scola, Bernard
   Abrahao, Jonatas S.
TI Samba virus: a novel mimivirus from a giant rain forest, the Brazilian
   Amazon
SO VIROLOGY JOURNAL
LA English
DT Article
DE Mimiviridae; DNA virus; Giant virus; NCLDV; Virophage; Amazon; Brazil
ID PNEUMONIA PATIENTS; VIROPHAGE; RELATIVES; AMEBAS
AB Background: The identification of novel giant viruses from the nucleocytoplasmic large DNA viruses group and their virophages has increased in the last decade and has helped to shed light on viral evolution. This study describe the discovery, isolation and characterization of Samba virus (SMBV), a novel giant virus belonging to the Mimivirus genus, which was isolated from the Negro River in the Brazilian Amazon. We also report the isolation of an SMBV-associated virophage named Rio Negro (RNV), which is the first Mimivirus virophage to be isolated in the Americas.
   Methods/results: Based on a phylogenetic analysis, SMBV belongs to group A of the putative Megavirales order, possibly a new virus related to Acanthamoeba polyphaga mimivirus (APMV). SMBV is the largest virus isolated in Brazil, with an average particle diameter about 574 nm. The SMBV genome contains 938 ORFs, of which nine are ORFans. The 1,213.6 kb SMBV genome is one of the largest genome of any group A Mimivirus described to date. Electron microscopy showed RNV particle accumulation near SMBV and APMV factories resulting in the production of defective SMBV and APMV particles and decreasing the infectivity of these two viruses by several logs.
   Conclusion: This discovery expands our knowledge of Mimiviridae evolution and ecology.
C1 [Campos, Rafael K.; Boratto, Paulo V.; Assis, Felipe L.; Silva, Lorena C. F.; Albarnaz, Jonas D.; Dornas, Fabio P.; Trindade, Giliane S.; Ferreira, Paulo P.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Lab Virus, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Aguiar, Eric R. G. R.; Marques, Joao T.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270 Belo Horizonte, MG, Brazil.
   [Robert, Catherine; Raoult, Didier; La Scola, Bernard] Aix Marseille Univ, Fac Med, INSERM U1095, URMITE,CNRS IRD 7278 198, Marseille, France.
RP La Scola, B (corresponding author), Aix Marseille Univ, Fac Med, INSERM U1095, URMITE,CNRS IRD 7278 198, Marseille, France.
EM bernard.la-scola@univ-amu.fr; jonatas.abrahao@gmail.com
RI Abrahao, Jonatas/B-3895-2015; Kroon, Erna/V-5444-2019; Aguiar, Eric
   RGR/L-7989-2018; Campos, Rafael Kroon/AAB-5135-2020; Marques, Joao
   T/F-7683-2012; LA SCOLA, Bernard/P-6477-2016; Kroon, Erna
   Geessien/B-3631-2015; Dornas, Fabio/AAI-3582-2020; Aguiar,
   Eric/T-5076-2019; Albarnaz, Jonas Dutra/E-4526-2010
OI Abrahao, Jonatas/0000-0001-9420-1791; Aguiar, Eric
   RGR/0000-0002-8143-5756; Campos, Rafael Kroon/0000-0002-4852-0449;
   Marques, Joao T/0000-0002-3457-3320; LA SCOLA,
   Bernard/0000-0001-8006-7704; Kroon, Erna Geessien/0000-0003-2721-3826;
   Dornas, Fabio/0000-0001-7926-5551; Aguiar, Eric/0000-0002-8143-5756;
   Albarnaz, Jonas Dutra/0000-0002-8792-813X; raoult,
   didier/0000-0002-0633-5974
CR Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108
   Boughalmi M, 2012, ENVIRON MICROBIOL, V53, P344
   Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108
   Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003
   Claverie JM, 2009, J INVERTEBR PATHOL, V101, P172, DOI 10.1016/j.jip.2009.03.011
   Culley AI, 2011, CURR OPIN VIROL, V1, P52, DOI 10.1016/j.coviro.2011.05.003
   Dare RK, 2008, EMERG INFECT DIS, V14, P465, DOI 10.3201/eid1403.071027
   Desnues C, 2010, INTERVIROLOGY, V53, P293, DOI 10.1159/000312914
   Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109
   Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412
   Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107
   Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62
   Krupovic M, 2011, NAT REV MICROBIOL, V9, P762, DOI 10.1038/nrmicro2676
   La Scola B, 2005, EMERG INFECT DIS, V11, P449, DOI 10.3201/eid1103.040538
   La Scola B, 2003, SCIENCE, V299, P2033
   La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218
   Legendre Matthieu, 2012, Commun Integr Biol, V5, P102
   Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Slimani M, 2013, J VIROL, V87, P4783, DOI 10.1128/JVI.02948-12
   Suzan-Monti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000328
   Williamson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042047
   Xiao CA, 2005, J MOL BIOL, V353, P493, DOI 10.1016/j.jmb.2005.08.060
   Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092
   Yamada T, 2011, CURR OPIN VIROL, V1, P58, DOI 10.1016/j.coviro.2011.05.008
   Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108
   Zauberman N, 2008, PLOS BIOL, V6, P1104, DOI 10.1371/journal.pbio.0060114
NR 28
TC 65
Z9 66
U1 0
U2 19
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD MAY 14
PY 2014
VL 11
AR 95
DI 10.1186/1743-422X-11-95
PG 11
WC Virology
SC Virology
GA AH1DA
UT WOS:000335858700001
PM 24886672
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Marques, JT
   Wang, JP
   Wang, XH
   de Oliveira, KPV
   Gao, C
   Aguiar, ERGR
   Jafari, N
   Carthew, RW
AF Marques, Joao Trindade
   Wang, Ji-Ping
   Wang, Xiaohong
   Vieira de Oliveira, Karla Pollyanna
   Gao, Catherine
   Guimaraes Rocha Aguiar, Eric Roberto
   Jafari, Nadereh
   Carthew, Richard W.
TI Functional Specialization of the Small Interfering RNA Pathway in
   Response to Virus Infection
SO PLOS PATHOGENS
LA English
DT Article
ID DOUBLE-STRANDED-RNA; ANTIVIRAL IMMUNITY; INNATE IMMUNITY; DISTINCT
   ROLES; DROSOPHILA; REPLICATION; MECHANISMS; DICER-2; R2D2; SUPPRESSION
AB In Drosophila, post-transcriptional gene silencing occurs when exogenous or endogenous double stranded RNA (dsRNA) is processed into small interfering RNAs (siRNAs) by Dicer-2 (Dcr-2) in association with a dsRNA-binding protein (dsRBP) cofactor called Loquacious (Loqs-PD). siRNAs are then loaded onto Argonaute-2 (Ago2) by the action of Dcr-2 with another dsRBP cofactor called R2D2. Loaded Ago2 executes the destruction of target RNAs that have sequence complementarity to siRNAs. Although Dcr-2, R2D2, and Ago2 are essential for innate antiviral defense, the mechanism of virus-derived siRNA (vsiRNA) biogenesis and viral target inhibition remains unclear. Here, we characterize the response mechanism mediated by siRNAs against two different RNA viruses that infect Drosophila. In both cases, we show that vsiRNAs are generated by Dcr-2 processing of dsRNA formed during viral genome replication and, to a lesser extent, viral transcription. These vsiRNAs seem to preferentially target viral polyadenylated RNA to inhibit viral replication. Loqs-PD is completely dispensable for silencing of the viruses, in contrast to its role in silencing endogenous targets. Biogenesis of vsiRNAs is independent of both Loqs-PD and R2D2. R2D2, however, is required for sorting and loading of vsiRNAs onto Ago2 and inhibition of viral RNA expression. Direct injection of viral RNA into Drosophila results in replication that is also independent of Loqs-PD. This suggests that triggering of the antiviral pathway is not related to viral mode of entry but recognition of intrinsic features of virus RNA. Our results indicate the existence of a vsiRNA pathway that is separate from the endogenous siRNA pathway and is specifically triggered by virus RNA. We speculate that this unique framework might be necessary for a prompt and efficient antiviral response.
C1 [Marques, Joao Trindade; Wang, Xiaohong; Vieira de Oliveira, Karla Pollyanna; Gao, Catherine; Carthew, Richard W.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.
   [Marques, Joao Trindade; Vieira de Oliveira, Karla Pollyanna; Guimaraes Rocha Aguiar, Eric Roberto] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Wang, Ji-Ping] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA.
   [Jafari, Nadereh] Northwestern Univ, Genom Core, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA.
RP Marques, JT (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.
EM jtm@ufmg.br; r-carthew@northwestern.edu
RI Aguiar, Eric/T-5076-2019; Marques, Joao T/F-7683-2012; Aguiar, Eric
   RGR/L-7989-2018
OI Aguiar, Eric/0000-0002-8143-5756; Marques, Joao T/0000-0002-3457-3320;
   Aguiar, Eric RGR/0000-0002-8143-5756; Gao, Catherine
   A./0000-0001-5576-3943
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [GM068743, GM077581]; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM068743, R01GM068743,
   R01GM077581, R01GM077581, R01GM077581, R01GM068743, R01GM077581,
   R01GM068743, R01GM068743, R01GM068743, R01GM068743, R01GM068743,
   R01GM068743, R01GM077581, R01GM068743, R01GM077581, R01GM068743,
   R01GM077581, R01GM077581, R01GM077581, R01GM077581, R01GM068743,
   R01GM068743] Funding Source: NIH RePORTER
FX This work was supported by the NIH (www.nih.gov) with grants GM068743
   and GM077581 awarded to RWC. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001
   BANERJEE AK, 1987, MICROBIOL REV, V51, P66, DOI 10.1128/MMBR.51.1.66-87.1987
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002
   Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x
   Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007
   Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028
   Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Flynt A, 2009, P NATL ACAD SCI USA, V106, P5270, DOI 10.1073/pnas.0813412106
   Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236
   Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002
   Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Gerbasi VR, 2011, P NATL ACAD SCI USA, V108, P3204, DOI 10.1073/pnas.1009781108
   Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396
   Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220
   Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI 10.2217/FMB.09.59
   Joshua-Tor L, 2010, COLD SPRING HARB PER, V3
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Kim K, 2007, RNA, V13, P22, DOI 10.1261/rna.283207
   Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220
   Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2
   Lim KI, 2006, PLOS COMPUT BIOL, V2, P1001, DOI 10.1371/journal.pcbi.0020116
   Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710
   Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004
   Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735
   Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044
   Miyoshi K, 2010, RNA, V16, P506, DOI 10.1261/rna.1952110
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006
   Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698
   Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065
   Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204
   Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027
   Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060
   Plaskon NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007468
   Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386
   Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458
   SAWICKI DL, 1976, J VIROL, V20, P446, DOI 10.1128/JVI.20.2.446-464.1976
   Sorefan Karim, 2012, Silence, V3, P4, DOI 10.1186/1758-907X-3-4
   Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1
   Szittya G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000838
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724
   Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057
   Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
   Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263
   Zhou R, 2009, RNA, V15, P1886, DOI 10.1261/rna.1611309
NR 61
TC 38
Z9 39
U1 1
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD AUG
PY 2013
VL 9
IS 8
AR e1003579
DI 10.1371/journal.ppat.1003579
PG 14
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 211EQ
UT WOS:000323888200067
PM 24009507
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU de Faria, IJD
   Olmo, RP
   Silva, EG
   Marques, JT
AF da Silva de Faria, Isaque Joao
   Olmo, Roenick Proveti
   Silva, Emanuele Guimaraes
   Marques, Joao Trindade
TI dsRNA Sensing During Viral Infection: Lessons from Plants, Worms,
   Insects, and Mammals
SO JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
LA English
DT Review
ID DOUBLE-STRANDED-RNA; SMALL INTERFERING RNAS; DICERS HELICASE DOMAIN;
   DEXD/H-BOX HELICASE; RIG-I HELICASE; ANTIVIRAL IMMUNITY; STRUCTURAL
   BASIS; INNATE IMMUNITY; PROTEIN-KINASE; GENETIC INTERFERENCE
AB Host defense systems often rely on direct and indirect pattern recognition to sense the presence of invading pathogens. Patterns can be molecules directly produced by the pathogen or indirectly generated by changes in host parameters as a consequence of infection. Viruses are intracellular pathogens that hijack the cellular machinery to synthesize their own molecules making direct recognition of viral molecules a great challenge. Antiviral systems in prokaryotes and eukaryotes commonly exploit aberrant nucleic acid sensing to recognize virus infection as host and viral nucleic acid metabolism can greatly differ. Indeed, the generation of dsRNA is often associated with viral infection. In this review, we discuss current knowledge on the mechanisms of viral dsRNA sensing utilized by 2 important antiviral defense systems, RNA interference (RNAi) and the vertebrate immune system. The major viral sensors of the vertebrate immune systems are RIG-like receptors, while RNAi pathways depend on Dicer proteins. These 2 families of sensors share a similar helicase domain with high specificity for dsRNA, which is necessary, but not sufficient for efficient recognition by these receptors. Additional intrinsic features to the dsRNA molecule are also necessary for activation of antiviral systems. Studies utilizing synthetic ligands, in vitro biochemistry and reporter systems have greatly helped increase our knowledge on intrinsic features of dsRNA recognition. However, characteristics such as subcellular localization are extrinsic to the dsRNA itself, but certainly influence the recognition in vivo. Thus, mechanisms of viral dsRNA recognition must address how cellular sensors are recruited to nucleic acids or vice versa. Accessory proteins are likely important for in vivo recognition of extrinsic features of viral RNA, but have mostly remained undiscovered due to the limitations of previous strategies. Hence, the identification of novel components of antiviral systems must take into account the complexities involved in viral recognition in vivo.
C1 [da Silva de Faria, Isaque Joao; Olmo, Roenick Proveti; Silva, Emanuele Guimaraes; Marques, Joao Trindade] Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Av Antonio Carlos 6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Marques, Joao T/F-7683-2012; Olmo, Roenick/AAF-6412-2020
OI Marques, Joao T/0000-0002-3457-3320; 
FU PRPq-UFMG; CNPqNational Council for Scientific and Technological
   Development (CNPq); CAPESCAPES; FAPEMIGMinas Gerais State Research
   Foundation (FAPEMIG)
FX We acknowledge PRPq-UFMG, CNPq, CAPES, and FAPEMIG for funding.
CR Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132
   Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560
   Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001
   Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910
   Aregger M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002941
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280
   Batista TM, 2011, J PROTEOMICS, V74, P1504, DOI 10.1016/j.jprot.2011.02.032
   Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174
   Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886
   Blevins T, 2011, NUCLEIC ACIDS RES, V39, P5003, DOI 10.1093/nar/gkr119
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Bronkhorst AW, 2012, P NATL ACAD SCI USA, V109, pE3604, DOI 10.1073/pnas.1207213109
   Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689
   Bruns AM, 2013, J BIOL CHEM, V288, P938, DOI 10.1074/jbc.M112.424416
   Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002
   Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x
   Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015
   Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49
   Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007
   Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032
   Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352
   Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007
   Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664
   Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214
   Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247
   Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005
   Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945
   Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105
   Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]
   Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880
   Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909
   Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597
   Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586
   FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010
   Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523
   Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873
   Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5
   Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505
   Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041
   Jakubiec A, 2012, PLANT J, V69, P14, DOI 10.1111/j.1365-313X.2011.04765.x
   Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x
   Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537
   Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022
   Joshua-Tor L, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003772
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010
   Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0
   Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454
   Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130
   Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039
   KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028
   Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268
   Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2
   Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948
   Lindbo JA, 2005, ANNU REV PHYTOPATHOL, V43, P191, DOI 10.1146/annurev.phyto.43.040204.140228
   Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710
   LONG WF, 1971, J GEN VIROL, V12, P1, DOI 10.1099/0022-1317-12-1-1
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870
   Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286
   Luo DH, 2013, RNA BIOL, V10, P111, DOI 10.4161/rna.22706
   Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023
   Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005
   Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009
   Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758
   MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638
   MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238
   Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735
   Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205
   Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749
   Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771
   Matranga C, 2010, J BIOL CHEM, V285, P25363, DOI 10.1074/jbc.M110.117010
   Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2
   MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N
   Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10
   Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802
   Mukherjee K, 2013, MOL BIOL EVOL, V30, P627, DOI 10.1093/molbev/mss263
   Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279
   Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687
   Nishida KM, 2013, MOL CELL, V49, P680, DOI 10.1016/j.molcel.2012.12.024
   Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764
   Parker GS, 2006, RNA, V12, P807, DOI 10.1261/rna.2338706
   Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108
   Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998
   Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585
   Qin HN, 2010, RNA, V16, P474, DOI 10.1261/rna.1965310
   Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105
   Qu F, 2010, MOL PLANT MICROBE IN, V23, P1248, DOI 10.1094/MPMI-06-10-0124
   Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042
   Robertson M. P., 2012, COLD SPRING HARB PER, V4
   Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103
   ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x
   Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111
   Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439
   Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107
   Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008
   SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957
   Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007
   Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008
   Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032
   Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6
   Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028
   Takeshita D, 2007, J MOL BIOL, V374, P106, DOI 10.1016/j.jmb.2007.08.069
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001
   Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444
   VILCEK J, 1968, J VIROL, V2, P648, DOI 10.1128/JVI.2.6.648-650.1968
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107
   Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003
   Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Weinberg DE, 2011, CELL, V146, P262, DOI 10.1016/j.cell.2011.06.021
   Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005
   Welker NC, 2010, RNA, V16, P893, DOI 10.1261/rna.2122010
   Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016
   Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957
   WILLIAMS BRG, 1979, NUCLEIC ACIDS RES, V6, P1335, DOI 10.1093/nar/6.4.1335
   Wisskirchen C, 2011, J VIROL, V85, P8646, DOI 10.1128/JVI.02559-10
   Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
   Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104
   Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x
   Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033
   Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
NR 162
TC 11
Z9 12
U1 2
U2 43
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1079-9907
EI 1557-7465
J9 J INTERF CYTOK RES
JI J. Interferon Cytokine Res.
PD MAY
PY 2013
VL 33
IS 5
BP 239
EP 253
DI 10.1089/jir.2013.0026
PG 15
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 143DQ
UT WOS:000318847000002
PM 23656598
DA 2020-12-16
ER

PT J
AU Batista, TM
   Marques, JT
AF Batista, Thiago Mafra
   Marques, Joao Trindade
TI RNAi pathways in parasitic protists and worms
SO JOURNAL OF PROTEOMICS
LA English
DT Review
DE RNA interference; Non-coding RNA; Argonaute; Protists; Parasitic worms;
   Tropical diseases
ID DOUBLE-STRANDED-RNA; SCHISTOSOMA-JAPONICUM; PLASMODIUM-FALCIPARUM;
   ARGONAUTE PROTEINS; TRYPANOSOMA-BRUCEI; C-ELEGANS; GENETIC INTERFERENCE;
   ANTIGENIC VARIATION; ENDOGENOUS SIRNAS; MALARIA PARASITE
AB Tropical diseases caused by parasitic worms and protists are of major public health concern affecting millions of people worldwide. New therapeutic and diagnostic tools would be of great help in dealing with the public health and economic impact of these diseases. RNA interference (RNAi) pathways utilize small non-coding RNAs to regulate gene expression in a sequence-specific manner. In recent years, a wealth of data about the mechanisms and biological functions of RNAi pathways in distinct groups of eukaryotes has been described. Often, RNAi pathways have unique features that are restricted to groups of eukaryotes. The focus of this review will be on RNAi pathways in specific groups of parasitic eukaryotes that include Trypanosoma cruzi, Plasmodium and Schistosoma mansoni. These parasites are the causative agents of Chagas disease, Malaria, and Schistosomiasis, respectively, all of which are tropical diseases that would greatly benefit from the development of new diagnostic and therapeutic tools. In this context, we will describe specific features of RNAi pathways in each of these parasitic eukaryotic groups and discuss how they could be exploited for the treatment of tropical diseases. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Batista, Thiago Mafra; Marques, Joao Trindade] Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Batista, Thiago Mafra] Univ Fed Minas Gerais, Nucleo Bioinformat NUBio, Ctr Excelencia Bioinformat CEBio, BR-31270901 Belo Horizonte, MG, Brazil.
RP Marques, JT (corresponding author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Av Antonio Carlos,6627 Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM jtm@ufmg.br
RI Marques, Joao T/F-7683-2012
OI Marques, Joao T/0000-0002-3457-3320; Mafra Batista,
   Thiago/0000-0002-0755-1206
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG);
   CAPESCAPES
FX We thank Pei-Hsuan Wu, Daniel Mansur, Giliane Trindade and Gustavo
   Menezes for critical reading of this manuscript. We thank CNPq, FAPEMIG
   and CAPES for funding research in the laboratory of J.T.M.
CR Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253
   Braun L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000920
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x
   Chen J, 2010, PARASITOL RES, V107, P889, DOI 10.1007/s00436-010-1946-3
   Copeland CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-464
   Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604
   Couvillion MT, 2010, GENE DEV, V24, P2742, DOI 10.1101/gad.1996210
   Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209
   Dacks JB, 2002, MOL BIOL EVOL, V19, P830, DOI 10.1093/oxfordjournals.molbev.a004140
   DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005
   Djikeng A, 2001, RNA, V7, P1522
   Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945
   Durand-Dubief M, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-2
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056
   Silva MRG, 2010, GENE, V466, P26, DOI 10.1016/j.gene.2010.06.012
   Garcia-Silva MR, 2010, MOL BIOCHEM PARASIT, V171, P64, DOI 10.1016/j.molbiopara.2010.02.003
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917
   Gomes MS, 2009, PARASITOL INT, V58, P61, DOI 10.1016/j.parint.2008.10.002
   Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415
   Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7
   Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352
   Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870
   Hao LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-55
   Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   JOSHUATOR L, 2010, COLD SPRING HARB PER
   Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670
   Krautz-Peterson G, 2007, MOL BIOCHEM PARASIT, V153, P194, DOI 10.1016/j.molbiopara.2007.03.006
   Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017
   Kuo CH, 2008, MOL BIOL EVOL, V25, P2689, DOI 10.1093/molbev/msn213
   Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2
   Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123
   Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513
   Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733
   Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161
   MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638
   Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29
   Malhotra P, 2002, MOL MICROBIOL, V45, P1245, DOI 10.1046/j.1365-2958.2002.03105.x
   Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735
   McRobert L, 2002, MOL BIOCHEM PARASIT, V119, P273, DOI 10.1016/S0166-6851(01)00429-7
   Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1
   Mohmmed A, 2003, BIOCHEM BIOPH RES CO, V309, P506, DOI 10.1016/j.bbrc.2003.08.027
   Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373
   Muller B, 2010, J PROTEOMICS, V73, P2054, DOI 10.1016/j.jprot.2010.08.002
   Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317
   Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687
   O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708
   Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204
   Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014
   Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462
   Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585
   Rathjen T, 2006, FEBS LETT, V580, P5185, DOI 10.1016/j.febslet.2006.08.063
   Rivero FD, 2010, NAT MED, V16, P551, DOI 10.1038/nm.2141
   Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040
   Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011
   Shi HF, 2000, RNA, V6, P1069, DOI 10.1017/S1355838200000297
   Simoes MC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-47
   Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006
   Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514
   Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103
   Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023
   Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309
   Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334
   Vaucheret H, 2001, J CELL SCI, V114, P3083
   Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Wang ZX, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000596
   Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851
   Xue XY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-47
   Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033
   Zeiner GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008742
   Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219
NR 77
TC 20
Z9 21
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1874-3919
J9 J PROTEOMICS
JI J. Proteomics
PD AUG 24
PY 2011
VL 74
IS 9
SI SI
BP 1504
EP 1514
DI 10.1016/j.jprot.2011.02.032
PG 11
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 823TI
UT WOS:000295149000003
PM 21385631
DA 2020-12-16
ER

PT J
AU Chattopadhyay, S
   Marques, JT
   Yamashita, M
   Peters, KL
   Smith, K
   Desai, A
   Williams, BRG
   Sen, GC
AF Chattopadhyay, Saurabh
   Marques, Joao T.
   Yamashita, Michifumi
   Peters, Kristi L.
   Smith, Kevin
   Desai, Avanti
   Williams, Bryan R. G.
   Sen, Ganes C.
TI Viral apoptosis is induced by IRF-3-mediated activation of Bax
SO EMBO JOURNAL
LA English
DT Article
DE apoptosis; Bax; IRF-3; RIG-1; Sendai virus
ID DOUBLE-STRANDED-RNA; NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3;
   SENDAI-VIRUS INFECTION; TOLL-LIKE RECEPTOR-3; RIG-I; SIGNALING PATHWAY;
   ADAPTER PROTEIN; TRANSCRIPTION; RECOGNITION
AB Upon infection with many RNA viruses, the cytoplasmic retinoic acid inducible gene-I (RIG-I) pathway activates the latent transcription factor IRF-3, causing its nuclear translocation and the induction of many antiviral genes, including those encoding interferons. Here, we report a novel and distinct activity of IRF-3, in virus-infected cells, that induces apoptosis. Using genetically defective mouse and human cell lines, we demonstrated that, although both pathways required the presence of RIG-I, IPS1, TRAF3 and TBK1, only the apoptotic pathway required the presence of TRAF2 and TRAF6 in addition. More importantly, transcriptionally inactive IRF-3 mutants, such as the one missing its DNA-binding domain, could efficiently mediate apoptosis. Apoptosis was triggered by the direct interaction of IRF-3, through a newly identified BH3 domain, with the pro-apoptotic protein Bax, their co-translocation to the mitochondria and the resulting activation of the mitochondrial apoptotic pathway. Thus, IRF-3 is a dual-action cytoplasmic protein that, upon activation, translocates to the nucleus or to the mitochondrion and triggers two complementary antiviral responses of the infected cell. The EMBO Journal (2010) 29, 1762-1773. doi: 10.1038/emboj.2010.50; Published online 1 April 2010
C1 [Chattopadhyay, Saurabh; Marques, Joao T.; Yamashita, Michifumi; Peters, Kristi L.; Smith, Kevin; Desai, Avanti; Sen, Ganes C.] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA.
   [Williams, Bryan R. G.] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia.
RP Sen, GC (corresponding author), Cleveland Clin, Dept Mol Genet, Lerner Res Inst, 9500 Euclid Ave,NE20, Cleveland, OH 44195 USA.
EM seng@ccf.org
RI Marques, Joao T/F-7683-2012; Chattopadhyay, Saurabh/I-4091-2019;
   Williams, Bryan R. G./A-5021-2009
OI Marques, Joao T/0000-0002-3457-3320; Chattopadhyay,
   Saurabh/0000-0002-2930-1523; Williams, Bryan R. G./0000-0002-4969-1151;
   Yamashita, Michifumi/0000-0001-6221-8900
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI073303, CA062220];
   NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI073303, R01AI073303, R01AI073303, R01AI073303, R01AI073303,
   R01AI073303, R01AI073303, R01AI073303, R01AI073303, R01AI073303] Funding
   Source: NIH RePORTER
FX We thank Shizuo Akira, Michael Diamond, Michael Knudson, Marco Colonna,
   Michael Gale, Xiaxioa Li, Nywana Sizemore, George Stark and Robert
   Silverman for providing knock-out cells and John Hiscott, Michael David
   and Shigemi Matsuyama for providing the important reagents. We also
   thank Christine White for assistance with DC isolation. This work was
   supported by National Institutes of Health grants AI073303 (GCS) and
   CA062220 (GCS and BRGW).
CR Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560
   Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823
   Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279
   Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4
   Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005
   Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08
   Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921
   Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018
   Ghosh A, 2001, J BIOL CHEM, V276, P25447, DOI 10.1074/jbc.M100496200
   Goubau D, 2009, EUR J IMMUNOL, V39, P527, DOI 10.1002/eji.200838832
   Hamilton TA, 1996, J LEUKOCYTE BIOL, V59, P940
   Heylbroeck C, 2000, J VIROL, V74, P3781, DOI 10.1128/JVI.74.8.3781-3792.2000
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091
   Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243
   Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303
   Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005
   Lin RT, 1999, MOL CELL BIOL, V19, P959
   Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986
   Marques JT, 2005, J VIROL, V79, P11105, DOI 10.1128/JVI.79.17.11105-11114.2005
   Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087
   Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199
   Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07
   Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Weaver BK, 2001, FASEB J, V15, P501, DOI 10.1096/fj.00-0222com
   Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014
   Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
NR 32
TC 156
Z9 159
U1 1
U2 10
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD MAY 19
PY 2010
VL 29
IS 10
BP 1762
EP 1773
DI 10.1038/emboj.2010.50
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 598JU
UT WOS:000277833100014
PM 20360684
OA Green Published
DA 2020-12-16
ER

PT J
AU Marques, JT
   Kim, K
   Wu, PH
   Alleyne, TM
   Jafari, N
   Carthew, RW
AF Marques, Joao Trindade
   Kim, Kevin
   Wu, Pei-Hsuan
   Alleyne, Trevis M.
   Jafari, Nadereh
   Carthew, Richard W.
TI Loqs and R2D2 act sequentially in the siRNA pathway in Drosophila
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID DOUBLE-STRANDED-RNA; SMALL INTERFERING RNAS; SMALL SILENCING RNAS;
   ENDOGENOUS SIRNAS; MICRORNA MATURATION; DISTINCT ROLES; MESSENGER-RNAS;
   SOMATIC-CELLS; MOUSE OOCYTES; C-ELEGANS
AB In Drosophila melanogaster, the small interfering RNA (siRNA) pathway is triggered by exogenous double-stranded RNA (dsRNA) or upon viral infection. This pathway requires Dicer-2 (Dcr-2) in association with a dsRNA-binding protein (dsRBP) called R2D2. A potentially distinct siRNA pathway, which requires Dcr-2 in association with a different dsRBP, called Loquacious (Loqs), is activated by endogenous dsRNA derived from transposons, structured loci and overlapping transcripts. Here we show that different sources of dsRNA enter a common siRNA pathway that requires R2D2 and Loqs. R2D2 and loqs mutants show impaired silencing triggered by injection of exogenous dsRNA or by artificial and natural expression of endogenous dsRNA. In addition, we show that these dsRBPs function sequentially and nonredundantly in collaboration with Dcr-2. Loqs is primarily required for dsRNA processing, whereas R2D2 is essential for the subsequent loading of siRNAs into effector Ago-RISC complexes.
C1 [Marques, Joao Trindade; Kim, Kevin; Wu, Pei-Hsuan; Carthew, Richard W.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.
   [Alleyne, Trevis M.; Jafari, Nadereh] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Evanston, IL USA.
RP Carthew, RW (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.
EM r-carthew@northwestern.edu
RI Marques, Joao T/F-7683-2012; Wu, Pei-Hsuan/AAL-1704-2020
OI Marques, Joao T/0000-0002-3457-3320; Wu, Pei-Hsuan/0000-0002-6690-0744
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [GM68743];
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM068743,
   R01GM077581, R01GM077581, R01GM068743, R01GM068743, R01GM068743,
   R01GM068743, R01GM068743, R01GM077581, R01GM077581, R01GM077581,
   R01GM068743, R01GM077581, R01GM077581, R01GM077581, R01GM077581,
   R01GM068743, R01GM077581, R01GM068743, R01GM068743, R01GM068743,
   R01GM068743, R01GM068743] Funding Source: NIH RePORTER
FX We thank C. Reinke, Y. Bei and Carthew laboratory members for valuable
   discussion; F. Valsecchi for help with bioinformatics; C. Horvath, E.
   Sontheimer and J. Brickner (Northwestern University) for sharing
   equipment and reagents; P. Zamore (University of Massachusetts Medical
   School) for loqsf00791; M. Siomi (Keio University School of Medicine)
   for ago2414 stocks; Q. Liu (University of Texas Southwestern Medical
   Center) for R2D21 and loqsKO stocks and G. Hannon (Cold Spring Harbor
   Laboratory) for anti-Loqs antibody. This work was supported by a grant
   from the US National Institutes of Health (GM68743) to R. W. C.
CR Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006
   Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007
   Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103
   Fahlgren N, 2009, RNA, V15, P992, DOI 10.1261/rna.1473809
   Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236
   Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030
   Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005
   Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938
   Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802
   Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200
   Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2
   Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029
   Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710
   Liu X, 2007, RNA, V13, P2324, DOI 10.1261/rna.723707
   Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606
   Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002
   Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045
   Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204
   Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479
   Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438
   Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015
   Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839
   Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112
   Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060
   Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200
   Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2
   Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578
   Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439
   Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102
   Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904
   Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755
   Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057
   Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191
   Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908
   Zhou R, 2009, RNA, V15, P1886, DOI 10.1261/rna.1611309
   Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018
NR 42
TC 90
Z9 90
U1 2
U2 15
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD JAN
PY 2010
VL 17
IS 1
BP 24
EP U37
DI 10.1038/nsmb.1735
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 541CL
UT WOS:000273390300006
PM 20037596
OA Green Accepted
DA 2020-12-16
ER

PT J
AU Marques, J
   Anwar, J
   Eskildsen-Larsen, S
   Rebouillat, D
   Paludan, SR
   Sen, G
   Williams, BRG
   Hartmann, R
AF Marques, Joao
   Anwar, Jangawar
   Eskildsen-Larsen, Signe
   Rebouillat, Dominique
   Paludan, Soren R.
   Sen, Ganes
   Williams, Bryan R. G.
   Hartmann, Rune
TI The p59 oligoadenylate synthetase-like protein possesses antiviral
   activity that requires the C-terminal ubiquitin-like domain
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID MOLECULAR-WEIGHT INHIBITOR; GENE STRUCTURE; INTERFERON; EXPRESSION;
   ENZYME; KINASE; CELLS
AB Viral infection of mammalian cells prompts the innate immune system to initiate an antiviral response. The recognition of the virus triggers several antiviral signalling pathways, which among others include the family of 2'-5' oligoadenylate synthetase (OAS) proteins. The p59 protein encoded by the OAS-like (OASL) gene is an atypical member of the OAS family in the sense that it lacks the characteristic 2'-5' oligoadenylate synthetase activity. We decided to investigate the putative antiviral activity of p59 by ectopically expressing this protein in Vero cells and then infecting these cells with virus. We demonstrate that OASL has an antiviral effect against the single-stranded RNA virus picornavirus, encephalomyocarditis virus, but not against a large DNA virus, herpes simplex virus 1. Importantly, this antiviral activity was lost in a truncated version of p59 lacking the ubiquitin-like C-terminal domain of p59. Taken together our results indicate that p59 is indeed an antiviral protein that works through a novel mechanism distinct from other OAS proteins.
C1 [Anwar, Jangawar; Eskildsen-Larsen, Signe; Hartmann, Rune] Univ Aarhus, Dept Mol Biol, Struct Biol Ctr, DK-8000 Aarhus C, Denmark.
   [Marques, Joao; Rebouillat, Dominique] Cleveland Fdn, Dept Canc Biol, Cleveland, OH 44195 USA.
   [Paludan, Soren R.] Univ Aarhus, Inst Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark.
   [Williams, Bryan R. G.] Monash Inst Med Res, Clayton, Vic 3168, Australia.
   [Sen, Ganes] Cleveland Fdn, Dept Mol Genet, Cleveland, OH 44195 USA.
RP Hartmann, R (corresponding author), Univ Aarhus, Dept Mol Biol, Struct Biol Ctr, Gustav Wieds Vej 10 C, DK-8000 Aarhus C, Denmark.
EM rh@mb.au.dk
RI Williams, Bryan R. G./A-5021-2009; Marques, Joao T/F-7683-2012
OI Williams, Bryan R. G./0000-0002-4969-1151; Marques, Joao
   T/0000-0002-3457-3320; Hartmann, Rune/0000-0003-1159-066X
FU Novo Nordisk FoundationNovo Nordisk Foundation; Danish Medical Research
   CouncilDanish Medical Research Council [22-04-0704]
FX We thank Susanne Vends for technical assistance. R. H. was supported by
   a senior investigator grant from the Novo Nordisk Foundation and by a
   grant from the Danish Medical Research Council (grant no. 22-04-0704).
CR CHEBATH J, 1987, NATURE, V330, P587, DOI 10.1038/330587a0
   Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623
   DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Eskildsen S, 2003, NUCLEIC ACIDS RES, V31, P3166, DOI 10.1093/nar/gkg427
   Ghosh A, 2000, VIROLOGY, V266, P319, DOI 10.1006/viro.1999.0085
   Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891
   Hartmann R, 1998, NUCLEIC ACIDS RES, V26, P4121, DOI 10.1093/nar/26.18.4121
   Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7
   HOVANESSIAN AG, 1977, NATURE, V268, P537, DOI 10.1038/268537a0
   Hovnanian A, 1998, GENOMICS, V52, P267, DOI 10.1006/geno.1998.5443
   Justesen J, 2000, CELL MOL LIFE SCI, V57, P1593, DOI 10.1007/PL00000644
   Marie I, 1999, EUR J BIOCHEM, V262, P155, DOI 10.1046/j.1432-1327.1999.00361.x
   Perelygin AA, 2006, J MOL EVOL, V63, P562, DOI 10.1007/s00239-006-0073-3
   Rebouillat D, 1998, EUR J BIOCHEM, V257, P319, DOI 10.1046/j.1432-1327.1998.2570319.x
   ROBERTS WK, 1976, NATURE, V264, P477, DOI 10.1038/264477a0
   Sanchez R, 2007, J VIROL, V81, P3455, DOI 10.1128/JVI.02520-06
   Sarkar SN, 1999, J BIOL CHEM, V274, P25535, DOI 10.1074/jbc.274.36.25535
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Tatsumi R, 2000, BBA-GENE STRUCT EXPR, V1494, P263, DOI 10.1016/S0167-4781(00)00174-3
   Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127
NR 21
TC 45
Z9 50
U1 0
U2 6
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD NOV
PY 2008
VL 89
BP 2767
EP 2772
DI 10.1099/vir.0.2008/003558-0
PN 11
PG 6
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA 372ES
UT WOS:000260885500015
PM 18931074
OA Bronze
DA 2020-12-16
ER

PT J
AU Chattopadhyay, S
   Marques, JT
   Williams, B
   Sen, GC
AF Chattopadhyay, Saurabh
   Marques, Joao T.
   Williams, Bryan
   Sen, Ganes C.
TI New pathway for IRF-3-activation by RIG-I that causes its mitochondrial
   translocation and apoptosis
SO CYTOKINE
LA English
DT Meeting Abstract
CT 7th Joint Conference of the
   International-Cytokine-Society/International-Society-for-Interferon-and-
   Cytoklin-Research
CY OCT 12-16, 2008
CL Montreal, CANADA
SP Int Cytokine Soc, Int Soc Interferon & Cytokin Res
C1 [Chattopadhyay, Saurabh; Marques, Joao T.; Sen, Ganes C.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA.
   [Williams, Bryan] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia.
RI Chattopadhyay, Saurabh/I-4091-2019; Marques, Joao T/F-7683-2012
OI Chattopadhyay, Saurabh/0000-0002-2930-1523; Marques, Joao
   T/0000-0002-3457-3320
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
J9 CYTOKINE
JI Cytokine
PD SEP
PY 2008
VL 43
IS 3
BP 238
EP 238
DI 10.1016/j.cyto.2008.07.046
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 362QT
UT WOS:000260212900025
DA 2020-12-16
ER

PT J
AU Marques, JT
   White, CL
   Peters, GA
   Williams, BRG
   Sen, GC
AF Marques, Joao T.
   White, Christine L.
   Peters, Gregory A.
   Williams, Bryan R. G.
   Sen, Ganes C.
TI The role of PACT in mediating gene induction, PKR activation, and
   apoptosis in response to diverse stimuli
SO JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
LA English
DT Article
ID DEPENDENT PROTEIN-KINASE; CELLULAR ACTIVATOR; RAX; BINDING; INHIBITION;
   EXPRESSION; MICE; TRBP
AB PACT, the protein activator of the double-stranded (ds) RNA-activated protein kinase (PKR) has been shown to strongly interact with and activate PKR in cultured cells and in vitro. To further analyze the functions of PACT we have recently generated PACT knockout (KO) mice and described several developmental defects that are absent in PKR KO mice. Importantly, PACT has been previously suggested to be involved in different signaling pathways that include endoplasmic reticulum stress, serum deprivation, growth factor withdrawal, viral infection, and cytokine responses. In this study, we have analyzed the contribution of PACT to these pathways using cells derived from wildtype (WT) and PACT KO mice. Notably, we have been unable to detect any significant differences in the responses to stress stimuli comparing WT and PACT KO cells, although we have been able to validate the specific interaction between PACT and PKR. Taken together, our results reinforce the importance of genetic loss of function analysis to infer protein function.
C1 [Marques, Joao T.; White, Christine L.; Peters, Gregory A.; Sen, Ganes C.] Cleveland Clin, Dept Mol Genet, Cleveland, OH 44195 USA.
   [Marques, Joao T.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA.
   [Williams, Bryan R. G.] Monash Inst Med Res, Clayton, Vic, Australia.
RP Sen, GC (corresponding author), Cleveland Clin, Dept Mol Genet, NE20,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM seng@ccf.org
RI Marques, Joao T/F-7683-2012; Williams, Bryan R. G./A-5021-2009; White,
   Christine/D-7788-2014
OI Marques, Joao T/0000-0002-3457-3320; Williams, Bryan R.
   G./0000-0002-4969-1151; White, Christine/0000-0002-5920-0029; Peters,
   Gregory/0000-0001-6914-7316
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [CA068782-21];
   NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01CA068782, R01CA068782, R01CA068782, R01CA068782,
   R01CA068782, R01CA068782, R01CA068782, R01CA068782, R01CA068782,
   R01CA068782, R01CA068782, R01CA068782, R01CA068782, R01CA068782,
   R01CA068782, R01CA068782, R01CA068782, R01CA068782, R01CA068782,
   R01CA068782, R01CA068782, R01CA068782, R01CA068782] Funding Source: NIH
   RePORTER
FX This work was supported by National Institutes of Health grant
   CA068782-21 (G. C. S).
CR Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953
   Bennett RL, 2006, BLOOD, V108, P821, DOI 10.1182/blood-2005-11-006817
   Bennett RL, 2004, J BIOL CHEM, V279, P42687, DOI 10.1074/jbc.M403321200
   Chen G, 2006, J BIOL CHEM, V281, P15909, DOI 10.1074/jbc.M600612200
   Fasciano S, 2007, GENE, V388, P74, DOI 10.1016/j.gene.2006.10.003
   Gupta V, 2003, VIROLOGY, V315, P283, DOI 10.1016/S0042-6822(03)00589-0
   Huang X, 2002, BIOCHEM J, V366, P175, DOI 10.1042/bj20020204
   Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427
   Iwamura T, 2001, BIOCHEM BIOPH RES CO, V282, P515, DOI 10.1006/bbrc.2001.4606
   Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004
   Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303
   Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200
   Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406
   Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942
   Li SD, 2003, J INTERF CYTOK RES, V23, P689, DOI 10.1089/107999003772084806
   Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161
   Marques JT, 2005, J VIROL, V79, P11105, DOI 10.1128/JVI.79.17.11105-11114.2005
   Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899
   Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200
   Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379
   Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911
   Peters GA, 2002, J VIROL, V76, P11054, DOI 10.1128/JVI.76.21.11054-11064.2002
   Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001
   Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103
   Ruvolo PP, 2001, J BIOL CHEM, V276, P11754, DOI 10.1074/jbc.M011400200
   Silva AM, 2007, J BIOL CHEM, V282, P10164, DOI 10.1074/jbc.M609996200
   Terenzi F, 2005, VIROLOGY, V340, P116, DOI 10.1016/j.virol.2005.06.011
   Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2
   Yang ML, 2003, J BIOL CHEM, V278, P38325, DOI 10.1074/jbc.M303420200
   Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x
NR 30
TC 14
Z9 15
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1079-9907
EI 1557-7465
J9 J INTERF CYTOK RES
JI J. Interferon Cytokine Res.
PD AUG
PY 2008
VL 28
IS 8
BP 469
EP 475
DI 10.1089/jir.2007.0006
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 341NS
UT WOS:000258721800001
PM 18729737
OA Green Accepted, Green Published
DA 2020-12-16
ER

PT J
AU Zamanian-Daryoush, M
   Marques, JT
   Gantier, MP
   Behlke, MA
   John, M
   Rayman, P
   Finke, J
   Williams, BRG
AF Zamanian-Daryoush, Maryam
   Marques, Joao T.
   Gantier, Michael P.
   Behlke, Mark A.
   John, Matthias
   Rayman, Patricia
   Finke, James
   Williams, Bryan R. G.
TI Determinants of cytokine induction by small interfering RNA in human
   peripheral blood mononuclear cells
SO JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
LA English
DT Article
ID DOUBLE-STRANDED-RNA; PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTOR-9;
   DEPENDENT STIMULATION; MAMMALIAN-CELLS; SYNTHETIC SIRNA; INNATE
   IMMUNITY; CPG-DNA; ACTIVATION; TLR7
AB Synthetic small interfering RNAs (siRNAs) can trigger a strong innate immune response in mammalian cells. This nonspecific side effect may hinder the application of siRNAs as tools in gene silencing. Chemically synthesized siRNAs, including traditional 19-mers with 2-nt 3' overhangs, longer duplexes with blunt or 3' overhangs, and asymmetric duplexes with a blunt end and a 2-nt 3' overhang, can evoke strong dose-dependent interferon-alpha (IFN-alpha) and tumor necrosis factor-alpha (TNF-alpha) release in human peripheral blood mononuclear cells (PBMCs). This response is independent of retinoic acid-inducible gene I but may involve endosomal toll-like receptors (TLRs). The immunostimulatory effect of the siRNAs is directly related to either or both of the strands of the duplex in a sequence-dependent manner. However, although some single-stranded RNAs and siRNAs potently evoked both IFN-alpha and TNF-alpha induction, these responses were not always coupled. In accordance with this, specific chemical modifications differentially altered cytokine production, suggesting recruitment of different TLRs in a sequence-dependent manner.
C1 [Gantier, Michael P.; Williams, Bryan R. G.] Monash Univ, Monash Inst Med Res, Monash Med Ctr, Clayton, Vic 3168, Australia.
   [Zamanian-Daryoush, Maryam] Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA.
   [Marques, Joao T.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.
   [Behlke, Mark A.] Integrated DNA Technol, Coralville, IA 52241 USA.
   [John, Matthias] Alnylam Europe AG, Biol & Bioanalyt, D-95326 Kulmbach, Germany.
   [Rayman, Patricia; Finke, James] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA.
RP Williams, BRG (corresponding author), Monash Univ, Monash Inst Med Res, Monash Med Ctr, 246 Clayton Rd, Clayton, Vic 3168, Australia.
EM bryan.williams@med.monash.edu.au
RI Marques, Joao T/F-7683-2012; Gantier, Michael/B-7512-2011; Gantier,
   Michael/H-7954-2019; Williams, Bryan R. G./A-5021-2009
OI Marques, Joao T/0000-0002-3457-3320; Gantier,
   Michael/0000-0003-3740-698X; Gantier, Michael/0000-0003-3740-698X;
   Williams, Bryan R. G./0000-0002-4969-1151; Behlke,
   Mark/0000-0002-4218-857X
FU NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI034039, R01AI034039, R01AI034039, R01AI034039, R01AI034039,
   R01AI034039, R01AI034039, R01AI034039, R01AI034039, R01AI034039,
   R01AI034039, R01AI034039, R01AI034039, R01AI034039, R01AI034039] Funding
   Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) [P01 CA 062220] Funding Source: Medline; NIAID
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI 034039] Funding Source: Medline
CR Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259
   Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022
   He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379
   Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238
   Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620
   Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191
   Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531
   Hume D A, 2001, BMC Immunol, V2, P11, DOI 10.1186/1471-2172-2-11
   Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706
   Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081
   Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002
   Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008
   Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545
   Kato S, 2004, J AM SOC NEPHROL, V15, P1289
   Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940
   Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051
   Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U
   Ma Z, 2005, BIOCHEM BIOPH RES CO, V330, P755, DOI 10.1016/j.bbrc.2005.03.041
   Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205
   Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161
   Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873
   Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a
   Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401
   Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904
   Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199
   Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732
   Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218
   Sioud M, 2003, BIOCHEM BIOPH RES CO, V312, P1220, DOI 10.1016/j.bbrc.2003.11.057
   Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013
   Sioud M, 2006, EUR J IMMUNOL, V36, P1222, DOI 10.1002/eji.200535708
   Sledz CA, 2005, BLOOD, V106, P787, DOI 10.1182/blood-2004-12-4643
   Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038
   Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568
   Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186
   Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105
   Wang JY, 2006, J BIOL CHEM, V281, P37427, DOI 10.1074/jbc.M605311200
   Whitmore MM, 2004, CANCER RES, V64, P5850, DOI 10.1158/0008-5472.CAN-04-0063
NR 43
TC 46
Z9 48
U1 0
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1079-9907
J9 J INTERF CYTOK RES
JI J. Interferon Cytokine Res.
PD APR
PY 2008
VL 28
IS 4
BP 221
EP 233
DI 10.1089/jir.2007.0090
PG 13
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 305QU
UT WOS:000256193700002
PM 18439100
DA 2020-12-16
ER

PT J
AU Marques, JT
   Carthew, RW
AF Marques, Joao T.
   Carthew, Richard W.
TI A call to arms: coevolution of animal viruses and host innate immune
   responses
SO TRENDS IN GENETICS
LA English
DT Review
ID DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER;
   ANTIVIRAL RESPONSE; MAMMALIAN-CELLS; NUCLEAR EXPORT; INTERFERENCE;
   SUPPRESSION; APOPTOSIS; INFECTION
AB Virus infection is generally disadvantageous to the host and strongly selects for host antiviral mechanisms. Therefore, viruses must develop counter-mechanisms to guarantee their survival. This arms race between pathogen and host leads to positive selection for both cellular antiviral mechanisms and viral inhibitors of such mechanisms. Here, we characterize this arms race in the context of the RNA interference (RNAi) pathway, which is used as an innate immune response against viral infection by animals. We review how RNAi is used as an antiviral strategy and the mechanisms that viruses have evolved to suppress the RNAi response.
C1 Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.
RP Carthew, RW (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.
EM r-carthew@northwestern.edu
RI Marques, Joao T/F-7683-2012
OI Marques, Joao T/0000-0002-3457-3320
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM072830,
   R01GM072830, R01GM068743, R01GM068743, R01GM068743, R01GM068743,
   R01GM068743, R01GM068743, R01GM072830, R01GM068743, R01GM068743,
   R01GM068743, R01GM072830, R01GM068743, R01GM072830, R01GM068743,
   R01GM068743, R01GM068743] Funding Source: NIH RePORTER; NIGMS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM68743, GM72830, R01 GM068743] Funding
   Source: Medline
CR ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290
   Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950
   Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005
   Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013
   Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204
   Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05
   CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825
   Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005
   Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868
   Clarke TE, 2003, INT REV IMMUNOL, V22, P401, DOI 10.1080/08830180305215
   Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702
   Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623
   Everett H, 2001, VIROLOGY, V288, P1, DOI 10.1006/viro.2001.1081
   Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509
   Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024
   Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504
   Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900
   Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x
   HUGHES AL, 1995, J MOL EVOL, V41, P539, DOI 10.1007/BF00175811
   Hughes AL, 2000, J INTERF CYTOK RES, V20, P737, DOI 10.1089/10799900050116444
   Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259
   Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kibler KV, 1997, J VIROL, V71, P1992, DOI 10.1128/JVI.71.3.1992-2003.1997
   Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Leib DA, 2000, P NATL ACAD SCI USA, V97, P6097, DOI 10.1073/pnas.100415697
   Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205
   Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948
   Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100
   Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513
   Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870
   Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004
   Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599
   Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205
   Marques JT, 2005, J VIROL, V79, P11105, DOI 10.1128/JVI.79.17.11105-11114.2005
   Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007
   Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102
   Schultz U, 2004, DEV COMP IMMUNOL, V28, P499, DOI 10.1016/j.dci.2003.09.009
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005
   Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000
   Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Van Rij RP, 2006, TRENDS BIOTECHNOL, V24, P186, DOI 10.1016/j.tibtech.2006.02.006
   Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957
   Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x
   Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824
NR 55
TC 56
Z9 58
U1 0
U2 12
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0168-9525
J9 TRENDS GENET
JI Trends Genet.
PD JUL
PY 2007
VL 23
IS 7
BP 359
EP 364
DI 10.1016/j.tig.2007.04.004
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA 191LR
UT WOS:000248133200009
PM 17467114
DA 2020-12-16
ER

PT J
AU Marques, JT
   Devosse, T
   Wang, D
   Zamanian-Daryoush, M
   Serbinowski, P
   Hartmann, R
   Fujita, T
   Behlke, MA
   Williams, BRG
AF Marques, JT
   Devosse, T
   Wang, D
   Zamanian-Daryoush, M
   Serbinowski, P
   Hartmann, R
   Fujita, T
   Behlke, MA
   Williams, BRG
TI A structural basis for discriminating between self and nonself
   double-stranded RNAs in mammalian cells
SO NATURE BIOTECHNOLOGY
LA English
DT Article
ID INNATE IMMUNE-RESPONSE; ANTIVIRAL RESPONSE; INTERFERING RNAS; DEPENDENT
   STIMULATION; GENE-EXPRESSION; PROTEIN-KINASE; RIG-I; ACTIVATION; SIRNAS;
   INHIBITION
AB Nonspecific effects triggered by small interfering RNAs (siRNAs) complicate the use of RNA interference (RNAi) to specifically downregulate gene expression(1-5). To uncover the basis of these nonspecific activities, we analyzed the effect of chemically synthesized siRNAs on mammalian double-stranded RNA (dsRNA)-activated signaling pathways. siRNAs ranging from 21 to 27 nucleotides (nt) in length activated the interferon system when they lacked 2-nt 3' overhangs, a characteristic of Dicer products. We show that the recognition of siRNAs is mediated by the RNA helicase RIG-I and that the presence of 3' overhangs impairs its ability to unwind the dsRNA substrate and activate downstream signaling to the transcription factor IRF-3. These results suggest a structural basis for discrimination between microRNAs that are endogenous Dicer products, and nonself dsRNAs such as by-products of viral replication. These findings will enable the rational design of siRNAs that avoid nonspecific effects or, alternatively, that induce bystander effects to potentially increase the efficacy of siRNA-based treatments of viral infections or cancer.
C1 Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA.
   Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus, Denmark.
   Kyoto Univ, Inst Virus Res, Genet Mol Lab, Kyoto 6068507, Japan.
   Integrated DNA Technol Inc, Coralville, Iwate 52241, Japan.
   Monash Univ, Monash Inst Med Res, Clayton, Vic 3168, Australia.
RP Williams, BRG (corresponding author), Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.
EM bryan.williams@med.monash.edu.au
RI Marques, Joao T/F-7683-2012; Williams, Bryan R. G./A-5021-2009
OI Marques, Joao T/0000-0002-3457-3320; Williams, Bryan R.
   G./0000-0002-4969-1151; Hartmann, Rune/0000-0003-1159-066X; Behlke,
   Mark/0000-0002-4218-857X
FU NCI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01
   CA 62220] Funding Source: Medline; NIAID NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R01
   AI34039] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI034039, R01AI034039, R01AI034039,
   R01AI034039, R01AI034039, R01AI034039, R01AI034039, R01AI034039,
   R01AI034039, R01AI034039, R01AI034039, R01AI034039, R01AI034039,
   R01AI034039, R01AI034039] Funding Source: NIH RePORTER
CR Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798
   Carpick BW, 1997, J BIOL CHEM, V272, P9510, DOI 10.1074/jbc.272.14.9510
   Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002
   Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191
   Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282
   Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081
   Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545
   Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010
   Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940
   Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051
   Levy DE, 2004, NAT IMMUNOL, V5, P699, DOI 10.1038/ni0704-699
   MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238
   Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161
   Marques JT, 2005, J VIROL, V79, P11105, DOI 10.1128/JVI.79.17.11105-11114.2005
   Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263
   Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904
   Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199
   Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732
   Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052
   Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038
   Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003
   Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174
NR 28
TC 288
Z9 306
U1 1
U2 16
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD MAY
PY 2006
VL 24
IS 5
BP 559
EP 565
DI 10.1038/nbt1205
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 039TX
UT WOS:000237331300031
PM 16648842
DA 2020-12-16
ER

PT J
AU Coelho, LFL
   Mota, BEF
   Sales, PCM
   Marques, JT
   de Oliveira, JG
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Leomil Coelho, Luiz Felipe
   Fernandes Mota, Bruno Eduardo
   Motta Sales, Paula Cristiane
   Trindade Marques, Joao
   Germano de Oliveira, Jacquelline
   Antonio Bonjardim, Claudio
   Peregrino Ferreira, Paulo Cesar
   Geessien Kroon, Erna
TI Integrin alpha 11 is a novel type I interferon stimulated gene
SO CYTOKINE
LA English
DT Article
DE integrin alpha 11; interferons alpha/beta; PKR
ID DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; NF-KAPPA-B; TUMOR-SUPPRESSOR
   P53; CHROMOSOMAL LOCALIZATION; INTERSTITIAL COLLAGENS; VIRAL-INFECTION;
   CELL-MIGRATION; ADHESION; ACTIVATION
AB Interferons (IFNs) are a family of cytokines that have many biological functions in the cell, including regulation of cellular growth, differs entiation, immunomodulation, and viral replication by inducing a set of interferon stimulated genes (ISGs). Based on their structure and biological activities IFNs are subdivided into two groups: type I IFNs, which includes IFN-alpha and IFN-beta and type 11 IFNs, represented by IFN-gamma. The aim of this work was to investigate whether integrin alpha-11 (ITGA-11), a novel collagen-binding integrin, is responsive to type I IFN treatment. Our findings indicated that type I IFNs were able to induce the ITGA-11 mRNA levels in T98G cells. Increased levels of ITGA-11 protein were also observed in IFN-treated cells. The in vivo induction of ITGA-11 was detected in spleen and lungs of IFN-treated BALB/c mice. T98G cells infected with Murine encephalomyocarditis virus showed increased levels of ITGA-11 mRNA and protein. We observed that the ITGA-11 promoter has binding sites for transcriptional factors regulated by IFNs and the double-stranded RNA dependent protein kinase (PKR). Therefore we investigated the role of PKR in the induction of ITGA-11 by using a PKR deficient mouse embryo fibroblast cell line (MEFs). PKR-/- MEFs treated with IFN did not show increased levels of ITGA-11 protein nor mRNA although that could be promptly detected in wild type MEFs. Taken together our data suggest that ITGA-11 is a new interferon stimulated gene. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Virus Lab, BR-31270910 Belo Horizonte, MG, Brazil.
   Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Virus Lab, Av Antonio Carlos,6627, BR-31270910 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Coelho, Luiz FL/G-5853-2012; Bonjardim, Claudio A/J-2601-2014; Marques,
   Joao T/F-7683-2012; Kroon, Erna/V-5444-2019; Kroon, Erna
   Geessien/B-3631-2015
OI Marques, Joao T/0000-0002-3457-3320; Kroon, Erna
   Geessien/0000-0003-2721-3826; Mota, Bruno/0000-0003-0348-4875; Coelho,
   Luiz Felipe/0000-0003-4289-384X
CR Bandyopadhyay SK, 2000, J IMMUNOL, V164, P2077, DOI 10.4049/jimmunol.164.4.2077
   Ben-Horin S, 2004, CLIN IMMUNOL, V113, P119, DOI 10.1016/j.clim.2004.06.007
   Bhatia R, 1998, LEUKEMIA LYMPHOMA, V28, P241, DOI 10.3109/10428199809092680
   Bonjardim CA, 1998, BRAZ J MED BIOL RES, V31, P1389, DOI 10.1590/S0100-879X1998001100004
   Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845
   Campos MAS, 1999, CELL BIOL INT, V23, P81, DOI 10.1006/cbir.1998.0323
   Carvalho AF, 1998, PLACENTA, V19, P307, DOI 10.1016/S0143-4004(98)90063-7
   Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6
   Cuddihy AR, 1999, MOL CELL BIOL, V19, P2475
   Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620
   DAO T, 1995, FOLIA BIOL-PRAGUE, V41, P213
   de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912
   FERREIRA PCP, 1979, J CLIN MICROBIOL, V9, P471
   Flaishon L, 2001, J BIOL CHEM, V276, P46701, DOI 10.1074/jbc.M103484200
   Gil J, 2000, ONCOGENE, V19, P1369, DOI 10.1038/sj.onc.1203448
   Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241
   Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004
   GULLBERG D, 1995, DEV DYNAM, V204, P57, DOI 10.1002/aja.1002040108
   Higuchi A, 2003, J BIOMED MATER RES A, V65A, P369, DOI 10.1002/jbm.a.10428
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049
   Kontsek P, 2003, ACTA VIROL, V47, P201
   Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406
   Lau JF, 2002, MT SINAI J MED, V69, P156
   Lee JH, 2005, GLIA, V50, P66, DOI 10.1002/glia.20156
   Lehnert K, 1999, GENOMICS, V60, P179, DOI 10.1006/geno.1999.5909
   LEVIN D, 1978, P NATL ACAD SCI USA, V75, P1121, DOI 10.1073/pnas.75.3.1121
   Maemura M, 1999, ONCOL REP, V6, P557
   Mainiero F, 1998, J EXP MED, V188, P1267, DOI 10.1084/jem.188.7.1267
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652
   Muraro PA, 2004, J NEUROIMMUNOL, V150, P123, DOI 10.1016/j.jneuroim.2004.01.002
   Oliveira JG, 1999, ARCH DERMATOL RES, V291, P659, DOI 10.1007/s004030050471
   Paludan SR, 2001, J VIROL, V75, P8008, DOI 10.1128/JVI.75.17.8008-8015.2001
   Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006
   Sambrook J, 1989, MOL CLONING LAB MANU
   SANTALA P, 1991, J BIOL CHEM, V266, P23505
   Sims TN, 2002, IMMUNOL REV, V186, P100, DOI 10.1034/j.1600-065X.2002.18610.x
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Tenaud I, 2002, INT J DERMATOL, V41, P836, DOI 10.1046/j.1365-4362.2002.01598.x
   Thomsen AR, 2003, IMMUNOL LETT, V85, P119, DOI 10.1016/S0165-2478(02)00236-5
   Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363
   Uddin S, 2004, J BIOCHEM MOL BIOL, V37, P635
   VALENZUELA D, 1985, NATURE, V313, P698, DOI 10.1038/313698a0
   Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735
   Wang K, 2002, ONCOGENE, V21, P7598, DOI 10.1038/sj.onc.1205953
   WEBER H, 1987, EMBO J, V6, P591, DOI 10.1002/j.1460-2075.1987.tb04795.x
   WILIAMS BR, 2001, SCI STKE, pRE2
   Williams BRG, 1997, BIOCHEM SOC T, V25, P509, DOI 10.1042/bst0250509
   Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291
   Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200
   Zhang WM, 2002, MATRIX BIOL, V21, P513, DOI 10.1016/S0945-053X(02)00054-9
NR 55
TC 3
Z9 3
U1 0
U2 1
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD MAR 21
PY 2006
VL 33
IS 6
BP 352
EP 361
DI 10.1016/j.cyto.2006.03.007
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 055QG
UT WOS:000238464800007
PM 16697656
DA 2020-12-16
ER

PT J
AU Nguyen, QN
   Chavli, RV
   Marques, JT
   Conrad, PG
   Wang, D
   He, WH
   Belisle, BE
   Zhang, AG
   Pastor, LM
   Witney, FR
   Morris, M
   Heitz, F
   Divita, G
   Williams, BRG
   McMaster, GK
AF Nguyen, Quan N.
   Chavli, Rajesh V.
   Marques, Joao T.
   Conrad, Peter G., II
   Wang, Die
   He, Weihai
   Belisle, Barbara E.
   Zhang, Aiguo
   Pastor, Larry M.
   Witney, Frank R.
   Morris, May
   Heitz, Frederic
   Divita, Gilles
   Williams, Bryan R. G.
   McMaster, Gary K.
TI Light controllable siRNAs regulate gene suppression and phenotypes in
   cells
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article; Proceedings Paper
CT Conference on Mechanisms of Carrier-Mediated Intra-Cellular Delivery of
   Therapeutics
CY AUG 25-26, 2005
CL Montpellier, FRANCE
DE light controllable siRNAs to regulate gene expression; MPG delivery for
   difficult to transfect cell types; branch DNA quantitation of mRNA
   expression; non-specific effects of the double-stranded RNA (dsRNA)
   regulated protein kinase PKR kinase and induction of the IFN response;
   immunofluorescence detection of protein expression; western blot
   detection of protein expression; apoptosis and multinucleation
   phenotypic assays
ID RNA INTERFERENCE; EXPRESSION; SYSTEM; ACTIVATION; SHRNAS
AB Small interfering RNA (siRNA) is widely recognized as a powerful tool for targeted gene silencing. However, siRNA gene silencing occurs during transfection, limiting its use is in kinetic studies, deciphering toxic and off-target effects and phenotypic assays requiring temporal, and/or spatial regulation. We developed a novel controllable siRNA (csiRNA) that is activated by light. A single photo removable group is coupled during oligonucleotide synthesis to the 5' end of the antisense strand of the siRNA, which blocks the siRNA's activity. A low dose of light activates the siRNA, independent of transfection resulting in knock down of specific target mRNAs and proteins (GAPDH, p53, survivin, hNuf2) without stimulating non-specific effects such as regulated protein kinase PKR and induction of the interferon response. We demonstrate survivin and hNuf2 csiRNAs temporally knockdown their mRNAs causing multinucleation and cell death by mitotic arrest, respectively. Furthermore, we demonstrate a dose-dependent light regulation of hNuf2 csiRNA activity and resulting phenotype. The light controllable siRNAs are introduced into cells using commercially available reagents including the MPG peptide based delivery system. The csiRNAs are comparable to standard siRNAs in their transfection efficiency and potency of gene silencing. This technology should be of interest for phenotypic assays such as cell survival, cell cycle regulation, and cell development. (c) 2006 Elsevier B.V. All rights reserved.
C1 Genospectra Inc, Fremont, CA 94555 USA.
   Lerner Res Inst, Dept Canc Biol, Cleveland Clin Fdn, Cleveland, OH 44195 USA.
   CNRS, CRBM, FRE 2593, Mol Biophy & Therapeut, F-34293 Montpellier 5, France.
RP McMaster, GK (corresponding author), Genospectra Inc, 6519 Dumbarton Circle, Fremont, CA 94555 USA.
EM gmcmaster@genospectra.com
RI Williams, Bryan R. G./A-5021-2009; MORRIS, May C/J-5940-2016; Marques,
   Joao T/F-7683-2012
OI Williams, Bryan R. G./0000-0002-4969-1151; MORRIS, May
   C/0000-0001-8106-9728; Marques, Joao T/0000-0002-3457-3320
FU PHS HHSUnited States Public Health Service [R0134039] Funding Source:
   Medline
CR Ando H, 2001, NAT GENET, V28, P317, DOI 10.1038/ng583
   Caplen NJ, 2004, GENE THER, V11, P1241, DOI 10.1038/sj.gt.3302324
   Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612
   Chaulk SG, 1998, NUCLEIC ACIDS RES, V26, P3173, DOI 10.1093/nar/26.13.3173
   Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703
   Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4
   DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159
   Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   GIVENS RS, 2004, CRC HDB ORGANIC PHOT, V69, P1
   Guo HS, 2003, PLANT J, V34, P383, DOI 10.1046/j.1365-313X.2003.01723.x
   Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101
   Ihrig I, 1999, RADIAT RES, V152, P303, DOI 10.2307/3580330
   Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051
   Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604
   Lin WY, 2002, CHEM BIOL, V9, P1347, DOI 10.1016/S1074-5521(02)00288-0
   McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908
   Monroe WT, 1999, J BIOL CHEM, V274, P20895, DOI 10.1074/jbc.274.30.20895
   Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372
   Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5
   Paddison PJ, 2003, CURR OPIN MOL THER, V5, P217
   Shah S, 2005, ANGEW CHEM INT EDIT, V44, P1328, DOI 10.1002/anie.200461458
   Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385
   Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052
   Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038
   Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121
   Veldhuyzen WF, 2003, J AM CHEM SOC, V125, P13358, DOI 10.1021/ja037801x
   Walker JW, 1998, P NATL ACAD SCI USA, V95, P1568, DOI 10.1073/pnas.95.4.1568
   Wertz K, 2005, J INVEST DERMATOL, V124, P428, DOI 10.1111/j.0022-202X.2004.23593.x
   Xu Z, 2004, J INTERF CYTOK RES, V24, P522, DOI 10.1089/1079990041992730
NR 30
TC 55
Z9 60
U1 1
U2 12
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 1879-2642
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD MAR
PY 2006
VL 1758
IS 3
BP 394
EP 403
DI 10.1016/j.bbamem.2006.01.003
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 054AF
UT WOS:000238347000016
PM 16497269
OA Bronze
DA 2020-12-16
ER

PT J
AU Sutton, D
   Kim, SJ
   Shuai, XT
   Leskov, K
   Marques, JT
   Williams, BRG
   Boothman, DA
   Gao, JM
AF Sutton, Damon
   Kim, Saejeong
   Shuai, Xintao
   Leskov, Konstantin
   Marques, Joao T.
   Williams, Bryan R. G.
   Boothman, David A.
   Gao, Jinming
TI Efficient suppression of secretory clusterin levels by polymer-siRNA
   nanocomplexes enhances ionizing radiation lethality in human MCF-7
   breast cancer cells in vitro
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE siRNA delivery; polyethylenimine; nanomedicine; secretory clusterin;
   cancer radiotherapy
ID GENE DELIVERY-SYSTEM; RNA INTERFERENCE; MAMMALIAN-CELLS; PROTEIN
   CLUSTERIN; EXPRESSION; INHIBITION; SURVIVAL; DEATH; NANOPARTICLE;
   SENSITIVITY
AB Small interfering RNA molecules (siRNA) hold great promise to specifically target cytoprotective factors to enhance cancer therapy. Like antisense RNA strategies, however, the use of siRNA is limited because of in vivo instability. As a first step to overcome delivery issues, a series of graft copolymers of polyethylene glycol and polyethylenimine (PEI-g-PEG) were synthesized and investigated as nontoxic carriers for delivery of siRNA targeting the signaling peptide of secretory clusterin (sCLU), a prosurvival factor that protects cells from ionizing radiation (IR) injury, as well as chemotherapeutic agents. Three copolymers with different PEG grafting densities were tested for their abilities to bind and form nanocomplexes with siRNA. A copolymer composed of 10 PEG grafts (2 kDa each) per PEI polymer (2k10 copolymer) gave the highest binding affinity to siRNA by ethidium bromide exclusion assays, and had the smallest nanocomplex size (115 +/- 13 nm diameter). In human breast cancer MCF-7 cells, 2k10-siRNA-sCLU nanocomplexes suppressed both basal as well as IR-induced sCLU protein expression, which led to an over 3-fold increase in IR-induced lethality over 2k10-siRNA scrambled controls. In summary, this study demonstrates the proof-of-principle in using nanoparticle-mediated delivery of specific siRNAs to enhance the lethality of IR exposure in vitro, opening the door for siRNA-mediated knockdown of specific cytoprotective factors, such as DNA repair, antiapoptotic, free radical scavenging, and many other proteins.
C1 [Sutton, Damon; Leskov, Konstantin; Boothman, David A.; Gao, Jinming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.
   [Kim, Saejeong; Shuai, Xintao] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Marques, Joao T.; Williams, Bryan R. G.] Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA.
RP Gao, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.
EM jinming.gao@utsouthwestern.edu
RI Williams, Bryan R. G./A-5021-2009; Boothman, David/Q-7776-2019; Shuai,
   Xintao/C-5819-2008; Marques, Joao T/F-7683-2012
OI Williams, Bryan R. G./0000-0002-4969-1151; Shuai,
   Xintao/0000-0003-4271-0310; Marques, Joao T/0000-0002-3457-3320
FU NCI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30
   CA142543, R01 CA102792, R01 CA078530, R01-CA-90696] Funding Source:
   Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) [P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, R01CA102792, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, R01CA090696, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, R01CA102792, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   R01CA102792, P30CA142543, R01CA078530, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, R01CA102792, R01CA102792,
   R01CA102792, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, R01CA102792, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, R01CA102792, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, R01CA078530, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   R01CA102792, P30CA142543, P30CA142543, R01CA102792, P30CA142543,
   P30CA142543, P30CA142543, R01CA090696, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   R01CA090696, P30CA142543, P30CA142543, R01CA102792, P30CA142543,
   R01CA078530, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, R01CA090696,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, R01CA102792,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, R01CA102792,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, R01CA090696, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, R01CA102792, P30CA142543, R01CA090696,
   R01CA102792, P30CA142543, R01CA102792, R01CA090696, P30CA142543,
   P30CA142543, P30CA142543, R01CA078530, P30CA142543, P30CA142543,
   R01CA090696, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, R01CA078530,
   P30CA142543, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   P30CA142543, P30CA142543, R01CA102792, R01CA090696, P30CA142543,
   R01CA102792, P30CA142543, P30CA142543, P30CA142543, P30CA142543,
   R01CA102792] Funding Source: NIH RePORTER
CR Bettuzzi Saverio, 2003, Acta Biomed, V74, P101
   BOOTHMAN DA, 1993, P NATL ACAD SCI USA, V90, P7200, DOI 10.1073/pnas.90.15.7200
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Brownlie A, 2004, INT J PHARMACEUT, V274, P41, DOI 10.1016/j.ijpharm.2003.12.029
   Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8
   Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999
   Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200
   Criswell T, 2003, CANCER BIOL THER, V2, P372, DOI 10.4161/cbt.2.4.430
   De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495
   Devroe E, 2004, EXPERT OPIN BIOL TH, V4, P319, DOI 10.1517/14712598.4.3.319
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3
   Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101
   Gleave ME, 2001, UROLOGY, V58, P39, DOI 10.1016/S0090-4295(01)01241-9
   Itaka K, 2004, J AM CHEM SOC, V126, P13612, DOI 10.1021/ja047174r
   Izawa M, 1998, BIOCHEM MOL BIOL INT, V44, P9
   July LV, 2004, MOL CANCER THER, V3, P223
   Klokov D, 2004, MUTAT RES-FUND MOL M, V568, P97, DOI 10.1016/j.mrfmmm.2004.06.049
   Kunath K, 2002, PHARMACEUT RES, V19, P810, DOI 10.1023/A:1016152831963
   LAPING NJ, 1994, NEUROSCIENCE, V58, P563, DOI 10.1016/0306-4522(94)90081-7
   Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200
   LITTLE SA, 1995, TERATOLOGY, V52, P41, DOI 10.1002/tera.1420520106
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725
   PEATFIELD RC, 1991, MOV DISCORD, V6, P9
   Petersen H, 2002, BIOCONJUGATE CHEM, V13, P845, DOI 10.1021/bc025529v
   Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0
   Schiffelers RM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh140
   SUH J, 1994, BIOORG CHEM, V22, P318, DOI 10.1006/bioo.1994.1025
   WELSH J, 1994, BIOCHEM CELL BIOL, V72, P537, DOI 10.1139/o94-072
   Yang CR, 2000, P NATL ACAD SCI USA, V97, P5907, DOI 10.1073/pnas.97.11.5907
   Zauner W, 2001, J CONTROL RELEASE, V71, P39, DOI 10.1016/S0168-3659(00)00358-8
   Zellweger T, 2003, BJU INT, V92, P463, DOI 10.1046/j.1464-410X.2003.04349.x
   Zellweger T, 2002, CLIN CANCER RES, V8, P3276
NR 34
TC 38
Z9 39
U1 0
U2 21
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1176-9114
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2006
VL 1
IS 2
BP 155
EP 162
DI 10.2147/nano.2006.1.2.155
PG 8
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 246ZU
UT WOS:000252047700005
PM 17722531
OA DOAJ Gold, Green Published
DA 2020-12-16
ER

PT J
AU Marques, JT
   Williams, BRG
AF Marques, JT
   Williams, BRG
TI Activation of the mammalian immune system by siRNAs
SO NATURE BIOTECHNOLOGY
LA English
DT Review
ID DOUBLE-STRANDED-RNA; PLASMACYTOID DENDRITIC CELLS; TOLL-LIKE RECEPTORS;
   CPG-DNA; DEPENDENT STIMULATION; STRUCTURAL FEATURES; INTERFERING RNA;
   GENE-EXPRESSION; NUCLEIC-ACIDS; MESSENGER-RNA
AB Inhibition of gene expression through RNA interference (RNAi) is emerging as a powerful experimental tool for gene function and target validation studies. The potential uses of this technology seem unlimited, extending to the prevention and therapy of human diseases. However, recent work demonstrating that there are unanticipated, different nonspecific effects associated with the use of small interfering RNAs in mammals has raised concerns about the safe use of RNAi in vivo. These nonspecific effects include activation of the immune system, potentially harming the individual. The application of screening assays for nonspecific activation of both innate and acquired immunity will be necessary for further development of RNAi as a therapeutic tool.
C1 Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA.
RP Williams, BRG (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.
EM williab@ccf.org
RI Marques, Joao T/F-7683-2012; Williams, Bryan R. G./A-5021-2009
OI Marques, Joao T/0000-0002-3457-3320; Williams, Bryan R.
   G./0000-0002-4969-1151
FU NCI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01
   CA62220] Funding Source: Medline; NIAID NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R01
   AI34039] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI034039, R01AI034039, R01AI034039,
   R01AI034039, R01AI034039, R01AI034039, R01AI034039, R01AI034039,
   R01AI034039, R01AI034039, R01AI034039, R01AI034039, R01AI034039,
   R01AI034039, R01AI034039] Funding Source: NIH RePORTER
CR Agrawal S, 2004, NAT BIOTECHNOL, V22, P1533, DOI 10.1038/nbt1042
   Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101
   Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874
   Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043
   Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942
   Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798
   Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551
   Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703
   Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4
   Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253
   Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259
   Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636
   Heidel JD, 2004, NAT BIOTECHNOL, V22, P1579, DOI 10.1038/nbt1038
   Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238
   Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620
   Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547
   Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191
   Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935
   Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531
   Ishii KJ, 2005, INT J CANCER, V117, P517, DOI 10.1002/ijc.21402
   Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207
   Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112
   Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081
   Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008
   Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200
   Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545
   KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994
   KARLIN S, 1995, TRENDS GENET, V11, P283
   Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010
   Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940
   Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644
   Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5
   Koski GK, 2004, J IMMUNOL, V172, P3989, DOI 10.4049/jimmunol.172.7.3989
   KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0
   Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516
   Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200
   Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633
   Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154
   Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883
   Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873
   Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872
   Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093
   Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122
   Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977
   Obika S, 1998, TETRAHEDRON LETT, V39, P5401, DOI 10.1016/S0040-4039(98)01084-3
   Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401
   Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904
   Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102
   Robinson R, 2004, PLOS BIOL, V2, P18, DOI 10.1371/journal.pbio.0020028
   Rossi M, 2005, J IMMUNOL, V175, P1373, DOI 10.4049/jimmunol.175.3.1373
   Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Scheel B, 2005, EUR J IMMUNOL, V35, P1557, DOI 10.1002/eji.200425656
   Sen G, 2004, CELL IMMUNOL, V232, P64, DOI 10.1016/j.cellimm.2005.01.010
   Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC
   Sioud M, 2003, BIOCHEM BIOPH RES CO, V312, P1220, DOI 10.1016/j.bbrc.2003.11.057
   Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013
   Sledz CA, 2005, BLOOD, V106, P787, DOI 10.1182/blood-2004-12-4643
   Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038
   Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121
   Sugiyama T, 2005, J IMMUNOL, V174, P2273, DOI 10.4049/jimmunol.174.4.2273
   Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186
   Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105
   Verthelyi D, 2001, J IMMUNOL, V166, P2372, DOI 10.4049/jimmunol.166.4.2372
   Verthelyi D, 2003, TRENDS IMMUNOL, V24, P519, DOI 10.1016/S1471-4906(03)00243-6
   Whitmore MM, 2004, CANCER RES, V64, P5850, DOI 10.1158/0008-5472.CAN-04-0063
   Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2
   Yang SC, 2001, MOL CELL BIOL, V21, P7807, DOI 10.1128/MCB.21.22.7807-7816.2001
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
NR 75
TC 250
Z9 266
U1 1
U2 14
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD NOV
PY 2005
VL 23
IS 11
BP 1399
EP 1405
DI 10.1038/nbt1161
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 984FN
UT WOS:000233288000035
PM 16273073
DA 2020-12-16
ER

PT J
AU Marques, JT
   Rebouillat, D
   Ramana, CV
   Murakami, J
   Hill, JE
   Gudkov, A
   Silverman, RH
   Stark, GR
   Williams, BRG
AF Marques, JT
   Rebouillat, D
   Ramana, CV
   Murakami, J
   Hill, JE
   Gudkov, A
   Silverman, RH
   Stark, GR
   Williams, BRG
TI Down-regulation of p53 by double-stranded RNA modulates the antiviral
   response
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID TUMOR-SUPPRESSOR P53; PROTEIN-KINASE PKR; NF-KAPPA-B; VACCINIA VIRUS;
   ENCEPHALOMYOCARDITIS VIRUS; P53-DEPENDENT APOPTOSIS; SV40-TRANSFORMED
   CELLS; INTERFERON ACTION; VIRAL-INFECTION; INNATE IMMUNITY
AB p53 has been well characterized as a tumor suppressor gene, but its role in antiviral defense remains unclear. A recent report has demonstrated that p53 can be induced by interferons and is activated after vesicular stomatitis virus (VSV) infection. We observed that different nononcogenic viruses, including encephalomyocarditis virus (EMCV) and human parainfluenza virus type 3 (HPIV3), induced down-regulation of p53 in infected cells. Double-stranded RNA (dsRNA) and a mutant vaccinia virus lacking the dsRNA binding protein E3L can also induce this effect, indicating that dsRNA formed during viral infection is likely the trigger for down-regulation of p53. The mechanism of down-regulation of p53 by dsRNA relies on translation inhibition mediated by the PKR and RNase L pathways. In the absence of p53, the replication of both EMCV and HPIV3 was retarded, whereas, conversely, VSV replication was enhanced. Cell cycle analysis indicated that wild-type (WT) but not p53 knockout (KO) fibroblasts undergo an early-G(1) arrest following dsRNA treatment. Moreover, in WT cells the onset of dsRNA-induced apoptosis begins after p53 levels are down-regulated, whereas p53 KO cells, which lack the early-G(1) arrest, rapidly undergo apoptosis. Hence, our data suggest that the down-regulation of p53 facilitates apoptosis, thereby limiting viral replication.
C1 Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA.
   Cleveland Clin Fdn, Dept Mol Biol, Lerner Res Inst, Cleveland, OH 44195 USA.
   Yale Univ, Dept Med, New Haven, CT 06516 USA.
   Mazda Hosp, Dept Obstet & Gynecol, Fuchu, Hiroshima 7358585, Japan.
RP Williams, BRG (corresponding author), Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.
EM williab@ccf.org
RI Marques, Joao T/F-7683-2012; Williams, Bryan R. G./A-5021-2009
OI Marques, Joao T/0000-0002-3457-3320; Williams, Bryan R.
   G./0000-0002-4969-1151; Hill, Jason/0000-0003-2512-1661; chilakamarti,
   ramana/0000-0002-5153-8252; Gudkov, Andrei/0000-0003-2548-0154
FU NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220, P01CA062220, P01CA062220,
   P01CA062220, P01CA062220, P01CA062220] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI034039, R01AI034039, R01AI034039, R01AI034039, R01AI034039,
   R01AI034039, R01AI034039, R01AI034039, R01AI034039, R01AI034039,
   R01AI034039, R01AI034039, R01AI034039, R01AI034039, R01AI034039] Funding
   Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) [P01 CA062220, P01 CA62220] Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI34039, R01 AI034039]
   Funding Source: Medline
CR Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012
   Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5
   Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173
   Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569
   Collot-Teixeira S, 2004, REV MED VIROL, V14, P301, DOI 10.1002/rmv.431
   Cuddihy AR, 1999, MOL CELL BIOL, V19, P2475
   Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620
   da Fonseca FG, 1999, VIRUS GENES, V18, P151, DOI 10.1023/A:1008072720217
   Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279
   DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0
   Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0
   Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9
   Gurova KV, 2004, CANCER RES, V64, P1951, DOI 10.1158/0008-5472.CAN-03-1541
   HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225
   Hirasawa K, 2003, CANCER RES, V63, P348
   HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840
   Huang S, 2004, CELL CYCLE, V3, P1043
   Huang S, 2003, ONCOGENE, V22, P3721, DOI 10.1038/sj.onc.1206490
   Hummer BT, 2001, J VIROL, V75, P7774, DOI 10.1128/JVI.75.16.7774-7777.2001
   Ikeda K, 1999, NAT MED, V5, P881, DOI 10.1038/11320
   Kibler KV, 1997, J VIROL, V71, P1992, DOI 10.1128/JVI.71.3.1992-2003.1997
   LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0
   Leaman DW, 1998, P NATL ACAD SCI USA, V95, P9442, DOI 10.1073/pnas.95.16.9442
   LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9
   Nemunaitis J, 2000, CANCER RES, V60, P6359
   Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x
   Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199
   Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804
   Raj K, 2001, NATURE, V412, P914, DOI 10.1038/35091082
   RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z
   Roth MD, 2002, J IMMUNOL, V169, P4651, DOI 10.4049/jimmunol.169.8.4651
   Santos CR, 2004, VIROLOGY, V328, P254, DOI 10.1016/j.virol.2004.08.013
   Schwarz EM, 1998, J VIROL, V72, P5654, DOI 10.1128/JVI.72.7.5654-5660.1998
   Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200
   Smith JA, 2005, J VIROL, V79, P2240, DOI 10.1128/JVI.79.4.2240-2250.2005
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1
   Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850
   Weaver BK, 2001, FASEB J, V15, P501, DOI 10.1096/fj.00-0222com
   WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286
   Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2
   Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002
   Yeung MC, 1999, P NATL ACAD SCI USA, V96, P11860, DOI 10.1073/pnas.96.21.11860
   Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355
   Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738
NR 45
TC 53
Z9 58
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2005
VL 79
IS 17
BP 11105
EP 11114
DI 10.1128/JVI.79.17.11105-11114.2005
PG 10
WC Virology
SC Virology
GA 956ML
UT WOS:000231303900025
PM 16103161
OA Bronze, Green Published
DA 2020-12-16
ER

PT J
AU Trindade, GS
   da Fonseca, FG
   Marques, JT
   Diniz, S
   Leite, JA
   De Bodt, S
   Van der Peer, Y
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Trindade, GS
   da Fonseca, FG
   Marques, JT
   Diniz, S
   Leite, JA
   De Bodt, S
   Van der Peer, Y
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
TI Belo Horizonte virus: a vaccinia-like virus lacking the A-type inclusion
   body gene isolated from infected mice
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID EVOLUTIONARY DISTANCE; PROTEIN; SEQUENCE; MOUSEPOX; COWPOX; DNA;
   ALIGNMENT; POXVIRUS; HUMANS; GENOME
AB Here is described the isolation of a naturally occurring A-type inclusion body (ATI)-negative vaccinia-like virus, Belo Horizonte virus (VBH), obtained from a mousepox-like outbreak in Brazil. The isolated virus was identified and characterized as an orthopoxvirus by conventional methods. Molecular characterization of the virus was done by DNA cross-hybridization using Vaccinia virus (VACV) DNA. In addition, conserved orthopoxvirus genes such as vaccinia growth factor, thymidine kinase and haemagglutinin were amplified by PCR and sequenced. All sequences presented high similarity to VACV genes. Based on the sequences, phenograms were constructed for comparison with other poxviruses; VBH clustered consistently with VACV strains. Attempts to amplify the ATI gene (ati) by PCR, currently used to identify orthopoxviruses, were unsuccessful. Results presented here suggest that most of the ati gene is deleted in the VBH genome.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   State Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.
   Cleveland Clin Fdn, Dept Canc Biol, Cleveland, OH 44195 USA.
   Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Imunol Celular & Mol, BR-30190002 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Biol Microorganismos, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Ave Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@icb.ufmg.br
RI Marques, Joao T/F-7683-2012; Kroon, Erna Geessien/B-3631-2015; Kroon,
   Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014
OI Marques, Joao T/0000-0002-3457-3320; Kroon, Erna
   Geessien/0000-0003-2721-3826; 
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   da Fonseca FG, 1999, VIRUS GENES, V18, P151, DOI 10.1023/A:1008072720217
   da Fonseca FG, 1998, ARCH VIROL, V143, P1171
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   Diniz S, 2001, ARQ BRAS MED VET ZOO, V53, P152, DOI 10.1590/S0102-09352001000200003
   ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4
   FENNER F, 1989, ORTHOPOXVIRUSES, P317
   FUNAHASHI S, 1988, J GEN VIROL, V69, P35, DOI 10.1099/0022-1317-69-1-35
   GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2
   HALL TA, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.5598/IMAFUNGUS.2011.02.02.06
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hazel SM, 2000, EPIDEMIOL INFECT, V124, P551, DOI 10.1017/S0950268899003799
   JOHNSON GP, 1993, VIROLOGY, V196, P381, DOI 10.1006/viro.1993.1494
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   JUKES TH, 1969, MAMMALIAN PROTEIN ME, V3, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   MASSUNG RF, 1991, VIROLOGY, V180, P347, DOI 10.1016/0042-6822(91)90039-E
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   MEYER H, 1994, J GEN VIROL, V75, P1975, DOI 10.1099/0022-1317-75-8-1975
   Neubauer H, 1997, LAB ANIM, V31, P201, DOI 10.1258/002367797780596275
   OSTERRIEDER N, 1994, VIRUS GENES, V8, P125, DOI 10.1007/BF01703611
   RAES J, 1999, EMBNET NEWS, V6
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sambrook J., 1989, MOL CLONING LAB MANU, V2
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664
   SWOFFORD DL, 1998, PAUL ASTERISK PHYLOG
   TAJIMA F, 1984, MOL BIOL EVOL, V1, P269
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trindade GD, 2003, EMERG INFECT DIS, V9, P155
   vandePeer Y, 1997, COMPUT APPL BIOSCI, V13, P227
NR 36
TC 29
Z9 31
U1 0
U2 6
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD JUL
PY 2004
VL 85
BP 2015
EP 2021
DI 10.1099/vir.0.79840-0
PN 7
PG 7
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA 837ML
UT WOS:000222639500024
PM 15218187
OA Bronze
DA 2020-12-16
ER

PT J
AU Trindade, GD
   da Fonseca, FG
   Marques, JT
   Nogueira, ML
   Mendes, LCN
   Borges, AS
   Peiro, JR
   Pituco, EM
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Trindade, GD
   da Fonseca, FG
   Marques, JT
   Nogueira, ML
   Mendes, LCN
   Borges, AS
   Peiro, JR
   Pituco, EM
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
TI Aracatuba virus: A vaccinialike m virus associated with infection in
   humans and cattle
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; RIO-DE-JANEIRO; MOLECULAR CHARACTERIZATION;
   POXVIRUS; ORTHOPOXVIRUS; STATE; DIFFERENTIATION; BEAN-58058; SMALLPOX;
   PROTEIN
AB We describe a vaccinialike virus, Aragatuba virus, associated with a cowpoxlike outbreak in a dairy herd and a related case of human infection. Diagnosis was based on virus growth characteristics, electron microscopy, and molecular biology techniques. Molecular characterization of the virus was done by using polymerase chain reaction amplification, cloning, an DNA sequencing of conserved orthopoxvirus genes such as the vaccinia growth factor (VGF), thymidine kinase (TK), and hemagglutinin. We used VGF-homologous and TK gene nucleoticle sequences to construct a phylogenetic tree for comparison with other poxviruses. Gene sequences showed 99% homology with vaccinia virus genes and were clustered together with the isolated virus in the phylogenetic tree. Aragatuba virus is very similar to Cantagalo virus, showing the same signature deletion in the gene. Aragatuba virus could be a novel vaccinialike virus or could represent the spread of Cantagalo virus.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   NIH, Bethesda, MD 20892 USA.
   Univ Estadual Paulista, Sao Paulo, Brazil.
   Inst Biol, Sao Paulo, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
RI Mendes, Luiz Claudio Nogueira/N-2232-2019; Nogueira, Mauricio
   L/B-7599-2012; Marques, Joao T/F-7683-2012; Peiro, Juliana/C-4880-2012;
   Mendes, Luiz Claudio/B-8095-2012; Borges, Alexandre S/B-5506-2013;
   Bonjardim, Claudio A/J-2601-2014; Kroon, Erna/V-5444-2019; Pituco,
   Edviges Maristela/J-2424-2012; Kroon, Erna/B-3631-2015
OI Mendes, Luiz Claudio Nogueira/0000-0002-7696-6018; Nogueira, Mauricio
   L/0000-0003-1102-2419; Marques, Joao T/0000-0002-3457-3320; Mendes, Luiz
   Claudio/0000-0002-7696-6018; Pituco, Edviges
   Maristela/0000-0003-1469-9257; Kroon, Erna/0000-0003-2721-3826; Secorun
   Borges, Alexandre/0000-0001-6256-8089
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   BLOOD DC, 1979, CAN VET J, V20, P341
   BRENNER S, 1959, BIOCHIM BIOPHYS ACTA, V34, P103, DOI 10.1016/0006-3002(59)90237-9
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   DUMBELL K, 1993, ARCH VIROL, V128, P257, DOI 10.1007/BF01309438
   ESPOSITO JJ, 1980, J GEN VIROL, V47, P37, DOI 10.1099/0022-1317-47-1-37
   FENNER F, 1989, ORTHOPOXVIRUSES, P317
   Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365
   GIBBS EPJ, 1973, VET REC, V92, P56, DOI 10.1136/vr.92.3.56
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   LAUDER IM, 1971, VET REC, V89, P571, DOI 10.1136/vr.89.22.571
   LUM GS, 1967, AM J TROP MED HYG, V16, P332, DOI 10.4269/ajtmh.1967.16.332
   Marques JT, 2001, VIRUS GENES, V23, P291, DOI 10.1023/A:1012521322845
   MAZUR C, 1989, VET REC, V125, P419, DOI 10.1136/vr.125.16.419
   Mazur C, 2000, VET MICROBIOL, V73, P253, DOI 10.1016/S0378-1135(99)00151-0
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   MEYER H, 1994, J GEN VIROL, V75, P1975, DOI 10.1099/0022-1317-75-8-1975
   Moss B, 1996, FIELDS VIROLOGY, V2, P2637
   REIS R, 1970, ARQUIVOS DA ESCOLA DE VETERINARIA UNIVERSIDADE FEDERAL DE MINAS GERAIS, V22, P213
   ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P625, DOI 10.1590/S0074-02762000000500007
   SILVA P L D, 1986, Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, V38, P323
   Topciu V, 1976, Virologie, V27, P279
   Tryland M, 1998, J WILDLIFE DIS, V34, P240, DOI 10.7589/0090-3558-34.2.240
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
   VANBRESSEM MF, 1993, J WILDLIFE DIS, V29, P109, DOI 10.7589/0090-3558-29.1.109
   VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569
NR 30
TC 103
Z9 106
U1 0
U2 0
PU CENTER DISEASE CONTROL
PI ATLANTA
PA ATLANTA, GA 30333 USA
SN 1080-6040
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2003
VL 9
IS 2
BP 155
EP 160
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 646KR
UT WOS:000181034600002
PM 12603984
OA DOAJ Gold
DA 2020-12-16
ER

PT J
AU Marques, JT
   Trindade, GD
   Da Fonseca, FG
   Dos Santos, JR
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
AF Marques, JT
   Trindade, GD
   Da Fonseca, FG
   Dos Santos, JR
   Bonjardim, CA
   Ferreira, PCP
   Kroon, EG
TI Characterization of ATI, TK and IFN-alpha/beta R genes in the genome of
   the BeAn 58058 virus, a naturally attenuated wild Orthopoxvirus
SO VIRUS GENES
LA English
DT Article
DE BeAn 58058 virus; B18R gene; ATI; TK; vaccinia virus; IFN-alpha/beta R
ID INCLUSION-BODY; VACCINIA; INTERFERON; POXVIRUS; REPLICATION; PROTEIN;
   CELLS; RECEPTOR; STRAINS; ENCODES
AB The lack of knowledge about the natural host of Vaccinia virus (VV) along with the description of human infections caused by poxviruses after smallpox eradication has increased the need to characterize poxviruses isolated from the wild. Moreover, in the past years poxviruses have been widely studied as potential vaccination tools, with the discovery of several genes implicated in the evasion of the host immune response involved in virus pathogenesis. Among them, an Interferon (IFN)-binding protein was identified in the supernatant of VV strain WR infected cells coded by the B18R gene. It was shown that many other Orthopoxviruses also encode and express this soluble receptor although some VV strains such as Lister and modified Ankara, which were less reactogenic vaccines, do not. The BeAn 58058 virus (BAV) has been recently characterized and proposed to be an Orthopoxvirus. BAV was also shown to be less virulent in animal models than VV Lister. Here we report the identification of an IFN-alpha/betaR gene in the BAV genome with 99% of sequence identity with the VVWR B18R gene. The identified gene encodes a B18R-like IFN binding protein as demonstrated by its capacity to inhibit the IFN-mediated protection of VERO cells against EMC virus. In order to better characterize the virus we have searched for the A type inclusion body (ATI) gene currently used in the classification of Orthopoxviruses but did not detect it in the BAV genome. We have also sequenced the BAV thymidine kinase (TK) gene, a poxvirus-conserved gene, which, as expected, showed high homology with the TK gene of other poxviruses. Phylogenetic trees were constructed based on sequences of the IFN-alpha/betaR and TK genes from several poxviruses and in both cases BAV was placed in the same cluster as other VV strains. These observations strengthened the hypothesis that this virus is a variant of the VV vaccine used in Brazil. However the explanation for the BAV lack of virulence remains to be discovered.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 2496, BR-31270901 Belo Horizonte, MG, Brazil.
EM kroone@mono.icb.ufmg.br
RI Kroon, Erna/V-5444-2019; Bonjardim, Claudio A/J-2601-2014; Kroon, Erna
   Geessien/B-3631-2015; Marques, Joao T/F-7683-2012
OI Kroon, Erna Geessien/0000-0003-2721-3826; Marques, Joao
   T/0000-0002-3457-3320
CR ALCAMI A, 1995, IMMUNOL TODAY, V16, P474, DOI 10.1016/0167-5699(95)80030-1
   Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   AMANO H, 1979, J GEN VIROL, V44, P265, DOI 10.1099/0022-1317-44-1-265
   BAXBY D, 1977, ARCH VIROL, V55, P169, DOI 10.1007/BF01319903
   BAXBY D, 1986, LANCET, V2, P850
   Bender BS, 1996, J VIROL, V70, P6418, DOI 10.1128/JVI.70.9.6418-6424.1996
   BLACK ME, 1992, J BIOL CHEM, V267, P9743
   Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159
   Boulanger D, 1996, VET REC, V138, P247, DOI 10.1136/vr.138.11.247
   BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991
   CAMPOS MAD, 1993, REV MICROBIOL, V24, P104
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974
   da Fonseca FG, 1998, ARCH VIROL, V143, P1171
   Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603
   ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4
   ESPOSITO JJ, 1980, J GEN VIROL, V47, P37, DOI 10.1099/0022-1317-47-1-37
   FERREIRA PCP, 1979, J CLIN MICROBIOL, V9, P471
   FUNAHASHI S, 1988, J GEN VIROL, V69, P35, DOI 10.1099/0022-1317-69-1-35
   INNIS MA, 1990, OPTIMIZATION PERS, P3
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   Mayr A, 1975, INFECTION, V3, P6, DOI DOI 10.1007/BF01641272
   Men R, 2000, VACCINE, V18, P3113, DOI 10.1016/S0264-410X(00)00121-3
   Meyer H, 1997, J VIROL METHODS, V64, P217, DOI 10.1016/S0166-0934(96)02155-6
   Miller CG, 1997, VIROLOGY, V229, P126, DOI 10.1006/viro.1996.8396
   MOSS B, 1990, ANNU REV BIOCHEM, V59, P661, DOI 10.1146/annurev.bi.59.070190.003305
   Nam JH, 1999, VACCINE, V17, P261, DOI 10.1016/S0264-410X(98)00156-X
   Ourmanov I, 2000, J VIROL, V74, P2740, DOI 10.1128/JVI.74.6.2740-2751.2000
   Sambrook J, 1989, MOL CLONING LAB MANU
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Smith GL, 1996, CURR OPIN IMMUNOL, V8, P467, DOI 10.1016/S0952-7915(96)80032-X
   Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x
   STUBER D, 1990, IMMUNOLOGICAL METHOD, V4, P121
   SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847
   SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4
   UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263
   VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569
   WOODAL JP, 1967, S A BIOT AM BEL, P31
   Wyatt LS, 1998, VIROLOGY, V251, P334, DOI 10.1006/viro.1998.9397
   Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2
NR 42
TC 18
Z9 20
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PY 2001
VL 23
IS 3
BP 291
EP 301
DI 10.1023/A:1012521322845
PG 11
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA 490BZ
UT WOS:000172031600006
PM 11778697
DA 2020-12-16
ER

PT J
AU da Fonseca, FG
   Silva, RLA
   Marques, JT
   Ferreira, PCP
   Kroon, EG
AF da Fonseca, FG
   Silva, RLA
   Marques, JT
   Ferreira, PCP
   Kroon, EG
TI The genome of cowpox virus contains a gene related to those encoding the
   epidermal growth factor, transforming growth factor alpha and vaccinia
   growth factor
SO VIRUS GENES
LA English
DT Article
DE cowpox virus; growth factor; VGF; CGF; cowpox gene; virokine
ID INTERLEUKIN-1-BETA CONVERTING-ENZYME; TUMORIGENIC POXVIRUS; SWINEPOX
   VIRUS; IMMUNE EVASION; MYXOMA VIRUS; PROTEIN; SEQUENCE; DNA; RECEPTOR;
   SERPIN
AB Cowpox virus (CPV) is a member of the Orthopoxvirus genus and has the genetic capacity to encode a multitude of genes that interfere with the host inflammatory and immune response or modulate the physiological state of infected and non-infected cells. Among these CPV factors are receptors homologous to interferon and tumor necrosis factor receptors and also a viral cellular serine-proteinase analog. Here we describe the detection of a CPV gene that encodes a protein homologous to epidermal growth factor, transforming growth factor alpha and poxvirus growth factors, such as the vaccinia growth factor (VGF). The VGF and other poxvirus growth factors are produced early in the infection and are secreted into the medium where they bind to the EGF receptors, generating mytotic responses. The cowpox growth factor (CGF) gene was detected in three copies on the virus genome by PCR, and by northern and southern blot hybridization using VGF nucleotide sequences as primers and probes. The CPV gene has a strong nucleotide and predicted amino acid similarity with VGF, and is also produced early in the infection.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, BR-31270901 Belo Horizonte, MG, Brazil.
RP Kroon, EG (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Virus Lab, Av Antonio Carlos 6627,Caixa Postal 2496, BR-31270901 Belo Horizonte, MG, Brazil.
RI Kroon, Erna/V-5444-2019; Marques, Joao T/F-7683-2012; Kroon, Erna
   Geessien/B-3631-2015
OI Marques, Joao T/0000-0002-3457-3320; Kroon, Erna
   Geessien/0000-0003-2721-3826
CR ALCAMI A, 1995, IMMUNOL TODAY, V16, P474, DOI 10.1016/0167-5699(95)80030-1
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   ARCHARD LC, 1984, J GEN VIROL, V65, P875, DOI 10.1099/0022-1317-65-5-875
   Bennett M, 1996, J MED MICROBIOL, V45, P157, DOI 10.1099/00222615-45-3-157
   BLOMQUIST MC, 1984, P NATL ACAD SCI-BIOL, V81, P7363, DOI 10.1073/pnas.81.23.7363
   BROWN JP, 1985, NATURE, V313, P491, DOI 10.1038/313491a0
   BULLER RML, 1988, VIROLOGY, V164, P162
   CHANG W, 1987, MOL CELL BIOL, V7, P535, DOI 10.1128/MCB.7.1.535
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DEFILIPPES FM, 1982, J VIROL, V43, P136, DOI 10.1128/JVI.43.1.136-149.1982
   Fenner F., 1989, The orthopoxviruses., P171
   GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2
   HU FQ, 1994, VIROLOGY, V204, P343, DOI 10.1006/viro.1994.1539
   JAMES R, 1984, ANNU REV BIOCHEM, V53, P259
   JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1
   KING CS, 1986, MOL CELL BIOL, V6, P332, DOI 10.1128/MCB.6.1.332
   KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331
   MASSUNG RF, 1991, VIROLOGY, V180, P347, DOI 10.1016/0042-6822(91)90039-E
   Massung RF, 1996, VIROLOGY, V221, P291, DOI 10.1006/viro.1996.0378
   MASSUNG RF, 1993, NATURE, V366, P748, DOI 10.1038/366748a0
   MASSUNG RF, 1993, VIROLOGY, V197, P511, DOI 10.1006/viro.1993.1625
   MASSUNG RF, 1994, VIROLOGY, V201, P215, DOI 10.1006/viro.1994.1288
   McFadden G, 1995, VIROCEPTORS VIROKINE, P1
   Miller CG, 1997, VIROLOGY, V229, P126, DOI 10.1006/viro.1996.8396
   MOSSMAN K, 1995, VIROLOGY, V208, P762, DOI 10.1006/viro.1995.1208
   OPGENORTH A, 1993, VIROLOGY, V192, P701, DOI 10.1006/viro.1993.1092
   PICKUP DJ, 1986, P NATL ACAD SCI USA, V83, P7698, DOI 10.1073/pnas.83.20.7698
   PICKUP DJ, 1984, P NATL ACAD SCI-BIOL, V81, P6817, DOI 10.1073/pnas.81.21.6817
   QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377
   RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y
   REISNER AH, 1985, NATURE, V313, P801, DOI 10.1038/313801a0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHULTZ GS, 1987, SCIENCE, V235, P350, DOI 10.1126/science.3492044
   Senkevich TG, 1996, SCIENCE, V273, P813, DOI 10.1126/science.273.5276.813
   SMITH GL, 1991, J GEN VIROL, V72, P511, DOI 10.1099/0022-1317-72-3-511
   Smith GL, 1996, CURR OPIN IMMUNOL, V8, P467, DOI 10.1016/S0952-7915(96)80032-X
   Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x
   SMITH GL, 1993, J GEN VIROL, V74, P1725, DOI 10.1099/0022-1317-74-9-1725
   SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F
   STROOBANT P, 1985, CELL, V42, P383, DOI 10.1016/S0092-8674(85)80133-1
   SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4
   TEWARI M, 1995, J BIOL CHEM, V270, P22705, DOI 10.1074/jbc.270.39.22705
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   UPTON C, 1987, J VIROL, V61, P1271, DOI 10.1128/JVI.61.4.1271-1275.1987
   UPTON C, 1991, VIROLOGY, V184, P370, DOI 10.1016/0042-6822(91)90853-4
   VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569
   VENKATESAN S, 1982, J VIROL, V44, P637, DOI 10.1128/JVI.44.2.637-646.1982
   VONHERRATH MG, 1995, TRENDS MICROBIOL, V3, P424, DOI 10.1016/S0966-842X(00)88995-7
NR 48
TC 15
Z9 15
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0920-8569
J9 VIRUS GENES
JI Virus Genes
PD APR
PY 1999
VL 18
IS 2
BP 151
EP 160
DI 10.1023/A:1008072720217
PG 10
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA 203ZB
UT WOS:000080737100007
PM 10403701
DA 2020-12-16
ER

EF